{"custom_id":"syn24875850","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn24875850\n\n\n# DNA methylation signatures in peripheral leukocytes of patients with Schwannomatosis or sporadic schwannoma\n\n## Opening the Data Drawers Initiative\n### Principal Investigator: Dr. Gelareh Zadeh\n### Institution: University Health Network of Toronto\n\n### Project Description: \nAberrant DNA methylation is associated with cancer development and progression. There are several types of specimens from which DNA methylation patterns can be measured and evaluated as an indicator of disease status (from normal biological process to pathologic condition) and even of pharmacologic response to therapy. Blood-based specimens such as cell-free circulating nucleic acid and DNA extracted from leukocytes in peripheral blood may be a potential source of non-invasive cancer biomarkers. As part of our synodos for schwannomatosis study we focused on multiplatform genomic analysis of schwannomatosis related schwannomas. We also performed DNA methylation profiling on whole genomic DNA isolated from peripheral blood leukocytes from 27 schwannomatosis patients and 22 patients with sporadic non-syndromic schwannomas. This analysis was outside the scope of the synodos for schwannomatosis study; however, we were interested in evaluating the proportion of immune cell types in the blood of patients with peripheral nerve sheath tumors including schwannomatosis patients. After performing QC analysis, we removed 5 schwannomatosis samples (failed QC: detp>0.05). We then Removed 176834 failed probes (detp>0.05), 12613 probes on the X and Y sex chromosomes, 23507 probes associated with SNPs at the CpG sites, and 24267 cross-reactive probes. Total 630553 probes were left for clustering analysis. We then performed cell deconvolution analysis using IDOLOptimizedCpGs method  to determine the proportion of immune cell types in blood of patients with schwannomatosis or non-syndromic sporadic schwannomas including neutrophils, monocytes, CD4 T cells, CD8 T cells, B cells and NK cells. We then clustered the samples based on immune cell proportions. We found that schwannomatosis samples clustered separate from sporadic schwannomas. Our results suggested that schwannomatosis patients harboured a higher neutrophil to lymphocyte ratio (NLR) compared to schwannomas. Further studies are required to determine the clinical implications of this result, in addition to continued work to uncover the biological underpinnings of these differences among these syndromic and non-syndromic disorders.\n\n### Quality Assurance of the Data:\n\nAll data was processed using appropriate DNA methylation analysis pipelines including minfi from Bioconductor. We performed in-depth QC analysis as described above. Samples that did not meet our QC threshold were removed. All failed probes and probes associated with SNPs, X/Y chromosomes, and cross-reactive probes were also removed. Detailed QC results and associated graphs are ready available for uploading upon request.\n\n\n## Tables for Curation\n1. ID: syn65467791\nName: DNA methylation signatures in peripheral leukocytes of patients with Schwannomatosis or sporadic schwannoma\nSummary:\n- Assays: methylation array, \n- Species: Homo sapiens, \n- Individual count: 54\n- Specimen count: 54\n- Diagnoses present: Sporadic Schwannoma, Schwannomatosis, \n- Tumor types present: Not Applicable, \n- Data types: chromatinActivity, \n- File formats present: idat, \n- Funders: CTF\n- Contains data created by: Sheila Mansouri, Robert Allaway\n- Example files present: 201536580019_R08C01_Grn.idat, 201536580019_R08C01_Red.idat, 201536580019_R07C01_Grn.idat, 201536580019_R07C01_Red.idat, 201536580019_R06C01_Grn.idat\n\n\n"}]}]}}
{"custom_id":"syn21355225","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn21355225\n\n# Evaluation of the use of antisense oligonucleotides as a personalized therapy for Neurofibromatosis Type 2 patients\n## Children's Tumor Foundation DDI\n\n### Principal Investigator: Dr. Elisabeth Castellanos\n### Project Lead / Data Coordinator: TBD\n### Institution: Germans Trias I Pujol Research Institute (IGTP) & Hospital Universitari Germans Trias i Pujol (HUGTP)\n\n### Project Description: \nNeurofibromatosis type 2 (NF2) is a devastating genetic condition, characterized by the development of multiple tumors of the nervous system for which effective therapeutic options with no adverse consequences need to be developed. The clinical presentation of the disease is variable and related to the type of constitutional mutation in the _NF2_ gene inherited: patients affected with truncating mutations have a more severe form of the disease, while patients with missense, splicing or large deletions present a milder phenotype. \n\nIn this context, the development of personalized therapies based on the type of _NF2_ mutation constitutes an opportunity. One of the therapeutic approaches that are being successfully developed for different hereditary diseases are therapies that act at the RNA level. Currently, it is possible to design antisense oligonucleotides (AONs) able to correct the effect of deleterious DNA mutations at the protein level, or to create proteins that still retain partial function from loss-of-function mutated alleles. AONs could be used to force the skipping of exons carrying truncating mutations when the reading frame is maintained. In this way, mutations that are associated to severe phenotypes could potentially be modified to less deleterious forms, associated to milder phenotypes. The NF2 gene is made up of 17 exons, 9 of them being in frame. Taken together, approximately 45% of the mutations detected in the NF2 gene could be susceptible to be treated by antisense therapy.\n\nHere we propose to evaluate the use of AONs to reduce the severity of _NF2_ truncating and splicing mutations to milder hypomorphic forms _in vitro_. In addition, we hope to recover merlin function in cases where splicing mutation could be corrected. Based on our previous studies, we will induce skipping of in frame exons in primary fibroblasts derived from NF2 patients carrying truncating, splicing and missense mutations using specific AONs for each exon. The effect on merlin activity will be analyzed through different functional analysis. \n\nThis work will allow the evaluation of the use of AONs as a personalized therapy for NF2 patients _in vitro_. The demonstration that the use of AONs reduce the severity of the _NF2_ truncating and splicing mutations, could open up the possibility to further studies using _in vivo_ models, thereby enabling to take a major step towards an effective therapy for NF2 patients.\n\n${image?fileName=imatge%5F2RFA%2Epng&align=None&scale=100&responsive=true&altText=Schematic representation of the effect of different mutation types in merlin’s function and the resulting merlin protein after the treatment with antisense oligomers %28PMOs%29%2E }\n\n${previewattachment?fileName=imatge%5F2RFA%2Epng}\n\n\nBackground: Neurofibromatosis type 2 (NF2) is a genetic condition characterized by the development of multiple tumors of the nervous system. The clinical presentation of the disease is variable and related to the type of the inherited constitutional mutation variant in the NF2 gene. The use of antisense oligonucleotides (AONs), acting at RNA level, could be useful to correct the effect of deleterious DNA mutations at the protein level, or to create proteins that still retain partial function from loss-of-function mutated alleles. AONs They could be used to force the skipping of exons carrying truncating mutations when the reading frame is maintained. We have shown that a deep intronic mutation responsible for an aberrant NF2 splicing could be corrected by the use of PMOs and recover Merlin function. Here, we propose to evaluate the use of AONs PMOs to reduce the severity of NF2 truncating and splicing mutations to milder hypomorphic forms in vitro. \n\nMethods: Samples: primary fibroblasts cultures from NF2 patients. Phosphorodiamidate morpholino oligomers (PMOs)AONs: We designed specific phosphorodiamidate morpholino oligomers (PMOs) targeting four independent disease-causing splicing mutationsvariants, and a pair of PMOs to induce exon skipping of exons 4, 6&7, 8, and 11 of the NF2 gene. Primary fibroblasts carrying nonsense mutations variants were treated with the corresponding pair of PMOs. A dose-response and a time course study were performed to set-up conditions and confirmed the in-frame skipping of the target exons by RT-PCR and Sanger sequencing. Functional analysis: Functional studies were performed from fibroblast cultures untreated and treated at different PMOs concentrations. We measured: 1) Merlin, ERK and their phosphorylated forms by Western Blot; 2) actin cytoskeleton organization; 3) NF2 and YAP1 nuclear translocation capacity by immunofluorescence, and 4) proliferation capacity. \n\nResults: MutationVariant-specific PMOs for splicing mutations: our results showed the PMOs designed for splicing variants located at +/- 15 (or less) from the intron-exon boundary region, were not specific enough and interfered in the correct splicing signaling of both wild-type and mutated alleles. Exon-specific PMOs for truncating mutationsvariants: the effect of the exon skipping on both the mutated and the WT allele, although maintaining the NF2 gene reading frame at cDNA level, caused the complete loss of Merlin. Despite these results, complementary functional analysis are being performed to confirm the absence of Merlin at a cellular level.\n\nConclusions: PMOs might be optimal for inducing targeted exon skipping without altering gene transcription in cells carrying deep intronic variants, or for the modulation of alternative spliced exons. However, here we show that, in the case of NF2, PMOs may not be useful for correcting splicing when mutations are located in splicing canonical sites, neither for inducing semi-functional Merlin isoforms, since the use of these antisense molecules results in total Merlin los\n\n## Publication\nCatasús, N., Rosas, I., Bonache, S., Negro, A., Torres-Martin, M., Plana-Pla, A., ... & Castellanos, E. (2022). Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype in vitro. Molecular Therapy-Nucleic Acids, 30, 493-505.\n\n## Acknowledgement Statements\nIn using this data, you promise to acknowledge the data contributors by including the following statement: \"Data was provided by: Catasús, N., Rosas, I., Bonache, S., Negro, A., Torres-Martin, M., Plana-Pla, A., ... & Castellanos, E. (2022). Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype in vitro. Molecular Therapy-Nucleic Acids, 30, 493-505.\" \n\nIn addition, please acknowledge the NF Data Portal like so: \"The results published here are in whole or in part based on data obtained from the NF Data Portal (http://www.nf.synapse.org, RRID:SCR_021683) and made available through the NF Open Science Initiative.\n\n\n## Tables for Curation\n1. ID: syn65467790\nName: Patient Data\nSummary:\n- Assays: polymerase chain reaction, \n- Species: Homo sapiens, \n- Individual count: 15\n- Specimen count: ?\n- Diagnoses present: NF2-related schwannomatosis, \n- Tumor types present: NF2-Associated Tumor, \n- Data types: drugScreen, \n- File formats present: excel, \n- Funders: CTF\n- Contains data created by: Elisabeth Castellanos, James Moon\n- Example files present: Raw_Data_CTF_v4.xlsx, Exon4_Patient_07.xlsx, Exon4_Patient_335.xlsx, Exon6and7_Patient_416.xlsx, Exon8_Patient_009.xlsx\n\n\n"}]}]}}
{"custom_id":"syn4984604","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn4984604\n\n${image?fileName=CTF Synodos Data Site Headers2%2Ejpg&align=Center&scale=100&responsive=true}\n#The CTF Biobank\nIn 2013, CTF began a neurofibromatosis biobank to collect NF samples to better study the disease. With all samples being collected under the same protocol, the biobank enables comprehensive analysis of diverse NF samples.\n---\n##Cutaneous Neurofibromas\nTo showcase the value the biobank, **CTF** has kicked off a pilot project designed to characterize the molecular landscape of cutaneous neurofibromas (NF) that grow in NF1 patients, sponsored by the Children's Tumor Foundation. This project includes high-throughput data from 11 different patient tumors and matched blood samples.  These data are then compared with one another to assess the distinct landscape of cutaneous NF for each patient.  A manuscript describing this resource can be found [here](https://www.nature.com/articles/sdata201745)\n---\n\nThe project represents a collaborative effort between physicians, scientists and CTF to collect high-quality data from a diverse panel of cutaneous neurofibromas.\n${image?fileName=newFig1%2Epng&align=Center&responsive=true}\n---\n##Data Release\nThe data can be downloaded directly from Synapse.  For details on how to get access to the data, navigate to the [data access wiki page](https://www.synapse.org/#!Synapse:syn4984604/wiki/400545). \n\n## Tables for Curation\n1. ID: syn64954691\nName: Immunohistochemistry\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: ?\n- File formats present: txt\n- Funders: CTF\n- Contains data created by: Robert Allaway\n- Example files present: Carroll_cNF_IHC.txt\n\n\n\n2. ID: syn52128513\nName: NFOSI to process 2023-07-21\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Thomas Yu\n- Example files present: C6E8YANXX_s8_1_GSLv3-7_02_SL106285.fastq.gz, C6E8YANXX_s8_1_GSLv3-7_01_SL106284.fastq.gz, C6E8YANXX_s8_1_GSLv3-7_03_SL106286.fastq.gz, C6E8YANXX_s8_1_GSLv3-7_04_SL106287.fastq.gz, C6E8YANXX_s8_1_GSLv3-7_05_SL106288.fastq.gz\n\n\n\n3. ID: syn64954692\nName: Proteomics\nSummary:\n- Assays: MudPIT\n- Species: Homo sapiens\n- Individual count: 11\n- Specimen count: 40\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma\n- Data types: proteomics\n- File formats present: txt, raw, msf\n- Funders: CTF\n- Contains data created by: Sara Gosline,  \n- Example files present: dermalNF_proteomics_sample_EMPTY_Normalized_P_SC__NP_SC_.txt, dermalNF_proteomics_sample_X45_Normalized_P_SC__NP_SC_.txt, dermalNF_proteomics_sample_X47_Normalized_P_SC__NP_SC_.txt, dermalNF_proteomics_sample_X49_Normalized_P_SC__NP_SC_.txt, dermalNF_proteomics_sample_X51_Normalized_P_SC__NP_SC_.txt\n\n\n\n4. ID: syn64954693\nName: RNA-Seq\nSummary:\n- Assays: RNA-seq, \n- Species: Homo sapiens, \n- Individual count: 44\n- Specimen count: 33\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma, \n- Data types: geneExpression, \n- File formats present: bam, bai, txt, gtf, png, tsv, fastq, sf\n- Funders: CTF\n- Contains data created by: Thomas Yu, Sara Gosline, Robert Allaway\n- Example files present: accepted_hits_SL106284.bam, accepted_hits_SL106284.bam.bai, accepted_hits_SL106285.bam, accepted_hits_SL106285.bam.bai, accepted_hits_SL106286.bam\n\n\n\n5. ID: syn40134517\nName: Raw cNF RNAseq Files\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 11\n- Specimen count: 33\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma\n- Data types: geneExpression\n- File formats present: fastq\n- Funders: CTF\n- Contains data created by: ?\n- Example files present: SL106284_1.fastq.gz, SL106284_2.fastq.gz, SL106285_1.fastq.gz, SL106285_2.fastq.gz, SL106286_1.fastq.gz\n\n\n\n6. ID: syn63126358\nName: Raw cNF RNAseq Files (unmerged)\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 11\n- Specimen count: 33\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma\n- Data types: geneExpression\n- File formats present: fastq\n- Funders: CTF\n- Contains data created by: ?\n- Example files present: C6E8YANXX_s8_1_GSLv3-7_02_SL106285.fastq.gz, C6E8YANXX_s8_1_GSLv3-7_01_SL106284.fastq.gz, C6E8YANXX_s8_1_GSLv3-7_03_SL106286.fastq.gz, C6E8YANXX_s8_1_GSLv3-7_04_SL106287.fastq.gz, C6E8YANXX_s8_1_GSLv3-7_05_SL106288.fastq.gz\n\n\n\n7. ID: syn64954694\nName: SNP\nSummary:\n- Assays: SNP array\n- Species: Homo sapiens\n- Individual count: 11\n- Specimen count: 48\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: , Cutaneous Neurofibroma\n- Data types: genomicVariants\n- File formats present: txt, csv\n- Funders: CTF\n- Contains data created by: Sara Gosline\n- Example files present: 3096-PBK_FinalReport.txt, 3096-PBK-0047_Final.csv, 3096-PBK-0049_Final.csv, 3096-PBK-0051_Final.csv, 3096-PBK-0053_Final.csv\n\n\n\n8. ID: syn64954695\nName: Sample Information\nSummary:\n- Assays: whole genome sequencing, RNA-seq, , MudPIT, questionnaire, SNP array\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: , Cutaneous Neurofibroma\n- Data types: genomicVariants,proteomics, geneExpression, , proteomics, clinical, geneExpression,genomicVariants, genomicVariants\n- File formats present: txt, pdf, doc, csv\n- Funders: CTF\n- Contains data created by: Sara Gosline\n- Example files present: Sample manifest_DNA_Protein_experiments.txt, Sample manifest_RNA-seq.txt, CTF CRF version 1 0 Final 04June2013.pdf, NF_Methods_Proteomics.docx, dermalNFPatientData.txt\n\n\n\n9. ID: syn64954696\nName: WGS\nSummary:\n- Assays: whole genome sequencing\n- Species: Homo sapiens\n- Individual count: 15\n- Specimen count: 62\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma, \n- Data types: genomicVariants\n- File formats present: vcf, maf, bam\n- Funders: CTF\n- Contains data created by: Thomas Yu, Sara Gosline\n- Example files present: SL102344.vcf, SL102345.vcf, SL102346.vcf, SL102347.vcf, SL102348.vcf\n\n\n\n10. ID: syn62667549\nName: cNF RNA-seq quantification files (salmon)\nSummary:\n- Assays: \n- Species: \n- Individual count: 0\n- Specimen count: ?\n- Diagnoses present: \n- Tumor types present: \n- Data types: \n- File formats present: \n- Funders: CTF\n- Contains data created by: ?\n- Example files present: quant.sf, quant.genes.sf, quant.genes.sf, quant.sf, quant.genes.sf\n\n\n"}]}]}}
{"custom_id":"syn6633069","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn6633069\n\n${image?fileName=CTF Synodos Data Site Headers%2Ejpg&align=Center&scale=100&responsive=true}\n###**Welcome to the Columbia University NF1 Glioma Project**\n\nThis site is the central place for all data from the NF1 Glioma grant awarded by CTF to Dr. Antonio Iavarone at Columbia University. The wiki area and specific folders can be accessed by all members of the group from the menu on the left.\n\n->${buttonlink?text=Back to NF Data Portal&url=https://nf.synapse.org/}<-\n\n\n\n\n## Tables for Curation\n1. ID: syn51915976\nName: Copy Number Variation from the Columbia University NF1 Glioma Project\nSummary:\n- Assays: whole exome sequencing\n- Species: Homo sapiens\n- Individual count: 56\n- Specimen count: 59\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Low-Grade Glioma NOS, High-Grade Glioma NOS\n- Data types: genomicVariants\n- File formats present: txt\n- Funders: CTF\n- Contains data created by: Fulvio D'Angelo\n- Example files present: AI_DT_10.seg.txt.gz, AI_DT_11.seg.txt.gz, AI_DT_12.seg.txt.gz, AI_DT_13.seg.txt.gz, AI_DT_16.seg.txt.gz\n\n\n\n2. ID: syn64954697\nName: CopyNumberVariation\nSummary:\n- Assays: whole exome sequencing\n- Species: Homo sapiens\n- Individual count: 56\n- Specimen count: 59\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Low-Grade Glioma NOS, High-Grade Glioma NOS\n- Data types: genomicVariants\n- File formats present: txt\n- Funders: CTF\n- Contains data created by: Fulvio D'Angelo\n- Example files present: AI_DT_10.seg.txt.gz, AI_DT_11.seg.txt.gz, AI_DT_12.seg.txt.gz, AI_DT_13.seg.txt.gz, AI_DT_16.seg.txt.gz\n\n\n\n3. ID: syn64954698\nName: GeneExpression\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 29\n- Specimen count: 32\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Low-Grade Glioma NOS, High-Grade Glioma NOS\n- Data types: geneExpression\n- File formats present: txt\n- Funders: CTF\n- Contains data created by: Fulvio D'Angelo\n- Example files present: AI_RT_10.counts.txt.gz, AI_RT_11.counts.txt.gz, AI_RT_12.counts.txt.gz, AI_RT_15.counts.txt.gz, AI_RT_16.counts.txt.gz\n\n\n\n4. ID: syn64954699\nName: Methylation\nSummary:\n- Assays: methylation array\n- Species: Homo sapiens\n- Individual count: 31\n- Specimen count: 31\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Low-Grade Glioma NOS, High-Grade Glioma NOS\n- Data types: chromatinActivity\n- File formats present: gz, txt\n- Funders: CTF\n- Contains data created by: Fulvio D'Angelo\n- Example files present: AI_DT_10.beta.txt.gz, AI_DT_11.beta.txt.gz, AI_DT_12.beta.txt.gz, AI_DT_13.beta.txt.gz, AI_DT_16.beta.txt.gz\n\n\n\n5. ID: syn64954700\nName: NucleotideVariation\nSummary:\n- Assays: whole exome sequencing\n- Species: Homo sapiens\n- Individual count: 56\n- Specimen count: 102\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: High-Grade Glioma NOS, Low-Grade Glioma NOS\n- Data types: genomicVariants\n- File formats present: txt\n- Funders: CTF\n- Contains data created by: Fulvio D'Angelo\n- Example files present: AI_DN_43.variants.txt.gz, AI_DN_44.variants.txt.gz, AI_DN_45.variants.txt.gz, AI_DN_46.variants.txt.gz, AI_DN_47.variants.txt.gz\n\n\n\n6. ID: syn64954701\nName: WholeGenomeVariants\nSummary:\n- Assays: whole genome sequencing\n- Species: Homo sapiens\n- Individual count: 11\n- Specimen count: 22\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Low-Grade Glioma NOS, High-Grade Glioma NOS\n- Data types: genomicVariants\n- File formats present: vcf\n- Funders: CTF\n- Contains data created by: Fulvio D'Angelo\n- Example files present: A1.indel.vcf.gz, H1.snp.vcf.gz, G4.snp.vcf.gz, G1.snp.vcf.gz, F1.snp.vcf.gz\n\n\n"}]}]}}
{"custom_id":"syn26347297","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn26347297\n\n# The effects of RAS signaling pathway inhibitors on tumor cells and the tumor immune microenvironment in malignant peripheral nerve sheath tumors\n## CTF Young Investigator Award\n\n### Principal Investigator: Lindy Zhang\n### Project Lead / Data Coordinator: Lindy Zhang, Christine Pratilas, Nicolas Llosa\n### Institution: Johns Hopkins University\n\n### Project Description: \nNF1-associated MPNSTs are resistant to MEK inhibition monotherapy because of activation of alternate cancer signaling pathways. This study will test combinations of MEK inhibitors, SHP2 inhibitors, and CDK inhibitors, which target different signaling pathways, to treat MPNSTs. Additionally, we will also investigate the role of the tumor microenvironment and the impact of various inhibitors on immune cells to design trials of immunotherapy drugs plus targeted drugs for MPNST.\n\n## Tables for Curation\n1. ID: syn64954915\nName: Flow Cytometry\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: CTF\n- Contains data created by: Lindy Zhang\n- Example files present: Human PNST_FACS data.xlsx\n\n\n\n2. ID: syn64954916\nName: Immunohistochemistry\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: CTF\n- Contains data created by: Lindy Zhang\n- Example files present: Human PNST_IHC data.xlsx\n\n\n"}]}]}}
{"custom_id":"syn11817821","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn11817821\n\nThe newly developed massively parallel technologies have enabled the simultaneous analysis of many pathways. There are several large scale international efforts to probe the genetics and drug sensitivity of cancer cell lines. However, there are some rare cancers that have not been analyzed in depth. One of these rare cancers is malignant peripheral nerve sheet tumors (MPNST). MPNST, although a rare cancer, are common in patients with neurofibromatosis type 1. We obtained funding from the Children’s Tumor Foundation to fill this gap, in a novel way by enlisting students in a hybrid research/education model through what is likely to be the first course in high throughput screening. In the course, students will take part in a high throughput discovery effort in two phases. \n\n###Phase 1\nPhase 1 is a training phase, which will consist of quantitative profiling the sensitivity of MPNST cell lines to a library of 130 common and experimental cancer drugs. These will be conducted in the UPenn High Throughput Screening Core with [Dr. David Schultz](http://www.med.upenn.edu/cores/High-ThroughputScreeningCore.shtml). While we call this a training phase, the data from this will be subject to rigorous quality control for eventual publication and development of a public database for rare tumors. Phase 1 will also include an introductory synthesis in the [Upenn/Merck High Throughput Experimentation Laboratory](https://www.chem.upenn.edu/facilities/penn-chemistry-high-throughput-experimentation-center).  \n\n###Phase 2\nPhase 2 is an independent research project. Examples of projects include, but are not limited to: Combinatorial screens (synthetic lethal); siRNA screens; novel compound screens; determining mechanisms of cell death; developing tools for data analysis and database development. During phase 2, students can also modify compounds of interest using the Penn Chemistry: Upenn/Merck High Throughput Experimentation Laboratory, and then retest them for activity to determine structure activity relationships. We will sponsor phase 2 projects relevant to neurofibromatosis. However, in phase 2 students can also perform experiments in other areas if they develop sponsorships from professors. We expect the course to be a hypothesis engine that generates ideas for further research.\n\n## Tables for Curation\n1. ID: syn64954768\nName: Exp008_analyzed Data\nSummary:\n- Assays: cell viability assay, immunofluorescence, \n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: drugScreen, image, \n- File formats present: excel, pzfx, jpg, txt, powerpoint, csv, pdf\n- Funders: CTF\n- Contains data created by: Jeffrey Field, yang yang\n- Example files present: Exp008_01_analysis.xlsx, Exp008_01_normalized_template.pzfx, Exp002_Analysis template_ST88-14_ATPLite_plates1-3.xlsx, Exp002_Analysis template_ST88-14_DAPI_plates4-6.xlsx, Exp002_ST88-14_ATPlite_48hr_Corrected IC50s.xlsx\n\n\n\n2. ID: syn64954770\nName: Raw Data and logs\nSummary:\n- Assays: cell viability assay, drug screen\n- Species: Homo sapiens, Rattus norvegicus,Homo sapiens, \n- Individual count: ?\n- Specimen count: 27\n- Diagnoses present: [\"Neurofibromatosis type 1\"], [\"Neurofibromatosis type 2\"], , [\"Neurofibromatosis type 1\", \"Neurofibromatosis type 2\"]\n- Tumor types present: [\"Malignant Peripheral Nerve Sheath Tumor\"], [\"Schwannoma\", \"Fibrosarcoma\", \"Colorectal Carcinoma\", \"Malignant Peripheral Nerve Sheath Tumor\"], [\"NF2\"], , [\"NF1\"], [\"Colorectal Carcinoma\"], [\"NF1\", \"NF2\"]\n- Data types: drugScreen\n- File formats present: csv, excel\n- Funders: CTF\n- Contains data created by: Jeffrey Field, yang yang\n- Example files present: 259_USLUM_384_20151123.csv, 267_USLUM_384_20151204.csv, 280_US_LUM_384_20151214.csv, 321_USLUM_384_20160118.csv, 322_USLUM_384_20160118.csv\n\n\n\n3. ID: syn64954773\nName: exome sequencing\nSummary:\n- Assays: , whole exome sequencing\n- Species: , Homo sapiens\n- Individual count: 13\n- Specimen count: ?\n- Diagnoses present: , Neurofibromatosis type 1, Cancer, Neurofibromatosis type 2\n- Tumor types present: , Malignant Peripheral Nerve Sheath Tumor, Schwannoma\n- Data types: , genomicVariants\n- File formats present: tsv, excel, pdf, txt, vcf, fastq, , maf\n- Funders: CTF\n- Contains data created by: Jeffrey Field, Robert Allaway\n- Example files present: 2213_JF_01_VCF_v1_c648_2016-09-20-13-21-912-2016-09-20-18-23-30699.tsv, 2213_JF_01_VCF_v1_c648_2016-09-20-13-21-912-2016-09-20-18-23-30699.xlsx, 2213_JF_01.xlsx, 2214_JF_02 nf1.xlsx, 2214_JF_02.xlsx\n\n\n"}]}]}}
{"custom_id":"syn4939876","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn4939876\n\n##Combination Index Validation Studies (2 drug combinations)\n**Initiative:** Cell Culture\n&nbsp;\n**Name:** D. Wade Clapp, M.D. \n**Contact Email:** dclapp@iupui.edu\n**Dates:** 7-15-15 to 12-31-15\n**Tumor Focus:** Plexiform Neurofibroma\n**Application:** Validation Translational Model\n&nbsp;\n**Background:** Preliminary High-throughput screening (HTS) data generated at National Center for Advancing Translational Sciences (NCATS) implicated a number of different compounds as potential candidates and combinations suitable for moving forward to preclinical testing, with nine combinations prioritized for validation in murine primary embryonic Schwann cell lines and/or immortalized cell lines. \n&nbsp;\n**Goals of Project:** The goal of these experiments was to validate the results of preliminary HTS at NIH/NCATS by Dr. Ferrer.  \n&nbsp;\n**Specific Aims:** \n1. Test the first two prioritized combinations in primary embryonic Schwann cell lines and murine plexiform-derived cell line (MTC): Rapamycin & Ganetespib and Selumetinib & Panobinostat.  \n2. Compare the results of the Caspase-Glo and CellTiter-Glo reagents with those obtained by mouse tumor tissue (MTT) (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) in simultan\n3. Compare the response of these two drug combinations in three different cell lines: 2 human derived NF1-/- cell lines (ipNF 95.6 and ipNF 05.5) and mouse pheochromocytoma (MPC)'s\n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n## Tables for Curation\n1. ID: syn64954677\nName: Spreadsheets\nSummary:\n- Assays: cell viability assay\n- Species: Mus musculus, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Plexiform Neurofibroma\n- Data types: drugScreen\n- File formats present: excel, csv\n- Funders: NTAP\n- Contains data created by: Heather Daniel, Xindi Guo\n- Example files present: NCATS SP RG in vitro data July 2015 - primary murine eSCs.xlsx, November 2015 3 cell line in vitro studies - Rapa+Gane and Selu+Pano-Clapp.xlsx, November 2015 NCATS MTT vs caspase-celltiterglo validation data-Clapp.xlsx, NCATS SP RG in vitro data July 2015 - primary murine eSCs_R+G apoptosis (16h).csv, NCATS SP RG in vitro data July 2015 - primary murine eSCs_R+G apoptosis (24h).csv\n\n\n"}]}]}}
{"custom_id":"syn22267330","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn22267330\n\n## **Malignant Peripheral Nerve Sheath Tumors Achilles Heel: Combinatorial Targeting of ERBB3 and Calcium Signaling**\n\n### CTF Young Investigator:\n#### Laurel Black\n\n### Investigator Institution:\nMedical University of South Carolina\n\n### Abstract:\nThis proposal will investigate the role that ErbB3 and calcium-mediated signaling pathways play in regulating cellular proliferation and survival by in malignant peripheral sheath tumors (MPNSTs). At present, there are no effective treatments for MPNSTs other than radical surgical resection. After resection, recurrence typically occurs and so patients with MPNSTs have abysmal survival rates. The pathogenesis of MPNSTs is driven by Ras hyperactivation, a result of NF1 loss, and the loss of other tumor suppressor genes such as p53, PTEN and CDKN2A that negatively regulate cell proliferation/survival. Clinically targeting hyperactive Ras and its effector molecules has failed and so there is a desperate need to identify new therapeutic targets. We have focused on identifying Ras- independent and -dependent signaling pathways necessary for MPNST proliferation and survival using comprehensive genomic analyses, kinase phospho-arrays, pharmacological screens and several animal models. Our efforts have identified ErbB3 (a receptor tyrosine kinase/RTK) and calmodulin (CaM) as potential therapeutic targets in MPNSTs. Although there is conflicting evidence that other RTKs can drive Ras hyperactivation in MPNSTs, the role of ErbB3 has not yet been investigated in MPNSTs. Interestingly, our transcriptomic analyses of NRG1? (an ErbB3 ligand) stimulated Schwann cells and our global shRNA screens implicate ErbB3 and calmodulin-mediated calcium signaling as key biological pathways driving MPNST proliferation. With the cumulative support of our screens and functional analyses, we hypothesize that simultaneous inhibition of NRG1? activated effector molecules and calmodulin regulated signaling pathways will cooperatively inhibit MPNST cellular proliferation and survival. In Aim 1, I will test the hypothesis that NRG1? activation of ErbB3 directly modulates calmodulin regulated signaling in MPNSTs to promote cellular proliferation and survival. In Aim 2, I will test the hypothesis that dual inhibition of the NRG1? effector, ErbB3, and calmodulin effector molecules induces a cytotoxic effect in MPNSTs. This work will yield novel information about MPNST tumorigenesis by investigating the role(s) of ErbB3 (an upstream activator of Ras) and calcium signaling pathways (which can be dependent or independent of Ras). My ultimate goal is to identify a novel combinatorial treatment for MPNSTs using FDA approved drugs or drugs that are already in clinical trials that can rapidly advance to clinical trials.\n\n### Acknowledgement:\nData was provided by:\n\n**Black, L. E., Longo, J. F., Anderson, J. C., & Carroll, S. L. (2023). Inhibition of erb-B2 receptor tyrosine kinase 3 and associated regulatory pathways potently impairs Malignant peripheral nerve sheath tumor proliferation and survival. The American Journal of Pathology, 193(9), 1298-1318.**\n\nThe results published here are in whole or in part based on data obtained from the NF Data Portal (http://www.nf.synapse.org, RRID:SCR_021683) and made available through the NF Open Science Initiative.\n**Accessing the data from this study requires a Synapse account.**\n\n## Tables for Curation\n1. ID: syn64954868\nName: Cell Viability Celigo Assays\nSummary:\n- Assays: cell viability assay, \n- Species: Homo sapiens, \n- Individual count: 1\n- Specimen count: ?\n- Diagnoses present: Not Applicable, \n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, \n- Data types: image, geneExpression, drugScreen, drugCombinationScreen, \n- File formats present: tif, excel, pzfx, \n- Funders: CTF\n- Contains data created by: Laurel Black, James Moon\n- Example files present: S462NT+TFP_Day9.tif, S462sh1+TFP_Day9.tif, STS-26T_Src_72hr.tif, STS-26T_Src+TFP_72hr.tif, STS-26T_Veh_72hr.tif\n\n\n\n2. ID: syn64954871\nName: Imaging\nSummary:\n- Assays: immunocytochemistry, \n- Species: Homo sapiens, \n- Individual count: 1\n- Specimen count: ?\n- Diagnoses present: Not Applicable, \n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, \n- Data types: image, \n- File formats present: tif, \n- Funders: CTF\n- Contains data created by: Laurel Black, James Moon\n- Example files present: Image_749_erbb3sc285.tif, Image_750_Neg.tif, Image_748_erbb3sc81455.tif, Image_746_erbb3sc285.tif, Image_747_Neg.tif\n\n\n\n3. ID: syn64954872\nName: Kinomics\nSummary:\n- Assays: immunoassay, \n- Species: Homo sapiens, \n- Individual count: 1\n- Specimen count: ?\n- Diagnoses present: Not Applicable, \n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, \n- Data types: kinomics, \n- File formats present: excel, powerpoint, \n- Funders: CTF\n- Contains data created by: Laurel Black, James Moon\n- Example files present: 7.9.22CarrollTMXMFS15GG.xls, 8.12.22Carroll.pptx, 7.5.22CarrolUpKin.xlsx, 7.9.22CarrollTFZMFS15GG.xls, synapse_storage_manifest_imagingassaytemplate.csv\n\n\n\n4. ID: syn64954873\nName: Microarray\nSummary:\n- Assays: array, \n- Species: Rattus norvegicus, \n- Individual count: 1\n- Specimen count: 1\n- Diagnoses present: Not Applicable, \n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, \n- Data types: geneExpression, \n- File formats present: excel, \n- Funders: CTF\n- Contains data created by: Laurel Black, James Moon\n- Example files present: NRG1 Beta Regulated Genes in Adult Schwann CellsJF.xlsx, synapse_storage_manifest_rnaseqtemplate.csv\n\n\n"}]}]}}
{"custom_id":"syn31619419","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn31619419\n\n# Early treatment of cutaneous neurofibromas type 1 (cNF) to markedly improve patient's quality of life\n## NTAP - DHART SPORE Developmental Research Program\n### Principal Investigator: Thomas E. Milner\n### Project Lead / Data Coordinator: Wangcun Jia\n### Institution: University of California, Irvine\n### Project Description:\nThe most common complication for neurofibromatosis 1 (NF1) patients is the appearance of cutaneous neurofibromas (cNF), which is considered as the most significant life burden of NF1. Current management of the tumors is eradication often with significant morbidity.\n\nThe goals of project are to improve the quality of life of NF1 patients through the identification of a biomarker to locate and evaluate cNF and through the development of a laser therapy solution. The proposed research has two aims. Aim 1 is to demonstrate an optical biomarker and validate using histology, and Aim 2 is to identify and demonstrate laser treatment mechanism of action. In Aim 1, two optical imaging modalities are utilized, Spatial Frequency Domain Imaging (SFDI) and optical coherence tomography (OCT) to first detect and then image tissue microstructure of cNF tumors. In Aim 2, two laser treatment modalities will be tested. The first treatment approach utilizes laser light to target the tumor vasculature to induce local hyperthermia and eradicate the tumor. The second treatment alternative utilizes near-infrared laser radiation to spatially target water and collagen to induce local hyperthermia and eradicate the tumor. \n\n\n## Tables for Curation\n1. ID: syn64954917\nName: Analysis\nSummary:\n- Assays: spatial frequency domain imaging, optical coherence tomography, \n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: image, \n- File formats present: tif, powerpoint, \n- Funders: NTAP,NIH-NCI\n- Contains data created by: Wangcun Jia, Junsoo Lee, Christina Parry\n- Example files present: back_2022.10.12.13.33.01-2_musp-SCALED-Marked-conc.tif, Chest_2022.10.12.13.24.20-0_musp-scaled-marked.gif, OCT_on_Chest_and_Back.pptx, Back-2_2022.10.20.14.44.48-1_musp-scaled-marked-conc.tif, chest_2022.10.20.14.28.00-0_musp-scaled-marked-conc.tif\n\n\n\n2. ID: syn64954918\nName: Histology\nSummary:\n- Assays: brightfield microscopy, \n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: image, metadata\n- File formats present: ?\n- Funders: NTAP,NIH-NCI\n- Contains data created by: Wangcun Jia\n- Example files present: Suspect_Invisible-cNF.jpg, Uninvolved-skin.jpg, Visible-cNF.jpg, Suspect_Invisible-cNF-deep.jpg, Suspect_Invisible-cNF.jpg\n\n\n\n3. ID: syn64954919\nName: OCT data\nSummary:\n- Assays: optical coherence tomography, \n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: image, \n- File formats present: ?\n- Funders: NTAP,NIH-NCI\n- Contains data created by: Junsoo Lee, Christina Parry\n- Example files present: Atten_Visible1.tif, Atten_Visible2.tif, Atten_Visible3.tif, Atten.tif, CDV.tiff\n\n\n\n4. ID: syn64954920\nName: Photos\nSummary:\n- Assays: photograph, \n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: image, metadata\n- File formats present: ?\n- Funders: NTAP,NIH-NCI\n- Contains data created by: Wangcun Jia\n- Example files present: DSC05394.JPG, DSC05402.JPG, DSC05414.JPG, DSC05423.JPG, DSC05427.JPG\n\n\n\n5. ID: syn64954921\nName: SFDI data\nSummary:\n- Assays: spatial frequency domain imaging, \n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: image, metadata\n- File formats present: ?\n- Funders: NTAP,NIH-NCI\n- Contains data created by: Wangcun Jia\n- Example files present: Chest_2022.10.12.13.24.20-0_ab, Chest_2022.10.12.13.24.20-0_ab.xml, Chest_2022.10.12.13.24.20-0_calibrated_position, Chest_2022.10.12.13.24.20-0_calibrated_rd, Chest_2022.10.12.13.24.20-0_calibrated_rd.xml\n\n\n"}]}]}}
{"custom_id":"syn4939890","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn4939890\n\n##Exploring the Plexiform Neurofibroma Interactome\n**Initiative:** Open\n&nbsp;\n**Name:** Jianqiang Wu\n**Contact Email:** Jianqiang.wu@cchmc.org\n**Name:** Kakajan Komurov\n**Contact Email:** kakajan.komurov@cchmc.org\n**Dates:** 5-15-13 to 11-14-15\n**Tumor Focus:** Plexiform Neurofibroma\n**Application:** Biomarkers, Omics\n&nbsp;\n**Background:** \n\nAdults with neurofibromas can be disfigured by thousands of neurofibromas and 25-50% of children with NF1 develop plexiform neurofibromas that can cause severe disfigurement and serious morbidity-- and death when they compress vital organs. Therefore, we focus on identification of therapeutic targets for plexiform neurofibromas.  \n\nNF1 mutations in Schwann cells (SCs) drive neurofibroma formation; thus the primary neoplastic cell type in neurofibromas is derived from the SC lineage.  The SC genes that are deregulated in mouse and human neurofibromas have not been fully identified. Many cell types are present in neurofibromas besides SCs.  These include fibroblasts, mast cells, macrophages, and endothelial cells that are NF1 wild type (as in solitary neurofibroma or in somatic mosaic patients) or NF1 heterozygous (as in many NF1 patients and some mouse models).  But how these cells and the intercellular communications contribute to plexiform neurofibroma growth is unknown. It has been recently identified that macrophage is a major cell type in neurofibromas. Macrophages shift gene expression and function in response to the environment, including after nerve injury. Macrophages show anti- tumor effects by secreting free-radicals and recruiting the adaptive immune system (primarily T-cells). However as tumors progress, macrophages stimulate tumor growth and blood vessel formation. Injury-associated inflammation facilitates neurofibroma development by recruiting macrophages in mouse models. How these inter- and intra-cellular interactions contribute to neurofibroma formation has not been studied yet.\n&nbsp;\n**Goals of Project:** \n1.  to characterize gene expression profiles of Schwann cells and macrophages in mouse nerves and neurofibromas\n2.  to identify cytokine/chemokine pathways that slow or promote tumor growth\n3. to identify molecular networks that mediate intra- and inter-cellular signaling in controlling neurofibroma growth.  \n&nbsp;\n**Impact:** \nSchwann cell lineage cells are the cells of origin for neurofibroma formation. Macrophages are abundant in neurofibromas and play important roles in neurofibroma formation. Our findings suggest that SCs and macrophages interact each other within neurofibromas.  Specifically, Nf1-/- SCs promote a chronic inflammatory microenvironment to alter gene expression in both SCs and macrophages. Our analysis also reveals that neurofibroma SCs and macrophages both progressively adapt  to pro-inflammatory states during tumor progression, that is, neurofibroma SCs initiate tumorigenesis, while neurofibroma macrophages may maintain the pro-inflammatory state in the neurofibroma microenvironment and account for prolonged chronic inflammation.  The neurofibroma system described here provides a platform to investigate mechanistic aspects of RAS/Interferon signaling.  Our results suggest that targeting SC-macrophage interactions might provide a potential therapy for neurofibroma patients.\n&nbsp;\n**Publications:** \n* Choi K, Komurov K, Fletcher JS, Jousma E, Cancelas JA, Wu J, Ratner N. An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system. **Scientific Reports** 2017 Mar; 7, 43315. DOI:10.1038/srep43315, https://www.readcube.com/articles/10.1038/srep43315\n\n\n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n## Tables for Curation\n1. ID: syn51915059\nName: Gene expression profiling of Schwann cells and macrophages in mouse nerves and neurofibromas\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Kwangmn Choi\n- Example files present: 1__28_+_30_Schwann_cell_(MoGene-2_0-st).CEL, 1__28_+_30_Schwann_cell_(MoGene-2_0-st).rma-gene-full.chp, 2__193_+_195_Schwann_cell_(MoGene-2_0-st).CEL, 2__193_+_195_Schwann_cell_(MoGene-2_0-st).rma-gene-full.chp, 3__196_+_197_+_198_Schwann_cell_(MoGene-2_0-st).CEL\n\n\n"}]}]}}
{"custom_id":"syn7217928","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn7217928\n\n##Plexiform Neurofibroma Model Systems for Preclinical Drug Screening\n\n**Initiative:** Cell Culture\n&nbsp;\n**Name:** Ray Mattingly, Ph.D.\n**Contact Email:** rmatting@med.wayne.edu\n**Dates:** 5-1-13 to 4-30-16\n**Tumor Focus:** Plexiform Neurofibroma\n**Application:** Preclinical Models\n&nbsp;\n**Background & Rationale:**\nUp to half of NF1 patients suffer with plexiform neurofibromas (PNs), for which there is no effective therapeutic approach. PNs are complex tumors that include a driving, deranged Schwann cell (NF1-/-) component plus other haploin sufficent (Nf1+/-) fibroblasts, perineural cells, mast cells and endothelial cells, together with secreted collagens and other matrix proteins. Surgery is the only current option for patients with PNs causing serious disfigurement or loss of function. At a recent NF patient forum in Detroit, it was reported that the high vascularity of these tumors can cause major problems during surgery. Most in vitro drug testing is still performed on cells growing in two dimensions (2D) on plastic dishes. In comparison to 2D cultures, cells growing in a 3-dimensional (3D) matrix that models the (patho) physiological environment typically: 1) adopt a morphology that better recapitulates that in vivo; 2) exhibit slower growth more akin to those in vivo; and 3) demonstrate drug sensitivity and resistance that may better reflect potential therapeutic response.\n&nbsp;\n**Goals of Project:** \nOur goals were to develop and optimize robust 3D co-culture models of NF1 PNs to allow preclinical drug screening that is both much more representative of likely translational effectiveness than provided by testing in 2D mono-culture, and at a much higher throughput than is available in animal models. Further, we predict that programs such as the NF Clinical Trials Consortium are more likely to be successful if they build on data from robust and representative pre-clinical models. Our aims were therefore to: 1. Develop, characterize and optimize 3D co-culture models to include the cell types found in NF1 PNs; and 2. Test potential drugs in the 3D models of NF1 PNs, with a focus on candidates chosen for translational potential.\n&nbsp;\n**Impact:** \n1. We have developed and optimized assays of cell proliferation that can be reproducibly used in 3D PN cultures and co-cultures and that will provide the basis for secondary screening of potential drug treatments. \n2. We have established and optimized what we believe to be the first 3D co-culture models of PN cells with endothelial cells. We suggest that these new models will provide an innovative way to investigate the clinically important aspect of the high vascularity of PNs. \n3. We have made major progress in the investigation of the interactions between the 3D PN co-cultures and their matrix through use of the live-cell collagen degradation assay. Development and refinement of this assay provides the groundwork for further studies on the pre-malignant phenotype of PNs.\n&nbsp;\n**Publications:** \n1. Review article published: Brock EJ, Ji K, Reiners JJ Jr. & Mattingly RR. How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization. **Mini Rev Med Chem.** 2016 ; 16(5): 358–369. PMID: 26423696, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955559/pdf/nihms802301.pdf\n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n2. Kraniak JM, Mattingly RR, Sloane BF (2018). Roles of pericellular proteases in tumor angiogenesis: therapeutic implications, ch14, in Extracellular Targeting of Cell Signaling in Cancer: Strategies Directed at MET and RON Receptor Tyrosine Kinase Pathways.  Janetka J (Ed). Wiley, 2018, ISBN: 9781119300212 \n3. Kraniak JM, Chalasani A, Wallace MR, Mattingly RR. Development of 3D Culture Models of Plexiform Neurofibroma and Initial Application for Phenotypic Characterization and Drug Screening.  Exp Neurol. 2018; J299(Pt B):289-298. PMID: 29055717\n\n\n\n## Tables for Curation\n1. ID: syn64954702\nName: Drug screen data\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: Anh Nguyet Vu\n- Example files present: RFP_97-4Samp3.csv, dapiD1_974_S3_4-15-15.csv, DQ_CS4_1_21_15.csv, dapi_D6_028_S1_4-8-15.csv, DQ_95-6_2lambS1_2-4-15.csv\n\n\n\n2. ID: syn52163155\nName: Drug screens with 3D Plexiform Neurofibroma Model System\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Anh Nguyet Vu\n- Example files present: RFP_97-4Samp3.csv, dapiD1_974_S3_4-15-15.csv, DQ_CS4_1_21_15.csv, dapi_D6_028_S1_4-8-15.csv, DQ_95-6_2lambS1_2-4-15.csv\n\n\n"}]}]}}
{"custom_id":"syn61696875","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn61696875\n\n# Supplementing The Children's Tumor Foundation-Neurofibromatosis Registry with Electronic Health Record Dataset from Mayo Clinic Rochester\n## CTF - Contract Award\n### Principal Investigator: Mayowa Osundiji\n### Project Lead / Data Coordinator: Mayowa Osundiji, Marlene Girardo\n### Institution: Mayo Clinic Arizona\n### Project Description:\nThe development of disease registries is a topical issue. Registries are robust resources that hold great promise for improving our understanding of disease processes, therapeutic responses and for enhancing the recruitment of patient populations into clinical trials. The Children’s Tumor Foundation (CTF) Neurofibromatosis (NF) [CTF-NF] registry provides a unique opportunity to study and improve NF clinical care. The CTF-NF registry utilizes web-based approaches for gathering patient reported clinical history. Although robust, the CTF-NF registry in its current form may potentially be limited by patient recollections and understanding of pertinent details of their clinical history. In the studies proposed herewith, we will complement the CTF-NF registry by extracting de-identified NF clinical data directly from electronic health records (EHRs) at Mayo Clinic to improve the CTF-NF registry. Individuals with NF have an increased risk of developing some types of cancers, and many other health concerns. Considering the health risks that can accompany NF, regular clinical surveillance is critical in the overall care of NF patients. A wealth of dataset is continuously generated during NF clinical surveillance. We will extract de-identified forms of the most relevant NF dataset at Mayo Clinic Rochester (estimated patients number is > 1000) into CTF-NF registry. The proposed preliminary studies will help pave the way for multi-institutional EHR driven enhancement of the current CTF-NF registry. The studies will help develop a protocol that may also be used for batch collection and importation of NF data from EHRs in other institutions onto the CTF-NF registry. Expanding the current CTF-NF registry to a multi-institutional EHR driven NF registry holds great potential for improving our current understanding of NF disease processes and for refining clinical management strategies. The proposed studies hold great promise for improving the accuracy of CTF-NF registry and providing novel insights into NF clinical management in line with the CTF's mission to drive research, expand knowledge and advance care.\n\n## Tables for Curation\n1. ID: syn64954927\nName: Mayo Clinic cohort REDCap database of de-identified phenotype and genotype information\nSummary:\n- Assays: genotyping\n- Species: Homo sapiens\n- Individual count: 1\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor\n- Data types: clinical, AggregatedData\n- File formats present: excel, doc\n- Funders: CTF\n- Contains data created by: Mayowa Osundiji\n- Example files present: Osundiji_data_de_30DEC24.xlsx, Clinical_data_30DEC24.doc\n\n\n"}]}]}}
{"custom_id":"syn2343195","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn2343195\n\n${image?fileName=CTF Synodos Data Site Headers4%2Ejpg&align=Center&scale=100&responsive=true}\n#### ->*Creating tools and treatment paradigms for NF2-associated meningioma and schwannoma*<-\n---\n### ->**Check out the the [2019 data release](https://www.synapse.org/#!Synapse:syn2343195/wiki/400095)!**<-\n\n${image?fileName=Screen Shot 2016%2D06%2D13 at 11%2E52%2E29 AM%2Epng&align=Center&responsive=true&scale=60}\n\nSynodos for NF2 is a first-of-its-kind Neurofibromatosis research collaboration dedicated to defeating the rare genetic disorder neurofibromatosis type 2 (NF2). This unique consortium brings together a multidisciplinary team of scientists from twelve world-class labs at academic and medical centers of excellence, who have pledged to work closely together – sharing information, datasets, results and more – at every step in research development, with the goal of speeding up the drug discovery process. The end goal of this effort is to find new approaches to the diagnosis and treatment of two primary NF2-related tumors:  schwannoma and meningioma. The expectation is to take the work from discovery to pre-clinical development, resulting in the development of an Investigational New Drug (IND) for NF2. _The consortium is funded by [Children's Tumor Foundation](http://www.ctf.org/)(CTF)_\n\n----\n->${buttonlink?highlight=true&text=NF2 Data Summary&url=https://www.synapse.org/#!Synapse:syn2343195/wiki/499423}<- \n->${buttonlink?highlight=true&text=NF2 Public Data&url=https://www.synapse.org/#!Synapse:syn6133098}<-\n${buttonlink?text=Back to CTF Data Portal&url=https://nf%2Esynapse%2Eorg/Organizations/DetailsPage%3Fabbreviation%3DCTF&highlight=true&align=Center}\n\n----\n\nThe Synodos NF2 project has generated several types of ‘omic and drug screening data from NF2 tumor models of schwannoma and meningioma, including: \n* Low throughput drug screening data: A panel of rationally-selected small molecules and drugs such as mTOR and HDAC inhibitors were tested against human and mouse cell line models of meningioma and schwannoma. \n* Single-agent and combination high throughput drug screening data: A panel of 1912 drugs and drug-like molecules (the MIPE 4.0 library from NCATS) was screened in 6 cell line models of meningioma and schwannoma with NF2 wildtype or NF2 deficient status. In addition, 4 of these cell lines were screened with 6x6 and 10x10 point combination dose-response assays with this panel of drugs. Both raw and processed data are available. \n* Genomic variant data (structural rearrangement): Jumping library sequencing facilitates detection of chromosomal abnormalities such as pathogenic breakpoints. There are processed data (bam files) from 11 human and mouse cell line models of meningioma and schwannoma with NF2 wildtype or NF2 deficient status. \n* Gene expression: Raw (fastq files) and processed (bam, count, and differential expression files) RNAseq data were generated from an Nf2fl/fl mouse model dorsal root ganglion tissue and cell line models of meningioma and schwannoma. In addition, data were generated from cell line models of meningioma and schwannoma with vehicle control, or 12 different single agent or combinations of small molecule inhibitors. Data from the 2017 release and the 2019 release are both now available for exploration.\n* Kinomics: Processed data are available from NF2 mouse model dorsal root ganglion tissue several cell line models of meningioma and schwannoma after treatment with a vehicle control or one of seven small molecules. Data from the 2017 release and the 2019 release are both now available for exploration.\n\n\n## Tables for Curation\n1. ID: syn64954668\nName: 2017 Release - Jumping Library Seq\nSummary:\n- Assays: jumping library\n- Species: Homo sapiens, Mus musculus, \n- Individual count: 11\n- Specimen count: 12\n- Diagnoses present: , Neurofibromatosis type 2\n- Tumor types present: Meningioma, Schwannoma, \n- Data types: genomicVariants\n- File formats present: bam, bai, doc\n- Funders: CTF\n- Contains data created by: Robert Allaway\n- Example files present: Syn1_i14.mkdup.coordsort.bam, Syn2_i2.mkdup.coordsort.bam, Syn5_i6.mkdup.coordsort.bam, Syn5_i5.mkdup.coordsort.bam, NF2_i7.mkdup.coordsort.bam\n\n\n\n2. ID: syn64954669\nName: 2017 Release - Proteomics_Kinome\nSummary:\n- Assays: MIB/MS\n- Species: Homo sapiens, Mus musculus, Homo sapiens,Mus musculus\n- Individual count: 11\n- Specimen count: 9\n- Diagnoses present: Neurofibromatosis type 2, \n- Tumor types present: [\"Schwannoma\"], [\"Meningioma\"], [\"Schwannoma\", \"Meningioma\"]\n- Data types: kinomics\n- File formats present: excel, txt, csv, tsv\n- Funders: CTF\n- Contains data created by: Abhishek Pratap\n- Example files present: HS01_run1_CUDC_and_Pano_kinome.xlsx, HS01_run1_CUDC_and_Pano_kinome_peptides.txt, HS01_run1_GSK458_kinome.xlsx, HS01_run1_GSK458_kinome_peptides.txt, HS01_run2_CUDC_and_Pano_kinome.xlsx\n\n\n\n3. ID: syn64954671\nName: 2019 Release - Animal Studies\nSummary:\n- Assays: in vivo bioluminescence\n- Species: Mus musculus, Homo sapiens\n- Individual count: ?\n- Specimen count: 2\n- Diagnoses present: Neurofibromatosis type 2\n- Tumor types present: Meningioma\n- Data types: volume\n- File formats present: csv, excel\n- Funders: CTF\n- Contains data created by: Robert Allaway\n- Example files present: GSK458_mouse_data_standardized.csv, GSK458_Panobinostat_CUDC907TreatmentData.xlsx, MK2206andBrigatinibAloneAndCombinationINTheBenMen1Model.xlsx, MK2206andBrigatinibCombinationAndBrigatinibAlonePostTxAndReTx.xlsx\n\n\n\n4. ID: syn64954672\nName: 2019 Release - High-Throughput Drug Screens\nSummary:\n- Assays: cell viability assay\n- Species: Homo sapiens, Mus musculus\n- Individual count: 7\n- Specimen count: 15\n- Diagnoses present: Neurofibromatosis type 2\n- Tumor types present: [\"Schwannoma\"], [\"Meningioma\"], [\"Schwannoma\", \"Meningioma\"]\n- Data types: drugScreen\n- File formats present: csv, txt, excel\n- Funders: CTF\n- Contains data created by: Robert Allaway\n- Example files present: HS01_CCG_20hours_calc_set1.csv, HS01_CCG_20hours_calc_set2.csv, HS01_CCG_20hours_metadata_set1.csv, HS01_CCG_20hours_metadata_set2.csv, HS01_CCG_20hours_responses_set1.csv\n\n\n\n5. ID: syn64954673\nName: 2019 Release - Proteomics_Kinome\nSummary:\n- Assays: MIB/MS, sandwich ELISA\n- Species: Homo sapiens, Homo sapiens,Mus musculus, Mus musculus\n- Individual count: 3\n- Specimen count: 2\n- Diagnoses present: Neurofibromatosis type 2\n- Tumor types present: , Meningioma, Schwannoma\n- Data types: kinomics, immunoassay\n- File formats present: pzf, excel, powerpoint, doc, pdf, xlsx\n- Funders: CTF\n- Contains data created by: Robert Allaway\n- Example files present: 170919-Syn1-Syn5-MK2206-Brig.pzf, 170925-PCA plot-allLFQ.pzf, Syn1Syn5-MK2206-Brigatinib-Combo.xlsx, 170927-HS11-HS01-Brig-Das-Sim-replicate1summary.pptx, 170927-PCA plot-allLFQ.pzf\n\n\n\n6. ID: syn64954674\nName: 2019 Release - RNASeq\nSummary:\n- Assays: RNA-seq, \n- Species: Homo sapiens, Mus musculus, \n- Individual count: 8\n- Specimen count: 109\n- Diagnoses present: Neurofibromatosis type 2, \n- Tumor types present: Meningioma, Schwannoma, \n- Data types: geneExpression, \n- File formats present: bam, fastq, log, R script, tsv\n- Funders: CTF\n- Contains data created by: Serkan Erdin, Robert Allaway\n- Example files present: Syn1_1.Aligned.out.bam, Syn1_10.Aligned.out.bam, Syn1_11.Aligned.out.bam, Syn1_12.Aligned.out.bam, Syn1_13.Aligned.out.bam\n\n\n\n7. ID: syn64954675\nName: 2021 - Raw Blot Images\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: CTF\n- Contains data created by: Abbi Smith\n- Example files present: S1_raw_images.pdf\n\n\n\n8. ID: syn55203921\nName: Gene Expression Quantification from RNA-seq\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 2\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 2, \n- Tumor types present: Schwannoma\n- Data types: geneExpression\n- File formats present: sf\n- Funders: CTF\n- Contains data created by: Robert Allaway\n- Example files present: quant.genes.sf, quant.genes.sf, quant.sf, quant.sf, quant.sf\n\n\n\n9. ID: syn64954676\nName: NF-OSI RNASeq Reprocessing\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 75\n- Specimen count: 84\n- Diagnoses present: Neurofibromatosis type 2, \n- Tumor types present: , Meningioma\n- Data types: geneExpression\n- File formats present: sf\n- Funders: CTF\n- Contains data created by: Sara Gosline\n- Example files present: HS01_1_quant.sf, HS01_10_quant.sf, HS01_11_quant.sf, HS01_12_quant.sf, HS01_13_quant.sf\n\n\n\n10. ID: syn51914478\nName: Synodos NF2 Drug Screen - 2017 Release\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Abhishek Pratap\n- Example files present: Synodos_DrugScreen_processed_data.tsv, Synodos_DrugScreen_combined_rawData.tsv\n\n\n\n11. ID: syn51914129\nName: Synodos NF2 Processed RNA-seq - 2017 Release\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Robert Allaway\n- Example files present: schwannoma_reseq_raw_counts_bedtoolsHtseq.txt, Synodos_mouseSchwannoma_RNASeq_diffExp_genes.tsv, meningioma_differential_expression.txt, schwannoma_differential_expression.txt, meningioma_raw_counts.txt\n\n\n\n12. ID: syn64954670\nName: Synodos NF2 RNA-seq Raw Data - 2017 Release\nSummary:\n- Assays: RNA-seq, \n- Species: Homo sapiens, , Mus musculus\n- Individual count: 47\n- Specimen count: 205\n- Diagnoses present: Neurofibromatosis type 2, \n- Tumor types present: Schwannoma, , Meningioma\n- Data types: geneExpression, \n- File formats present: fastq, txt, bam, tsv, bai, html, zip, bat\n- Funders: CTF\n- Contains data created by: Steven Angus, Robert Allaway\n- Example files present: HS01_CUDC907_Run1_S2_R1_001.fastq, HS01_CUDC907_Run2_S2_R1_001.fastq, HS01_CUDC907_Run3_S2_R1_001.fastq, HS01_DMSO_Run1_S1_R1_001.fastq, HS01_DMSO_Run2_S1_R1_001.fastq\n\n\n"}]}]}}
{"custom_id":"syn11374349","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn11374349\n\n###Modeling NF with human Schwann cells via tunable and reversible control of NF1 protein\n&nbsp;\n\n#####**PI:**  Gabsang Lee, Ph.D.\n**Johns Hopkins University**\n\n&nbsp;\n\n######**Study Design:**  \n\nWe will combine the human Schwann cell specification system and temporal ‘SMASh’ control of NF1 protein to develop a humanized cNF model with hESCs (**Figure**). First, we will modify the NF1 locus by ‘knocking-out’ one allele of NF1 and ‘knocking-in’ the SMASh tag and Puro-selection cassette (as a donor vector) into the other allele. The Lee and Kim labs have been working on genetic editing in human pluripotent stem cells for over three years and have generated many ‘knock-in’ and ‘knock-out’ lines. After verification of the gene targeting and pluripotency of the selected clones, established NF1-/SMASh hESC clones will be subjected to our Schwann cell specification protocol. We will treat cells with the asunaprevir (ASv) chemical compound at different time points to assess any cellular and molecular changes, either in intact cells or isolated populations (SOX10::GFP+ neural crest cells, CD49d+ Schwann cell precursors and EGFR+ Schwann cells).\n\n&nbsp;\n\n${image?fileName=lee%2Epng&align=Center&scale=100&responsive=true}\n\n&nbsp;\n\n######**Deliverables:**\n1. NF1-/SMASh SOX10::GFP hESC clones,\n2. Frozen stocks of SOX10::GFP+ neural crest cells, CD49d+ Schwann cell precursors and EGFR+ Schwann cells upon NF1 loss (at least three vials for each cells, ~20,000 cells per vial), and\n3. Cellular and molecular profiling of each cell type.\n\n&nbsp;\n\n######**Expected Outcomes:**\n\nThe goal of this project is to generate a viable human Schwann cell model for cNF and identify differences in susceptibility to NF1 loss in different stages of Schwann cell development. In addition, we will provide the tunable and reversible method of control of NF1 expression (culminated in NF1-/SMASh hESCs) to the general neurofibroma and neurofibromatosis research community.\n\n&nbsp;\n\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n\n\n## Tables for Curation\n1. ID: syn64954749\nName: 12 month deliverables\nSummary:\n- Assays: , immunohistochemistry, quantitative PCR, flow cytometry\n- Species: , Homo sapiens\n- Individual count: 1\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: , image, geneExpression\n- File formats present: doc, pdf\n- Funders: NTAP\n- Contains data created by: gabsang lee\n- Example files present: 1. Cell cycle data.docx, 2. qRT-PCR data.docx, 3. Karyotyping data.docx, 4. Staining data.docx, 20X-2-20-DAPI(B).tif\n\n\n\n2. ID: syn64954750\nName: 18 month deliverables\nSummary:\n- Assays: western blot, flow cytometry, quantitative PCR, immunohistochemistry, immunofluorescence\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: image\n- File formats present: doc, png, excel, tif\n- Funders: NTAP\n- Contains data created by: gabsang lee\n- Example files present: 1. western blot data.docx, 2. Annexin V-PI staining data.docx, 3. qRT-PCR.docx, 4. Immunostainig and FACS data.docx, wetern blot.png\n\n\n\n3. ID: syn64954751\nName: 24 month deliverables\nSummary:\n- Assays: western blot, quantitative PCR, immunofluorescence, immunocytochemistry, \n- Species: ?\n- Individual count: ?\n- Specimen count: 1\n- Diagnoses present: , \n- Tumor types present: , \n- Data types: geneExpression, immunoassay, \n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: gabsang lee\n- Example files present: 2. western blot data.docx, 3. qRT-PCR data.docx, 4. FACS analysis data.docx, 1. immunostaining data.docx, 3. qRT-PCR.png\n\n\n\n4. ID: syn64954752\nName: 30 month deliverables\nSummary:\n- Assays: immunocytochemistry, atomic force microscopy, immunofluorescence, RNA-seq, quantitative PCR, \n- Species: ?\n- Individual count: ?\n- Specimen count: 1\n- Diagnoses present: , \n- Tumor types present: , \n- Data types: immunoassay, image, geneExpression, \n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: gabsang lee\n- Example files present: 3. MBP staining data.docx, 4. TEM data.docx, 1. FACS sorting data.docx, 2. RNA-seq data.docx, 1. FACS sorting - CD49+ SCP cells.png\n\n\n\n5. ID: syn64954753\nName: 36 month deliverables\nSummary:\n- Assays: cell viability assay, quantitative PCR, atomic force microscopy, RNA-seq, immunofluorescence, \n- Species: , Homo sapiens\n- Individual count: ?\n- Specimen count: 16\n- Diagnoses present: ?\n- Tumor types present: , Not Applicable\n- Data types: cellularPhysiology, geneExpression, image, immunoassay, \n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: gabsang lee, NF Service\n- Example files present: 3. Cell proliferation assay.docx, 4. qRT-PCR assay.docx, 5. TEM imaging.docx, 1. RNA-seq data.docx, 2. Cell cycle analysis data.docx\n\n\n\n6. ID: syn64954754\nName: 6 month deliverables\nSummary:\n- Assays: , Sanger sequencing\n- Species: , Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: , genomicVariants\n- File formats present: doc, pdf\n- Funders: NTAP\n- Contains data created by: gabsang lee\n- Example files present: 1. Construction of Donor vector.docx, 2. Transfection data.docx, 3. Sequencing data.docx, 4. Expansion data.docx, 180723 NF1-SMASh Summary .docx\n\n\n\n7. ID: syn51930817\nName: Gene Expression Quantification from RNA-seq\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: 16\n- Diagnoses present: ?\n- Tumor types present: Not Applicable\n- Data types: geneExpression\n- File formats present: sf\n- Funders: ?\n- Contains data created by: NF Service\n- Example files present: quant.genes.sf, quant.sf, quant.genes.sf, quant.sf, quant.sf\n\n\n\n8. ID: syn51199006\nName: NFOSI-RNASeq-To-Process-2023-14-03\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: Not Applicable\n- Data types: geneExpression\n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: gabsang lee\n- Example files present: ES-SSEA4-A1_R1.fastq.gz, ES-SSEA4-A1_R2.fastq.gz, ES-SSEA4-A2_R1.fastq.gz, ES-SSEA4-A2_R2.fastq.gz, ES-SSEA4-D1_R1.fastq.gz\n\n\n"}]}]}}
{"custom_id":"syn5698493","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn5698493\n\n${image?fileName=CTF Synodos Data Site Headers3%2Ejpg&align=Center&scale=100&responsive=true}\n###**Welcome to the Synodos for NF1- Low Grade Glioma Site**\n\nThis site is the central place for all data related to the CTF-funded Synodos for NF1 - Low Grade Glioma project.  The wiki area and specific folders can be accessed by all members of the group from the menu on the left. \n\n###Data Generation Update\nTo access the data, please follow [these instructions](https://www.synapse.org/#!Synapse:syn5698493/wiki/617779). \n${plot?query=SELECT tumorType,assay,count(distinct individualID) as number FROM syn11614205 group by assay,tumorType&title=Tumors collected by data type&xaxis=tumorType&yaxis=Number of patients &type=BAR&barmode=GROUP&fill=assay&horizontal=TRUE}\n\nThe counts for these files can be found below:\n${plot?query=SELECT tumorType,assay,count(distinct id) as number FROM syn11614205 group by assay,tumorType&title=Files collected by data type&xaxis=tumorType&yaxis=Number of files &type=BAR&barmode=GROUP&fill=assay&horizontal=TRUE}\n\n->${buttonlink?text=Back to CTF Data Portal&url=http%3A%2F%2Fwww%2Esynapse%2Eorg%2Fctf}<-\n\n## Tables for Curation\n1. ID: syn30865300\nName: Synodos LGG Methylation Arrays\nSummary:\n- Assays: methylation array\n- Species: Homo sapiens\n- Individual count: 43\n- Specimen count: 43\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Pilocytic Astrocytoma, Unknown, Low-Grade Glioma NOS, Pilomyxoid Astrocytoma, Diffuse Astrocytoma, Atypical Pilocytic Astrocytoma, Glioblastoma Multiforme, Anaplastic Astrocytoma, Pleomorphic Xanthoastrocytoma\n- Data types: chromatinActivity\n- File formats present: idat\n- Funders: CTF\n- Contains data created by: ?\n- Example files present: 201194000076_R07C01_Grn.idat, 201194000076_R07C01_Red.idat, 201194000076_R08C01_Grn.idat, 201194000076_R08C01_Red.idat, 201194000077_R01C01_Grn.idat\n\n\n\n2. ID: syn30865196\nName: Synodos LGG RNAseq\nSummary:\n- Assays: RNA-seq, 3D microtissue viability\n- Species: Homo sapiens\n- Individual count: 23\n- Specimen count: 23\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Pilocytic Astrocytoma, Unknown, Low-Grade Glioma NOS, Pleomorphic Xanthoastrocytoma, Diffuse Astrocytoma, Pilomyxoid Astrocytoma\n- Data types: geneExpression\n- File formats present: fastq\n- Funders: CTF\n- Contains data created by: ?\n- Example files present: AS-167591-LR-25156_R1.fastq.gz, AS-167591-LR-25156_R2.fastq.gz, AS-167592-LR-25156_R1.fastq.gz, AS-167592-LR-25156_R2.fastq.gz, AS-167593-LR-25156_R1.fastq.gz\n\n\n\n3. ID: syn30865247\nName: Synodos LGG Whole Genome Sequencing (bam)\nSummary:\n- Assays: whole genome sequencing\n- Species: Homo sapiens\n- Individual count: 22\n- Specimen count: 44\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Pilocytic Astrocytoma, Unknown, Low-Grade Glioma NOS, Pilomyxoid Astrocytoma, Diffuse Astrocytoma, Atypical Pilocytic Astrocytoma, Not Applicable\n- Data types: genomicVariants\n- File formats present: bam\n- Funders: CTF\n- Contains data created by: ?\n- Example files present: tumor_XI065_SYN_NF_004_merged.mdup.bam, tumor_XI065_SYN_NF_006_merged.mdup.bam, tumor_XI065_SYN_NF_007_merged.mdup.bam, tumor_XI065_SYN_NF_009_merged.mdup.bam, tumor_XI065_SYN_NF_010_merged.mdup.bam\n\n\n"}]}]}}
{"custom_id":"syn21984813","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn21984813\n\n##Predictive Modeling Utilizing a Preclinical NF1-MPNST Platform Suitable for Precision Oncology\nPIs: Angela Hirbe, David Largaespada\n\n### Rationale\nNF1 is one of the most prevalent cancer predisposition syndromes, affecting 1 in 2500 individuals worldwide. Approximately 10-13% of affected individuals will develop an aggressive sarcoma, the malignant peripheral nerve sheath tumor (MPNST). One of the major barriers to the improving outcomes for these patients is the lack of preclinical models that accurately represent the genetic heterogeneity of these cancers. In this regard, no effective therapies have emerged from recent clinical trials, which likely reflects the use of a single mouse MPNST model system (Nf1+/-;Trp53+/- mice) and a paucity of human tumor xenografts. To address this critical problem, our laboratories have successfully generated a series of patient-derived MPNST xenografts that more accurately reflect the genetic heterogeneity seen in the human condition. To date, we have generated 15 NF1-MPNST patient-derived xenograft (PDX) lines propagated in immunocompromised mice.  We have demonstrated that these lines harbor the spectrum of genomic alterations that we see in patients with NF1, including germline and somatic NF1 mutations, and subsets with loss of CDKN2A, TP53 mutations, EED/SUZ12 mutations, and numerous copy number changes. We plan to use collagen microtissues generated from the PDX lines in vitro to perform high throughput drug screening, to accelerate identification of efficacious therapeutic combinations.  We will then proceed with in vivo testing of the promising combinations. This proposal brings together four institutions with deep expertise in NF1 research and a non-profit, collaborative research institute, Sage Bionetworks, to develop a truly integrated effort to explore the therapeutic potential of a set of well-vetted drugs for MPNST. \n\n### Specific Scientific Aims\n#### Aim 1: Continue development and characterization of NF1-MPNST PDX lines to maintain the platform for pre-clinical testing.  Our goal is to generate a total of at least 20 unique PDX lines available for use in Aims 2 and 3.\n#### Aim 2: Determine the in vitro response to cytotoxic chemotherapy or targeted therapy based on molecular phenotype and computational modeling.  Our goal is to screen all PDX for responses to a set of well vetted candidate drugs and drug combinations using a novel high throughput 3-dimensional tissue culture platform.\n#### Aim 3: Determine the in vivo response to cytotoxic chemotherapy or targeted therapy or their combination and identify molecular signatures that are associated with this response.\n\n### Funding\n\nIn addition to funding from the Neurofibromatosis Research Initiative, this project was also supported in part through NCI 3U54CA224083-02S1 award to Ramaswamy Govindan, Li Ding, and Shunqiang Li for the Washington University PDX Development and Trial Center.\n\n### Citation\n\nWang J, Calizo A, Zhang L, Pino JC, Lyu Y, Pollard K, Zhang X, Larsson AT, Conniff E, Llosa NJ, Wood DK, Largaespada DA, Moody SE, Gosline SJ, Hirbe AC, Pratilas CA. CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. Sci Adv. 2023 Nov 24;9(47):eadg8876. doi: 10.1126/sciadv.adg8876. Epub 2023 Nov 24. PMID: 38000020; PMCID: PMC10672174.\n\nLarsson AT, Bhatia H, Calizo A, Pollard K, Zhang X, Conniff E, Tibbitts JF, Rono E, Cummins K, Osum SH, Williams KB, Crampton AL, Jubenville T, Schefer D, Yang K, Lyu Y, Pino JC, Bade J, Gross JM, Lisok A, Dehner CA, Chrisinger JSA, He K, Gosline SJC, Pratilas CA, Largaespada DA, Wood DK, Hirbe AC. Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology. Neuro Oncol. 2023 Nov 2;25(11):2044-2057. doi: 10.1093/neuonc/noad097. PMID: 37246765; PMCID: PMC10628938.\n\n## Tables for Curation\n1. ID: syn64954847\nName: Animal Tumor Growth Studies\nSummary:\n- Assays: in vivo tumor growth, \n- Species: Homo sapiens, \n- Individual count: 9\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, \n- Data types: drugScreen, \n- File formats present: csv, xlsx, \n- Funders: NFRI,NIH-NCI\n- Contains data created by: Ana Calizo, himanshi bhatia, Daniel Schefer\n- Example files present: JHU Animal Tumor Growth JH-2-031 tram_tno_ribo.csv, JHU Animal Tumor Growth WU-225 tram_tno_ribo.csv, JHU Animal Tumor Growth WU-386 tram_tno_ribo.csv, JHU Animal Tumor Growth WU-545 tram_tno_ribo.csv, MN2 InVivo.xlsx\n\n\n\n2. ID: syn43094628\nName: Batch 1 RNA-seq (Drug Treated Cell Lines)\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: ?\n- Example files present: ?\n\n\n\n3. ID: syn64954848\nName: Cell_growth_data_annotation_files\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NFRI,NIH-NCI\n- Contains data created by: Yang Lyu\n- Example files present: syn25791480_annotation.csv, syn25791505_annotation.csv, syn25837063_annotation.csv, syn25837094_annotation.csv, syn25837122_annotation.csv\n\n\n\n4. ID: syn64954849\nName: Drug Combo Incucyte\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NFRI,NIH-NCI\n- Contains data created by: Sara Gosline\n- Example files present: Compile of incucyte data.xlsx\n\n\n\n5. ID: syn64954851\nName: Hirbe_s5180_MGI0731_Batch2_RNAseq\nSummary:\n- Assays: ?\n- Species: Homo sapiens, \n- Individual count: 8\n- Specimen count: 16\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: ?\n- Data types: geneExpression, \n- File formats present: fastq, \n- Funders: NFRI,NIH-NCI\n- Contains data created by: Kuangying Yang, Yang Lyu\n- Example files present: 2-079_pdx.CCTTCACCAT-ACGACGCTCC.HM3CHDSXY_CCTTCACCAT-ACGACGCTCC_L004_R1.fastq.gz, WU-536_pt.AGCTCGCTAT-ACGCAGAATC.HNJG2DSXY_AGCTCGCTAT-ACGCAGAATC_L001_R2.fastq.gz, mn3_pt.TTCCTGTTAT-ACAGTATCTT.HM3CHDSXY_TTCCTGTTAT-ACAGTATCTT_L004_R2.fastq.gz, mn2_pdx.GTGTCGGAAT-ACGCTTGCGC.HNJG2DSXY_GTGTCGGAAT-ACGCTTGCGC_L001_R1.fastq.gz, 2-055_pt_rna.ACTCGTGTAT-ACATTGGAAC.HM3CHDSXY_ACTCGTGTAT-ACATTGGAAC_L004_R1.fastq.gz\n\n\n\n6. ID: syn64954852\nName: Incucyte Drug Response Data\nSummary:\n- Assays: cell viability assay\n- Species: Homo sapiens, \n- Individual count: 4\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor\n- Data types: drugScreen\n- File formats present: xlsx\n- Funders: NFRI,NIH-NCI\n- Contains data created by: Ana Calizo\n- Example files present: Incucyte_JH-2-002_trametinib+trabectedin.xlsx, Incucyte_JH-2-002_mirdametinib+trabectedin.xlsx, Incucyte_JH-2-002_selumetinib+trabectedin.xlsx, Incucyte_JH-2-079_mirdametinib+trabectedin.xlsx, Incucyte_JH-2-079_selumetinib+trabectedin.xlsx\n\n\n\n7. ID: syn64954853\nName: JH_Samples_WEX_MAF\nSummary:\n- Assays: whole exome sequencing, \n- Species: Homo sapiens, \n- Individual count: 6\n- Specimen count: 6\n- Diagnoses present: Unknown, \n- Tumor types present: ?\n- Data types: genomicVariants, \n- File formats present: ?\n- Funders: NFRI,NIH-NCI\n- Contains data created by: Yang Lyu\n- Example files present: JH-2-009_Tumor_filtered_somatic_variants.maf, JH-2-079_Tumor_filtered_somatic_variants.maf, JH-2-055_Tumor_filtered_somatic_variants.maf, JH-2-002_Tumor_filtered_somatic_variants.maf, JH-2-023_Tumor_filtered_somatic_variants.maf\n\n\n\n8. ID: syn64954854\nName: MGI_DT-2862929_Batch2_WEX\nSummary:\n- Assays: whole exome sequencing, \n- Species: Homo sapiens, \n- Individual count: 8\n- Specimen count: 21\n- Diagnoses present: , high grade metastatic MPNST, high grade MPNST, Atypical Neurofibroma, NA\n- Tumor types present: Not Applicable, Malignant Peripheral Nerve Sheath Tumor, Recurrent MPNST, Atypical Neurofibroma, Atypical MPNST, \n- Data types: genomicVariants, \n- File formats present: fastq, \n- Funders: NFRI,NIH-NCI\n- Contains data created by: Yang Lyu\n- Example files present: gccactta-ctctactc_s69_l001_r1_001.fastq.gz, gccactta-ctctactc_s69_l001_r2_001.fastq.gz, hlvwkdsxy_acttagatcg-gccaacatta_l001_r1.fastq.gz, hlvwkdsxy_acttagatcg-gccaacatta_l001_r2.fastq.gz, hlvwkdsxy_agaggcacga-ctcgttgtcg_l001_r1.fastq.gz\n\n\n\n9. ID: syn64954855\nName: MGI_DT-2862929_Batch2_WEX_BAM\nSummary:\n- Assays: whole exome sequencing, \n- Species: Homo sapiens, \n- Individual count: 8\n- Specimen count: 14\n- Diagnoses present: ?\n- Tumor types present: normal, Malignant Peripheral Nerve Sheath Tumor, Atypical Neurofibroma, \n- Data types: genomicVariants, \n- File formats present: bam, \n- Funders: NFRI,NIH-NCI\n- Contains data created by: Yang Lyu\n- Example files present: jh-2-055_normal_trimmed_mk_dup_after_bqsr.bai, jh-2-055_normal_trimmed_mk_dup_after_bqsr.bam, jh-2-055_pdx_trimmed_mk_dup_after_bqsr.bai, jh-2-055_pdx_trimmed_mk_dup_after_bqsr.bam, jh-2-055_tumor_trimmed_merged_mkdup_after_bqsr.bai\n\n\n\n10. ID: syn64954856\nName: MGI_DT-2862930_Batch2_WGS\nSummary:\n- Assays: whole genome sequencing, \n- Species: Homo sapiens, \n- Individual count: 8\n- Specimen count: 22\n- Diagnoses present: NA, high grade MPNST, high grade metastatic MPNST, Atypical Neurofibroma, high grade MPNST with divergent differentiation, \n- Tumor types present: Not Applicable, Atypical MPNST, Recurrent MPNST, Malignant Peripheral Nerve Sheath Tumor, Atypical Neurofibroma, \n- Data types: genomicVariants, \n- File formats present: fastq, \n- Funders: NFRI,NIH-NCI\n- Contains data created by: Yang Lyu\n- Example files present: HLGL7DSXY_CACATGCCAG-GCACAGTGTG_L001_R1.fastq.gz, HLGL7DSXY_CACATGCCAG-GCACAGTGTG_L001_R2.fastq.gz, HLGL7DSXY_CAGTTGGAGG-ACGACAATGA_L001_R1.fastq.gz, HLGL7DSXY_CAGTTGGAGG-ACGACAATGA_L001_R2.fastq.gz, HLMY5DSXY_AACACGCCAC-ACACCAGCTG_L002_R1.fastq.gz\n\n\n\n11. ID: syn64954857\nName: MGI_DT_2862930_Batch2_WGS_BAM\nSummary:\n- Assays: whole genome sequencing, \n- Species: Homo sapiens, \n- Individual count: 8\n- Specimen count: ?\n- Diagnoses present: nan, \n- Tumor types present: ?\n- Data types: genomicVariants, \n- File formats present: bam, bai, \n- Funders: NFRI,NIH-NCI\n- Contains data created by: Yang Lyu\n- Example files present: JH-2-009_PDX_trimmed_mk_dup_after_BQSR.bam, JH-2-009_Normal_trimmed_mk_dup_after_BQSR.bam, JH-2-009_Tumor_trimmed_mk_dup_after_BQSR.bam, WU-487_PDX_trimmed_mk_dup_after_BQSR.bam, WU-487_Normal_trimmed_merged_mkdup_after_BQSR.bam\n\n\n\n12. ID: syn64954858\nName: MGI_WEX_2020_Batch1_BAM\nSummary:\n- Assays: whole exome sequencing, \n- Species: Homo sapiens, \n- Individual count: 8\n- Specimen count: 27\n- Diagnoses present: ?\n- Tumor types present: normal, Malignant Peripheral Nerve Sheath Tumor, \n- Data types: genomicVariants, \n- File formats present: bam, \n- Funders: NFRI,NIH-NCI\n- Contains data created by: Yang Lyu\n- Example files present: JH-2-002_Normal_trimmed_mk_dup_after_BQSR.bam, JH-2-002_Normal_trimmed_mk_dup_after_BQSR.bai, JH-2-002_PDX_trimmed_merged_mkdup_after_BQSR.bam, JH-2-002_PDX_trimmed_merged_mkdup_after_BQSR.bai, JH-2-002_Tumor_trimmed_merged_mkdup_after_BQSR.bam\n\n\n\n13. ID: syn50924729\nName: NF-OSI_processing_01242023\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Yang Lyu\n- Example files present: gerald_HN7F3BBXX_2_ATTACTCG-GGCTCTGA.bam, gerald_HN7F3BBXX_2_ATTCAGAA-GGCTCTGA.bam, gerald_HN7F3BBXX_2_CGCTCATT-GGCTCTGA.bam, gerald_HN7F3BBXX_2_CGGCTATG-GGCTCTGA.bam, gerald_HN7F3BBXX_2_CTGAAGCT-GGCTCTGA.bam\n\n\n\n14. ID: syn50207753\nName: NFOSI-processing_12192022\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Yang Lyu\n- Example files present: gerald_HN7F3BBXX_2_ATTACTCG-GGCTCTGA.bam, gerald_HN7F3BBXX_2_ATTCAGAA-GGCTCTGA.bam, gerald_HN7F3BBXX_2_CGCTCATT-GGCTCTGA.bam, gerald_HN7F3BBXX_2_CGGCTATG-GGCTCTGA.bam, gerald_HN7F3BBXX_2_CTGAAGCT-GGCTCTGA.bam\n\n\n\n15. ID: syn64954859\nName: Proteomics\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NFRI,NIH-NCI\n- Contains data created by: Sara Gosline, Camilo Posso\n- Example files present: 4008 Phospho crosstab.txt, 4007 Global crosstab.txt, FISH_metadata.xlsx, 4007 Phospho crosstab.txt, 4008 Global crosstab.txt\n\n\n\n16. ID: syn64954861\nName: Sample_annotation\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NFRI,NIH-NCI\n- Contains data created by: Yang Lyu\n- Example files present: WU_PDX_batch1_2_WU_samples.xlsx\n\n\n\n17. ID: syn64954862\nName: Somatic_Varaint_Calls_WEX_2020\nSummary:\n- Assays: whole exome sequencing\n- Species: ?\n- Individual count: 8\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: genomicVariants\n- File formats present: maf\n- Funders: NFRI,NIH-NCI\n- Contains data created by: Yang Lyu\n- Example files present: WU-436_PDX_filtered_somatic_variants.maf, WU-368_PDX_filtered_somatic_variants.maf, WU-225_PDX_filtered_somatic_variants.maf, WU-356_PDX_filtered_somatic_variants.maf, WU-386_PDX_filtered_somatic_variants.maf\n\n\n\n18. ID: syn64954863\nName: Updated Somatic Variant Calls\nSummary:\n- Assays: whole exome sequencing\n- Species: Homo sapiens\n- Individual count: 7\n- Specimen count: 14\n- Diagnoses present: high grade metastatic MPNST, high grade MPNST, high grade MPNST with divergent differentiation, , Atypical Neurofibroma\n- Tumor types present: Atypical MPNST, Malignant Peripheral Nerve Sheath Tumor, Recurrent MPNST, Atypical Neurofibroma\n- Data types: genomicVariants\n- File formats present: maf\n- Funders: NFRI,NIH-NCI\n- Contains data created by: Yang Lyu\n- Example files present: JH-2-055_PDX_filtered_somatic_variants.maf, JH-2-055_Tumor_plus_PDX_VCF_review_somatic.maf, JH-2-079_PDX_filtered_somatic_variants.maf, JH-2-079_Tumor_plus_PDX_VCF_review_somatic.maf, MN2_PDX_filtered_somatic_variants.maf\n\n\n\n19. ID: syn64954864\nName: WGS_CNVKIT_MGI2020_2862930\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NFRI,NIH-NCI\n- Contains data created by: Yang Lyu\n- Example files present: MN2_PDX_trimmed_mk_dup_after_BQSR.targetcoverage.cnn, MN3_PDX_trimmed_mk_dup_after_BQSR.targetcoverage.cnn, WU-225_PDX_trimmed_mk_dup_after_BQSR.targetcoverage.cnn, WU-356_PDX_trimmed_mk_dup_after_BQSR.targetcoverage.cnn, WU-368_PDX_trimmed_mk_dup_after_BQSR.targetcoverage.cnn\n\n\n"}]}]}}
{"custom_id":"syn5562324","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn5562324\n\n\n### Phenotypic screening of anti-NF2 drug candidates as a single agent or in combination using high content assays in merlin-deficient and normal mouse schwann cells\n\nThis project was an industry-academia collaboration between Cenix Bioscience and the University of Central Florida. MS01 and MS11 mouse Schwann cells (NF2-/- and NF2 wild-type) were screened with 95 different drugs and vehicle conditions for 48 hours in an 8-point dose response format. The screen also included a 30 minute incubation wih 10uM EdU to assess DNA replication in all conditions. At the end of the incubation period, phenotypic measurements were performed with an automated microscope (Image Express) and analyzed with the Definiens automated image analysis software. A variety of nuclear phenotypes were assessed for all conditions, including EDU-positive nuclei, number of nuclei, oversized nuclei, mitotic nuclei, undersized nuclei, non-ellipsoid nuclei, and condensed nuclei. MS11 were Mouse Schwann cells purchased from ScienCell (#M1700). MS01 were derived from Schwann cells from the sciatic nerves of adult Nf2flox2/flox2 mice that underwent Nf2 exon 2 deletion by in vitro infection with a Cre-expressing adenovirus (Ad-Cre).\n\n### Data\nAvailable [here.](syn5562327)\n\n#### Contributors: \n1. Children's Tumor Foundation \n2. Dr. Cristina Fernandez-Valle (UCF)\n3. Cenix Bioscience\n\n## Tables for Curation\n1. ID: syn51916091\nName: CTF-UCF-Cenix Complete Compound Drug Screen\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Abhishek Pratap\n- Example files present: CTF-UCF-Cenix-CompleteCompoundData-all passes in one tab_ to release_FINAL.xlsx\n\n\n"}]}]}}
{"custom_id":"syn22392179","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn22392179\n\n## Description\n\nEstablished cell lines have been extensively used in Malignant Peripheral Nerve Sheath Tumors (MPNST) research and are a vital tool for basic and preclinical works. However, the most widely used MPNST cell lines had not been exhaustively described and characterized at the genomic and epigenomic level, and for some of them, even the mutational status of critical genes for MPNST-genesis was missing. \n\nIn this project by the [Hereditary Cancer Laboratory](https://www.germanstrias.org/en/research/cancer/10/hereditary-cancer), at the [Germans Trias i Pujol Research Institute (IGTP)](http://www.igtp.cat) in Spain, we performed a deep genomic characterization of 8 of the most widely used MPNST cell lines to provide a solid foundation for MPNST basic and preclinical research. However, along the way, we found that some of the cell lines labeled as MPNST seemed to be derived from other tumor types. We found genomic evidence of this potential misdiagnosis and it perfectly matched with the potential misdiagnoses identified by a methylation-based sarcoma classifier.\n\nThis project was published in a paper titled \"[Deep genomic analysis of malignant peripheral nerve sheath tumor cell lines challenges current malignant peripheral nerve sheath tumor diagnosis](https://www.cell.com/iscience/fulltext/S2589-0042(23)00173-6)\" in iScience in 2023 with DOI [10.1016/j.isci.2023.106096](10.1016/j.isci.2023.106096) and previously in a BioRxiv preprint at [https://www.biorxiv.org/content/10.1101/2022.05.07.491026v1](https://www.biorxiv.org/content/10.1101/2022.05.07.491026v1).\n\nThis page contains all data generated in the project, including the raw data from the different genomic experiments (WGS, WES, SNP-array and Methylation arrays) as well as access to the summary information sheets we have generated for each cell line.\n\n### Citation\n\nIf you are using the data contained here you should cite Magallón-Lorenz _et. al._, 2023 at DOI [10.1016/j.isci.2023.106096](10.1016/j.isci.2023.106096)\n\n### Samples Summary\n\n${image?fileName=summary%5Ftable%2Epng&align=Center&scale=100&responsive=true&altText=Summary table with the genomic findings about the 8 MPNST cell lines}\n\n### Summary information sheets\n\nFor each of the cell lines analysed we created a summary information sheet summarizing the global genomic profile, the mutational status of MPNST-related genes, the STR profile, the methylome-based classification, ploidy analysis by flow cytometry, cell culture images and any additional information and mutations. \n\n${image?fileName=ST88%2D14%5FCellInfoSheet%5Fedited%2E2%2Epdf%2Epng&align=Center&scale=100&responsive=true&altText=}\n\n${buttonlink?text=ST88%2D14&url=https://www%2Esynapse%2Eorg/Portal/filehandleassociation%3FassociatedObjectId%3Dsyn51607061%26associatedObjectType%3DFileEntity%26fileHandleId%3D125171894&highlight=true&align=None}&nbsp;${buttonlink?text=S462&url=https://www%2Esynapse%2Eorg/Portal/filehandleassociation%3FassociatedObjectId%3Dsyn51607063%26associatedObjectType%3DFileEntity%26fileHandleId%3D125171898&highlight=true&align=None}&nbsp;${buttonlink?text=sNF96%2E2&url=https://www%2Esynapse%2Eorg/Portal/filehandleassociation%3FassociatedObjectId%3Dsyn51607062%26associatedObjectType%3DFileEntity%26fileHandleId%3D125171897&highlight=true&align=None}&nbsp;${buttonlink?text=NF90%2D8&url=https://www%2Esynapse%2Eorg/Portal/filehandleassociation%3FassociatedObjectId%3Dsyn51607069%26associatedObjectType%3DFileEntity%26fileHandleId%3D125171909&highlight=true&align=None}&nbsp;${buttonlink?text=NMS%2D2&url=https://www%2Esynapse%2Eorg/Portal/filehandleassociation%3FassociatedObjectId%3Dsyn51607065%26associatedObjectType%3DFileEntity%26fileHandleId%3D125171899&highlight=true&align=None}&nbsp;${buttonlink?text=STS%2D26T&url=https://www%2Esynapse%2Eorg/Portal/filehandleassociation%3FassociatedObjectId%3Dsyn51607068%26associatedObjectType%3DFileEntity%26fileHandleId%3D125171907&highlight=true&align=None}&nbsp;${buttonlink?text=HS%2DPSS&url=https://www%2Esynapse%2Eorg/Portal/filehandleassociation%3FassociatedObjectId%3Dsyn51607067%26associatedObjectType%3DFileEntity%26fileHandleId%3D125171904&highlight=true&align=None}&nbsp;${buttonlink?text=HS%2DSch%2D2&url=https://www%2Esynapse%2Eorg/Portal/filehandleassociation%3FassociatedObjectId%3Dsyn51607066%26associatedObjectType%3DFileEntity%26fileHandleId%3D125171901&highlight=true&align=None}\n\n## Access Restrictions\n\nThe data deposited here is freely available and has no access restrictions. \n\n## Access to raw data\n\nIn the Files tab, you can find the raw data for [SNP-array](https://www.synapse.org/#!Synapse:syn30058753), [WES](https://www.synapse.org/#!Synapse:syn30091998) and [WGS](https://www.synapse.org/#!Synapse:syn30093085) analysis.\n\n\n\n\n\n## Tables for Curation\n1. ID: syn51586253\nName: MPNST Cell Line Methylation Arrays\nSummary:\n- Assays: methylation array\n- Species: Homo sapiens, \n- Individual count: 8\n- Specimen count: 8\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable, \n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, Melanoma, Sarcoma, \n- Data types: chromatinActivity\n- File formats present: idat, \n- Funders: Fundación Proyecto Neurofibromatosis\n- Contains data created by: ?\n- Example files present: 205023290165_R06C01_Grn.idat, 205023290165_R06C01_Red.idat, 205023290165_R07C01_Grn.idat, 205023290165_R07C01_Red.idat, 205049780004_R06C01_Grn.idat\n\n\n\n2. ID: syn30613372\nName: MPNST Cell Line SNP Arrays\nSummary:\n- Assays: SNP array\n- Species: Homo sapiens\n- Individual count: 8\n- Specimen count: 8\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, Melanoma, Sarcoma\n- Data types: genomicVariants\n- File formats present: txt\n- Funders: Fundación Proyecto Neurofibromatosis\n- Contains data created by: ?\n- Example files present: NF90-8.txt, HS-Sch-2.txt, sNF96.2.txt, HS-PSS.txt, STS-26T.txt\n\n\n\n3. ID: syn51585807\nName: MPNST Cell Line Whole Exome Sequencing\nSummary:\n- Assays: whole exome sequencing\n- Species: Homo sapiens\n- Individual count: 8\n- Specimen count: 8\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, Sarcoma, Melanoma\n- Data types: genomicVariants\n- File formats present: fastq\n- Funders: Fundación Proyecto Neurofibromatosis\n- Contains data created by: ?\n- Example files present: S462_2.fastq.gz, HS_PSS_2.fastq.gz, STS-26T_2.fastq.gz, HS-Sch-2_1.fastq.gz, sNF96.2_2.fastq.gz\n\n\n\n4. ID: syn51585677\nName: MPNST Cell Line Whole Genome Sequencing\nSummary:\n- Assays: whole genome sequencing\n- Species: Homo sapiens\n- Individual count: 8\n- Specimen count: 8\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, Melanoma, Sarcoma\n- Data types: genomicVariants\n- File formats present: fastq\n- Funders: Fundación Proyecto Neurofibromatosis\n- Contains data created by: ?\n- Example files present: S462_2.fastq.gz, STS-26T_2.fastq.gz, HS-PSS_2.fastq.gz, HS-Sch-2_1.fastq.gz, sNF96.2_2.fastq.gz\n\n\n\n5. ID: syn64954877\nName: Methylation\nSummary:\n- Assays: methylation array, \n- Species: Homo sapiens, \n- Individual count: 8\n- Specimen count: 8\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable, \n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, Melanoma, Sarcoma, \n- Data types: chromatinActivity, \n- File formats present: idat, \n- Funders: Fundación Proyecto Neurofibromatosis\n- Contains data created by: Bernat Gel Moreno, Robert Allaway\n- Example files present: 205023290165_R06C01_Grn.idat, 205023290165_R06C01_Red.idat, 205023290165_R07C01_Grn.idat, 205023290165_R07C01_Red.idat, 205049780004_R06C01_Grn.idat\n\n\n\n6. ID: syn64954878\nName: SNP_array\nSummary:\n- Assays: SNP array, \n- Species: Homo sapiens, \n- Individual count: 8\n- Specimen count: 8\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable, \n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, Melanoma, Sarcoma, \n- Data types: genomicVariants, \n- File formats present: txt, \n- Funders: Fundación Proyecto Neurofibromatosis\n- Contains data created by: Bernat Gel Moreno, Robert Allaway\n- Example files present: NF90-8.txt, HS-Sch-2.txt, sNF96.2.txt, HS-PSS.txt, STS-26T.txt\n\n\n\n7. ID: syn64954879\nName: WES\nSummary:\n- Assays: whole exome sequencing, \n- Species: Homo sapiens, \n- Individual count: 8\n- Specimen count: 8\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable, \n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, Sarcoma, Melanoma, \n- Data types: genomicVariants, \n- File formats present: fastq, \n- Funders: Fundación Proyecto Neurofibromatosis\n- Contains data created by: Bernat Gel Moreno, Robert Allaway\n- Example files present: S462_2.fastq.gz, HS_PSS_2.fastq.gz, STS-26T_2.fastq.gz, HS-Sch-2_1.fastq.gz, sNF96.2_2.fastq.gz\n\n\n\n8. ID: syn64954882\nName: WGS\nSummary:\n- Assays: whole genome sequencing, \n- Species: Homo sapiens, \n- Individual count: 8\n- Specimen count: 8\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable, \n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, Melanoma, Sarcoma, \n- Data types: genomicVariants, \n- File formats present: fastq, \n- Funders: Fundación Proyecto Neurofibromatosis\n- Contains data created by: Bernat Gel Moreno, Robert Allaway\n- Example files present: S462_2.fastq.gz, STS-26T_2.fastq.gz, HS-PSS_2.fastq.gz, HS-Sch-2_1.fastq.gz, sNF96.2_2.fastq.gz\n\n\n"}]}]}}
{"custom_id":"syn11672851","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn11672851\n\n### Project Summary\n${image?fileName=Screen Shot 2018%2D02%2D19 at 4%2E46%2E36 PM%2Epng&align=Right&scale=50&responsive=true}\n\nPhenotypic high-throughput screens are often utilized in modern oncology drug discovery pipelines. Such screens are conducted with an array of molecules (panels of oncology drugs, drugs for other indications, and compounds with possibly unknown bioactivity), ultimately measuring a biological change within a disease model. While these screens can yield valuable hits, they also present the challenge of identifying the target(s) that mediate the effect seen in the screen for several reasons. For example, many drugs have a polypharmacologic target profile making it hard to identify which targets are biologically relevant for a given drug. Furthermore, some libraries contain molecules for which drug-target studies have never been conducted. \n&nbsp;\nTo address these challenges, we developed an application that enables exploration of the chemical-biological interaction space. Drug-target interaction data from [ChEMBL](https://www.ebi.ac.uk/chembl/) (CC BY-SA 3.0), [ChemicalProbes.org](www.chemicalprobes.org) (CC BY-SA 3.0), [DGIdb](http://www.dgidb.org/) (open), [DrugBank](https://www.drugbank.ca/) (CC BY-NC 4.0, used with approval), and [Klaeger, et al, 2017](http://science.sciencemag.org/content/358/6367/eaan4368) was collected for over 280,000 molecules. In addition, when quantitative data were obtained, pChEMBL values were calculated. Each molecule was annotated with a name and chemical structure, and every target was annotated with protein & gene identifiers. An interactive web interface was developed using the R Shiny platform and cheminformatics R packages. The app enables the end user with a specific query molecule to search a database of experimentally-derived drug-target interactions. The database can be queried using drug names or structures. A similarity parameter allows the user to expand their search to other structurally related molecules. The structure of the query molecule is compared to every database molecule, and structurally similar molecules and targets are presented in interactive tabular and network-based forms for in-depth exploration. \n&nbsp;\n\nThe app also performs enrichment analysis on the target lists, and allows the user to evaluate structure-activity relationships for drug response data using publicly-available in vitro datasets. Finally, if a user has a target of interest, they can search for molecules that bind that target and explore the resulting data interactively. This app provides a multifunctional platform for exploring chemical space as it relates to biological targets, and may be useful at several steps along the oncology drug development pipeline including target discovery, structure-activity relationship, and lead identification studies.\n\n## 2021 update:\n\nWow, it's been a while since this project was first released. Some updates: \n- I recently created an R package with functions that allow you to build a database locally. This might be of interest if you have some proprietary drug-target information that you'd like to aggregate alongside public data. Documentation is a work in progress, but please reach out if you'd like help: https://github.com/nf-osi/dtexbuilder\n- I've updated to v4 of the database. This database now contains content from ChEMBL v24.1, ChemicalProbes (07-02-2018), DGIdb 3.0.2, DrugBank 5.1.0 to ChEMBL v28, ChemicalProbes.org (03-10-2021), DGIdb 4.2.0, DrugBank 5.1.8.\n-this updates deprecates the concept of \"internal_id's\", and instead relies on the InChIKey to describe unique molecules. There is a small, but nonzero, chance that there are colliding hashed InChIs causing multiple molecules to be mis-aggregated together. However, this is unlikely considering the size of this database (e.g. the molecules in the database are restricted to \"real\" molecules and of those, only those that have been tested for activity against human targets). More reading on this issue here: https://depth-first.com/articles/2009/04/24/the-first-inchikey-collision/\n\nI've also made some updates to the front end app to make it compatible with the v4 database. I've also tackled some old bugs:\n- CIR search no longer works reliably, replaced with PUG-REST pubchem API query\n- enrichr data structure had a breaking change that resulted in the gene set enrichment analysis module no longer working. replaced Z-scores (which no longer exist) with combined scores.\n\n&nbsp;\n${buttonlink?text=Drug Target Explorer&url=https%3A%2F%2Fshiny%2Esynapse%2Eorg%2Fusers%2Frallaway%2Fpolypharmacology%2Ddb%2F}  \n&nbsp;\n${buttonlink?text=Drug Target Explorer Database v4&url=https://www.synapse.org/#!Synapse:syn25388367}\n&nbsp;\n\nThis app is licensed under the Apache 2.0 software license, and the [source code is available on Github](https://github.com/Sage-Bionetworks/polypharmacology-db).\n&nbsp;\nAs a requirement of the source database license agreements, this dataset is licensed under the [CC BY-SA 4.0](https://creativecommons.org/licenses/by-sa/4.0/) license. \n\n&nbsp;\n[${image?fileName=CC%5FBY%2DSA%5F3%2E0%2Epng&align=Left&scale=15&responsive=true}](https://creativecommons.org/licenses/by-sa/4.0/legalcode)\n\n\n\n\n## Tables for Curation\n1. ID: syn51927498\nName: Drug-Target Explorer\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Robert Allaway\n- Example files present: compound_target_associations_v4.rds, compound_target_associations_v4.csv, distinct_compound_names_v4.rds, distinct_compound_names_v4.csv, distinct_compound_synonyms_v4.csv\n\n\n"}]}]}}
{"custom_id":"syn37861830","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn37861830\n\n# From cold to hot - Reprogramming tumor microenvironment to target NF1 malignancies\n## CTF - Young Investigator Award\n### Principal Investigator: Bandarigoda Nipunika Somatilaka\n### Project Lead / Data Coordinator: Bandarigoda Nipunika Somatilaka\n### Institution: University of Texas Southwestern Medical Center\n### Project Description:\nNeurofibromatosis type 1 (NF1) affects about 1 in 3000 people worldwide. Patients with NF1 often develop benign tumors on the skin and along the nerves in the spinal cord and brain, and about 8-13% of those become cancerous over time. These cancerous tumors are called Malignant Peripheral Nerve Sheath Tumors (MPNST). The only method of curing MPNST is surgical removal, however, these tumors can be large and located close to complex nerve networks, making complete removal difficult. As a result, tumors tend to reappear after surgery or tumor cells migrate to different sites like lung or bone. When complete removal cannot be achieved, radiotherapy and chemotherapy are recommended to manage the tumor. Unfortunately, MPNST respond poorly to both these therapies. With this lack of treatment options, survival of patients with MPNST is low. \r NF1 is caused by a mutation of the NF1 gene, which encodes a protein called neurofibromin. Neurofibromin acts as an off-switch for downstream signaling pathways. Therefore, inactivating mutations of the NF1 gene produce non-functional neurofibromin resulting in constant signaling of these pathways. Researchers have tried to target these pathways with various drugs to treat MPNST, however clinical trials testing these drugs against MPNST were not successful. Therefore, finding a druggable target for MPNST has been challenging. Given the difficulty of surgical and clinical management, identifying an effective treatment strategy for MPNST is a desperate need. \r A recent approach to treating inoperable, undruggable cancer has been to use Immune Checkpoint Blockers (ICB). The role of immune checkpoints is to prevent the persistence of normal immune responses to avoid possible collateral tissue damage. Cancer cells hijack this mechanism and express immune checkpoint proteins to avoid detection by a patient’s immune cells. ICB disrupts this process, thus enhancing antitumor immunity. ICB has revolutionized the treatments of many cancers. However, for this approach to work, T cells and other types of immune cells must be present in the vicinity and within the tumor. Unfortunately, MPNST are “cold tumors” meaning they do not have many immune cells near and/or within the tumor. This makes using ICB against MPNST challenging. \r We hypothesize that turning MPNST into a “hot” tumor, i.e. increasing immune cell infiltration into the tumor, will make it susceptible to targeting with ICB. In this proposal, we will use a strategy to increase the number of T cells and other immune cells near and/or within the tumor: we will activate the cGAS-STING-IFN pathway, which enhances antitumor immunity through the production of a variety of small molecules capable of tumor cell destruction. We will treat MPNST-bearing mice with different small-molecule drugs to activate the STING pathway, thus turning the MPNST into “hot” tumors. We will then test various combinations of STING-activating drugs and immune checkpoint blockers to determine if they are effective in shrinking MPNST. If successful, this will represent a novel treatment strategy for MPNST, an aggressive and malignant tumor for which no molecular therapy currently exists.\n\n## Tables for Curation\n1. ID: syn64954925\nName: IHC Quantification\nSummary:\n- Assays: immunohistochemistry\n- Species: Mus musculus\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor\n- Data types: raw counts\n- File formats present: excel\n- Funders: CTF\n- Contains data created by: Anh Nguyet Vu\n- Example files present: JCI176748.sdval.xlsx\n\n\n"}]}]}}
{"custom_id":"syn4939874","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn4939874\n\n**Initiative:** Cell Culture\n**Name:** Peggy Wallace\n**Contact Email:** peggyw@mgm.ufl.edu\n**Dates:** 6-1-13 to 5-31-16\n**Tumor Focus:** Plexiform Neurofibroma\n**Application:** Preclinical Translational models\n&nbsp;\n**Background & Rationale:** Neurofibromas, which are benign Schwann cell tumors, are the hallmark feature in the autosomal dominant condition neurofibromatosis 1 (NF1) and are associated with biallelic loss of NF1 gene function. There is a need for effective therapies for neurofibromas, particularly the larger, plexiform neurofibromas. Tissue culture is an important tool for research. However, it is difficult to derive enriched human Schwann cell cultures, and most enter replicative senescence after 6–10 passages, impeding cell-based research in NF1.  We are well-positioned to develop cellular models, and collaborate with a robotics R&D/Lead Optimization group.\n&nbsp;\n**Goals of Project:** To identify (create/characterize) semi-immortalized pNF and normal/heterozygous SC lines with suitable phenotypes, such that these lines can be tested in and transitioned to an HTS environment.\n&nbsp;\n**Specific Aims:** \n (1) To create and characterize (semi)immortal PNF Schwann cell lines and normal /heterozygous Schwann cells and compare to the matched, primary cells\n (2) To identify phenotype(s) and genotype(s) that recapitulate original tumor SCs and distinguishes these from normal and heterozygous SCs\n (3) To work with HTS group in identifying optimal media/single culture conditions, prior to scaling the cell culturing and relevant assays to a high-throughput format\n&nbsp;\n**Impact:** Development of critical and much-needed cellular tool-set for the field of NF1\n&nbsp;\n**CELLS AVAILABLE FOR ORDERING WITH UP TO 100% REIMBURSEMENT OF PURCHASE BY NTAP! ** \nThe cells developed and characterized from this project are NOW AVAILABLE FOR ORDERING from ATCC.  To order cells,  [click here](https://www.atcc.org/search#q=NTAP&sort=relevancy).  Your purchase of these cells is up to 100% REIMBURSABLE  by the Neurofibromatosis Therapeutic Acceleration Program (NTAP)! To learn more about getting a reimbursement for your purchase,  [click here](http://www.n-tap.org/plexiform-neurofibromas/cell-lines/)\n\n\n## Tables for Curation\n1. ID: syn51199735\nName: NFOSI-WES-To-Process-2024-03\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Sara Gosline, Xindi Guo\n- Example files present: 69239-0209702975.bam, 69240-0209702974.bam, 69241-0209702973.bam, 69242-0209702972.bam, 69244-0209702964.bam\n\n\n\n2. ID: syn52386280\nName: Selected pNF cell line Kallisto output\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Sara Gosline\n- Example files present: C856CANXX_1_RNASeq_Kallisto_grch38_quants.tsv, C856CANXX_2_RNASeq_Kallisto_grch38_quants.tsv, C8581ANXX_6_RNASeq_Kallisto_grch38_quants.tsv, C8581ANXX_8_RNASeq_Kallisto_grch38_quants.tsv, C8581ANXX_7_RNASeq_Kallisto_gencodev24_quants.tsv\n\n\n\n3. ID: syn29542257\nName: pNF Cell Line RNA-seq (NFOSIprocessing-2022-04-18)\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 11\n- Specimen count: 11\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable\n- Tumor types present: Plexiform Neurofibroma, \n- Data types: geneExpression\n- File formats present: fastq\n- Funders: NTAP\n- Contains data created by: ?\n- Example files present: C856CANXX_1_0_1.fastq.gz, C856CANXX_1_0_2.fastq.gz, C856CANXX_2_0_1.fastq.gz, C856CANXX_2_0_2.fastq.gz, C856CANXX_3_0_1.fastq.gz\n\n\n"}]}]}}
{"custom_id":"syn8016650","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn8016650\n\n##TRAPping the metabolic adaptations of plexiform neurofibroma\n**Initiative:** Open\n&nbsp;\n**Names:** Giorgio Colombo, Ph.D.; Andrea Rasola, Ph.D., M.S.\n**Contact Email:** giorgio.colombo@gmail.com; andrea.rasola@unipd.it\n**Dates:** 1/1/2017 to 12/31/2019\n**Tumor Focus:** plexiform neurofibromas, MPNST\n**Application**:  preclinical, translational\n&nbsp;\n**Background:** \nPlexiform neurofibroma (PN) is a complex tumor that develops within perineural sheaths of nerve bundles in neurofibromatosis type I (NF1) patients. Albeit benign, PNs can be disfiguring, can dangerously compress surrounding tissues or undergo transformation into highly aggressive sarcomas termed malignant peripheral nerve sheath tumors (MPNSTs). PN formation and growth require mutations at the NF1 gene, leading to loss of the Ras GTPase activating protein (Ras-GAP) neurofibromin and to the ensuing induction of the Ras/ERK transduction axis. Oncogenic signalling via the Ras/ERK pathway contributes to the metabolic rewiring of tumor cells, a crucial hallmark of neoplastic transformation. In tumor cells changes in mitochondrial activity lead to accumulation of oncometabolites, such as succinate, that prompt neoplastic growth via regulation of transcription factors or epigenetic changes. The role of metabolism in PN formation or in PN transformation into MPNST was never investigated. We have previously shown that in tumor cells the Ras/ERK transduction pathway has a mitochondrial branch, and that the mitochondrial chaperone TRAP1 increases intracellular succinate, thus activating the tumorigenic programs mastered by the transcription factor HIF1. These observations suggest the possibility that hyperactive ERK might target TRAP1 in mitochondria of PN cells, thus leading to succinate-dependent, pro-neoplastic HIF-1 activation. \n&nbsp;\n**Goals of Project:** \nThis project aims at investigating the possibility that hyperactive Ras/ERK signalling could contribute to pro-neoplastic metabolic rearrangements in mitochondria of neurofibroma cells by regulating TRAP1 chaperone activity, thus crucially contributing to the processes of growth and malignant transformation of PNs. We will dissect the mode of action of TRAP1, connecting it with the metabolic status of PNs and MPNSTs, which will be thoroughly investigated in in vivo tumor models.\n&nbsp;\n**Methods:**\nStarting from these premises, we will design allosteric TRAP1 inhibitors to be tested as putative anti-neoplastic compounds on PN and MPNST models. Analysis of structure-dynamics-function relationships for complexes between TRAP1 and nucleotides or small ligands will be carried out in order to achieve a computational characterization of allosteric mechanisms of regulation of TRAP1 chaperone activity, and to find out druggable sites. This information will be translated into pharmacophore models that will be first used to screen drug libraries. Analysis of the efficacy of the selected compounds as TRAP1 allosteric inhibitors will be studied by a stepwise in vitro, in cell and in vivo approach, leading to the use of first generation molecules as leads for the design and synthesis of potentially more powerful derivatives\n &nbsp;\n**Impact:**  To gain insight on the mode of action and role of TRAP1, with regards to PN and MPNST metabolism.  \n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n## Tables for Curation\n1. ID: syn64954708\nName: ATP hydrolisis rate\nSummary:\n- Assays: ATPase activity assay\n- Species: Homo sapiens, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: NF1, \n- Data types: exel\n- File formats present: excel\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: fig36B hydrolysis.xlsx, fig36C hydrolysis-subparticle.xlsx\n\n\n\n2. ID: syn64954709\nName: CRC\nSummary:\n- Assays: calcium retention capacity assay\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: NF1\n- Data types: exel\n- File formats present: excel\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: fig37A CRC.xlsx\n\n\n\n3. ID: syn64954710\nName: NADH dehydrogenase activity\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: Fig.22_complexI.xlsx\n\n\n\n4. ID: syn64954711\nName: OCR and ECAR\nSummary:\n- Assays: oxygen consumption assay, \n- Species: Homo sapiens, Danio rerio, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: NF1, \n- Data types: exel, excel, \n- File formats present: excel, \n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: fig13rowdataOCR.xlsx, fig14rowdataOCR.xlsx, Figure 44 B.xlsx, Fig.8-9_Seahorse.xls, Fig.10_Seahorse.xls\n\n\n\n5. ID: syn64954712\nName: SDH activity\nSummary:\n- Assays: sorbitol dehydrogenase activity level assay\n- Species: Mus musculus, Homo sapiens, Danio rerio\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: NF1, , Malignant Peripheral Nerve Sheath Tumor\n- Data types: csv, excel, jpg\n- File formats present: csv, , jpg\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: SDH activity TRAP1 inhibitors.csv, cisMPNST SDH activity TRAP1 inhibitors.csv, S462 SDH activity TRAP1 inhibitors.csv, PN 95.6 SDH activity TRAP1 inhibitors.csv, cisMPNST dose-dependent SDH activity TRAP1 inhibitors.csv\n\n\n\n6. ID: syn64954713\nName: SDS and BN-PAGE\nSummary:\n- Assays: SDS-PAGE, blue native PAGE, immunoprecipitation, , gel filtration chromatography\n- Species: , Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: , NF1\n- Data types: , word, exel, ppt\n- File formats present: , word, excel\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: Purification recombinant human TRAP1_Batch 4.tif, Coomassie blue staining_purification human recombinant TRAP1_Batch 4.png, Fig31C BNP.docx, Fig34B IP.docx, Fig34B IP.xlsx\n\n\n\n7. ID: syn64954714\nName: Split GFP\nSummary:\n- Assays: Split GFP\n- Species: Mus musculus\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: experimentalData\n- File formats present: excel\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: Fig35B split IP.xlsx, Fig35C split IP.xlsx, fig42b split.xlsx\n\n\n\n8. ID: syn64954715\nName: TRAP1-HSP90 ATPase activity\nSummary:\n- Assays: ATPase activity assay\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: csv, jpg\n- File formats present: csv, jpg\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: TRAP1 activity drug screening.csv, Hsp90 activity TRAP1 inhibitors.csv, Dose-response curves TRAP1 inhibitors.csv, Figure TRAP1-Hsp90 activity drug screening.jpg, Figure TRAP1-Hsp90 activity Honokiol.jpg\n\n\n\n9. ID: syn64954716\nName: cell proliferation\nSummary:\n- Assays: cell proliferation assay\n- Species: Mus musculus\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: NF1\n- Data types: csv, jpg\n- File formats present: csv, jpg\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: Cell proliferation TRAP1 inhibitors.csv, Figure Cell proliferation Compound 5.jpg, Figure Cell proliferation Compound 2.jpg, Figure Cell proliferation TRAP1 inhibitors.jpg, Figure Cell proliferation Honokiol.jpg\n\n\n\n10. ID: syn64954717\nName: cell viability\nSummary:\n- Assays: , cell viability assay\n- Species: , Mus musculus\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: , NF1\n- Data types: , csv, image, jpg\n- File formats present: , csv, jpg\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: Fig.11_E880 SCR NORMOXIA vs HYPOXIA 24-48-72h 14.06.2018 analisi.xls, Cell viability TRAP1 inhibitors.csv, Figure Cell viability Compound 5.tif.jpg, Figure Cell viability TRAP1 inhibitors.jpg, Figure Cell viability Honokiol.jpg\n\n\n\n11. ID: syn64954718\nName: compound list\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: Structure Honokiol bis-dichloroacetate (HDCA).pdf, Structure TRAP1 inhibitors.pdf\n\n\n\n12. ID: syn64954719\nName: fluorescence microscopy\nSummary:\n- Assays: microscopy\n- Species: Mus musculus\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: Image 8.czi, Image 8.tif, Image 8_stack.czi, Image 8_stack_z00.tif, Image 8_stack_z01.tif\n\n\n\n13. ID: syn64954720\nName: immunohistochemistry\nSummary:\n- Assays: immunohistochemistry, \n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: image, \n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: A green 1 left 20x.jpg, A green 1 left 40x.jpg, A green 1 right 20x.jpg, A green 1 right 40x.jpg, B red 1 left 20x.tif\n\n\n\n14. ID: syn64954721\nName: in vitro interaction\nSummary:\n- Assays: in vitro\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: word\n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: Fig33Biocore.docx\n\n\n\n15. ID: syn64954722\nName: in vitro tumorigenesis\nSummary:\n- Assays: focus forming assay, Matrigel-based tumorigenesis assay\n- Species: Mus musculus\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: NF1, Malignant Peripheral Nerve Sheath Tumor\n- Data types: csv, jpg\n- File formats present: csv, , jpg\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: In vitro tumorigenesis TRAP1 inhibitors.csv, Dose-dependent in vitro tumorigenesis TRAP1 inhibitors.csv, Fig.26_EV - NDI1.xlsx, Figure In vitro tumorigenesis TRAP1 inhibitors.jpg, Figure dose-dependent in vitro tumorigenesis TRAP1 inhibitors.jpg\n\n\n\n16. ID: syn64954723\nName: in vivo tumorigenesis\nSummary:\n- Assays: , in vitro tumorigenesis\n- Species: , mus musculus\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: , Malignant Peripheral Nerve Sheath Tumor\n- Data types: ?\n- File formats present: , excel\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: Fig.7_N667-72 E880 Ad-Cre pCDH hTRAP1.xlsx, CD1 nude - sMPNST sgSCR sgTRAP1 +SIRT3 +NIC 2019.xls\n\n\n\n17. ID: syn64954724\nName: mass spec data\nSummary:\n- Assays: mass spectrometry, \n- Species: Homo sapiens, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: NF1, \n- Data types: exel, \n- File formats present: excel, \n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: Fig31A massData.xlsx, Fig.29_NAD+-NADH.xlsx\n\n\n\n18. ID: syn64954725\nName: mitochondrial ROS\nSummary:\n- Assays: , reactive oxygen species assay\n- Species: , Mus musculus\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: , NF1\n- Data types: , csv\n- File formats present: , csv\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: Fig.23_ROS.xlsx, ROS levels Honokiol.csv\n\n\n"}]}]}}
{"custom_id":"syn5610418","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn5610418\n\n${image?fileName=CTF Synodos Data Site Headers6%2Ejpg&align=Center&scale=100&responsive=true}\n#Welcome to Synodos NF1 Preclinical Models\nSynodos NF1 represents a unique endeavor to coordinate researchers from across scientific and clinical domains to accelerate cures for NF1.  This wiki represents an open space between the three Synodos groups.  To visit the private sites, navigate to the folder tab. \n\n\n### **Iowa, Sanford and Exemplar Genetics**\n\nData can be found [here](syn5611494). \n\n\n### **See the other team project (Minnesota, CCHMC and Recombinetics) at syn52740594**\n\n\n---\n${buttonlink?text=Back to CTF Data Portal&url=https://nf%2Esynapse%2Eorg/Organizations/DetailsPage%3Fabbreviation%3DCTF&align=None}\n\n## Tables for Curation\n1. ID: syn63141118\nName: Synodos NF1 Patient WES Data (GSE145064)\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens, \n- Individual count: 15\n- Specimen count: 46\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: , Plexiform Neurofibroma, Malignant Peripheral Nerve Sheath Tumor\n- Data types: geneExpression\n- File formats present: fastq\n- Funders: CTF\n- Contains data created by: ?\n- Example files present: PT4-26668-A11_lane3_20180514000_S8_L003_R1_001.fastq.gz, PT4-26668-A11_lane3_20180514000_S8_L003_R2_001.fastq.gz, PT4-26668-A11_lane4_20180514000_S16_L004_R1_001.fastq.gz, PT4-26668-A11_lane4_20180514000_S16_L004_R2_001.fastq.gz, PT4-26669-A5_lane3_20180514000_S7_L003_R1_001.fastq.gz\n\n\n"}]}]}}
{"custom_id":"syn8016599","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn8016599\n\n##Modeling signaling networks of NF1-deficient Schwann cells and plexiform neurofibromas using mass spectrometry-based proteomics\n**Initiative:** Open\n&nbsp;\n**Name:** James Walker, Ph.D.\n**Contact Email:** jwalker@helix.mgh.harvard.edu \n**Dates:** 12/1/2016 to 11/30/2018\n**Tumor Focus:** plexiform neurofibromas\n**Application**: preclinical translational, mouse models \n&nbsp;\n**Background:**\nPlexiform neurofibromas (PNs) are among the most serious symptoms of NF1. Although benign, they cause signficant morbidity, and a substantial fraction transform into typically fatal malignant peripheral nerve sheath tumors. NF1 is caused by loss of neurofibromin, a protein whose best-defined function is to serve as a GTPase Activating Protein (GAP) for Ras. Consequently, loss of neurofibromin can result in misregulation of signaling downstream of Ras, the best documented being the RAF/MEK/ERK and PI3K/AKT/mTOR pathways. Although disregulated Ras signalling is believed to be the proximal cause of NF1 symptoms, it is unclear which of the numerous effectors downstream of Ras are relevant for disease progression, as are the identities of the disease-pertinent targets of the signaling pathways mediating their effects. The situation is further complicated since there is undoubtedly cross-talk between these different pathways. Despite considerable effort, no effective therapy for Ras-driven cancers has yet emerged. Furthermore, it is clear that neurofibromin has other functions that likely play a role in clinical outcomes as well. This has motivated our work to find the precise pathways that are responsible for NF1 symptoms, in the hope that this will allow better-targeted therapy. \n&nbsp; \n**Goals of Project:**\nWe aim to identify putative proteomic and/or phosphoproteomic signatures associated with loss of NF1. Recent advances in mass-spectrometry (MS)-based proteomics permit the determination of the extent, localization, and site-specific stoichiometry of protein phosphorylation. We propose using two complementary MS-based approaches to define (i) the proteome and phosphoproteome and (ii) the activated kinome signature of NF1-deficient Schwann cells (SCs). We will perform analyses on a panel of SC lines derived from PNs. Transcriptome profiling of cell lines will complement these data sets, together providing a detailed view of the cellular signaling networks and the molecular targets controlled by neurofibromin in a cell-type relevant to the disease. Finally, we will use small molecule inhibitors to both known and any novel signaling pathways we identify to examine the adaptive kinome in treated cell lines. Combining the use of a novel panel of cell lines with the sensitivity of high-end MS, we expect to identify signaling pathways and targets previously implicated as being important in NF1-associated tumors, as well as new and unexpected targets downstream of NF1. \n&nbsp;\n**Specific Aims:** \n1) Test cell lines for tumorigenic potential in vivo and optimize growth conditions of cells. For determining the proteomic and kinomic signatures associated with loss of neurofibromin, we will select NF1-deficient cell lines derived from PNs that display tumorigenic potential in vivo. Xenograft assays on PN-derived cell lines in mice will be used to evaluate their tumoigenicity in vivo.\n2) Identify phospho-targets misregulated in NF1¬-deficient SCs. Multiplexed quantitative mass spectrometry-based phosphoproteomics will be used to quantitatively map phosphorylation level changes across all cell lines. Novel phosphoproteins identified as being misregulated in NF1-deficient cells will be validated using western blotting using available antibodies and also in independently CRISPR-generated NF1-deficient cell lines that we have available.\t\n3) Analysis of kinome signatures of NF1-deficient SCs using Multiplexed Inhibitor Beads (MIBs) and MS analysis. Knowledge of the relative expression and activation status of the kinome of NF1-deficient cells will enable a comprehensive understanding of the signaling pathways controlled by neurofibromin and mechanisms underlying any phosphoproteome changes. Transcriptome profiling of kinases using RNAseq will enable both the global kinome signature and PTMs to be assessed relative to changes in gene expression. The main focus of our attention will be on using the MIB/MS technique to define the kinome response signature of NF1-deficient SCs to selected inhibitors that are currently in pre-clinical and clinical testing for NF1. \n4) Create a network linking altered phosphorylation events with relative level of activated kinases caused by loss of NF1. The comprehensive set of molecular data consisting of gene expression (RNAseq), global protein levels (total proteome) and protein modifications/function (phosphoproteome/kinome) for each of the cell lines (with appropriate NF1+/+ and NF1+/- controls) will enable us to focus our attention on a common signaling pathway, gene target or group of genes that have altered expression/function in NF1-deficient tumorigenic cells. By incorporating kinome data sets obtained from treating NF1¬-deficient SC cell lines with small molecule inhibitors we will be able to define the adaptive kinome response (‘reprogramming’) in NF1¬-deficient SCs upon drug therapies for PNs. \n&nbsp;\n**Impact:** The datasets and systems analyses described will be made publically available at SAGE/Synapse and will provide a wealth of hypotheses and opportunities for the NF1 research community to gain a better understanding of the fundamental mechanisms involved in NF1-regulated signaling and plexiform neurofibroma development. \n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n## Tables for Curation\n1. ID: syn64954705\nName: Kinome_Data\nSummary:\n- Assays: MIB/MS\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Not Applicable\n- Tumor types present: ?\n- Data types: kinomics\n- File formats present: excel\n- Funders: NTAP\n- Contains data created by: Stephanie Bouley\n- Example files present: 112921_Kinome_NTAP_Walker.xlsx\n\n\n\n2. ID: syn51198962\nName: NFOSI-RNASeq-To-Process-2023-14-03\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Stephanie Bouley\n- Example files present: C23_1_CRRA190119813-1a_HMFNJDSXX_L1_1.fq.gz, C23_1_CRRA190119813-1a_HMFNJDSXX_L1_2.fq.gz, C23_2_CRRA190119823-1a_HMFVGDSXX_L4_1.fq.gz, C23_2_CRRA190119823-1a_HMFVGDSXX_L4_2.fq.gz, C23_2_CRRA190119823-1a_HMG35DSXX_L4_1.fq.gz\n\n\n\n3. ID: syn64954706\nName: Proteomics_Data\nSummary:\n- Assays: TMT quantitation\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Not Applicable\n- Tumor types present: ?\n- Data types: kinomics\n- File formats present: excel\n- Funders: NTAP\n- Contains data created by: Stephanie Bouley\n- Example files present: 112921_Total Proteome_NTAP_Walker.xlsx, 112921_Normalized_Phosphoproteome_NTAP_Walker.xlsx\n\n\n\n4. ID: syn64954707\nName: RNAseq_Raw Data\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Not Applicable, Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: geneExpression\n- File formats present: fastq\n- Funders: NTAP\n- Contains data created by: Stephanie Bouley\n- Example files present: C23_1_CRRA190119813-1a_HMFNJDSXX_L1_1.fq.gz, C23_1_CRRA190119813-1a_HMFNJDSXX_L1_2.fq.gz, C23_2_CRRA190119823-1a_HMFVGDSXX_L4_1.fq.gz, C23_2_CRRA190119823-1a_HMFVGDSXX_L4_2.fq.gz, C23_2_CRRA190119823-1a_HMG35DSXX_L4_1.fq.gz\n\n\n"}]}]}}
{"custom_id":"syn4939910","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn4939910\n\n##Targeting the mechanisms underlying cutaneous neurofibroma formation in NF1: a clinical translational approach\n**Initiative:** Francis Collins\n&nbsp;\n**Name:** Matthew R. Steensma, M.D.\n**Contact Email:** Steensma@Spectrumhealth.org\n**Dates:** 7-1-15 to 5-31-17\n**Tumor Focus:** plexiform neurofibroma, MPNST\n**Application:** Imaging Biomarkers (omics data)\n&nbsp;\n**Background:** \nCutaneous neurofibromas (CNFs) are ubiquitously expressed in Neurofibromatosis Type 1 (NF1) patients. They are one of three cutaneous diagnostic criteria in addition to café-au-lait spots and axillary freckling. They can be distinguished from other cutaneous manifestations of NF1 based on their size (0.5-3cm), sessile or polypoid morphology, and typical lack of pigment. CNFs account for substantial morbidity and disfigurement in NF1. Unlike plexiform neurofibromas, which are congenital lesions, CNFs manifest during adolescence suggesting that their pathogenesis is influenced by environmental or hormonal factors. CNFs are comprised of a confederacy of cell types with distinct embryonic lineages, including Schwann-like cells, perineural cells (neural crest or neuro-ectoderm), fibroblasts (mesoderm), and mast cells (bone marrow-derived).\n&nbsp;\nCNF’s cause significant morbidity  and disfigurement in Neurofibromatosis Type 1 (NF1). They bear histologic similarity to Plexiform Neurofibromas (PNFs), however they lack malignant potential, exhibit a less aggressive growth pattern, and arise during adolescence as opposed to being congenital lesions like PNFs. These clinical observations suggest that CNF molecular pathogenesis differs from that of PNFs. To further contrast the verified differences in peripheral nerve tumors, MPNSTs are verified to be highly aggressive sarcomas that do not respond to chemotherapy.  \n&nbsp;\n**Goals of Project:** To develop new therapy strategies for peripheral nerve sheath tumors associated with Neurofibromatosis Type 1: Cutaneous Neurofibromas (CNFs) and Malignant Peripheral Nerve Sheath Tumors (MPNSTs).  \n&nbsp;\n**Specific Aims:** \n1. To demonstrate that CNFs maintain a unique, targetable genomic profile that is distinct from that of PNFs, and varies based on the stage of CNF development (incipient versus established lesions).\n2. Address a current gap in knowledge in cNF pathophysiology by performing detailed histologic and pathoanatomic analysis of clinical cNF specimens.\n3. Leverage existing models of PN tumor initiation from secondary project to generate high quality preclinical data to support PN tumor therapy trials.\n&nbsp;\n**Methods:**\nOur first research project is to determine whether targetable epigenetic alterations exist between CNFs and PNFs. We designed a surgical trial to collect highly annotated CNF tissues at various stages of disease progression. We recently completed a large epigenetic profiling study comparing harvested CNF tissues with matched, tissue-­‐type controls to PNFs and MPNSTs. These data are currently being analyzed. Our secondary trial objective was to define the surgical anatomy of CNFs in comparison to other types of neurofibromas that involve the dermis. \n&nbsp;\n  Our second research project addresses the hypothesis that Ras and non Ras-­‐dependent kinase signaling drives disease progression and therapy resistance in NF1-­‐related MPNSTs, and that putative MPNST genomic alterations influence cellular adaptation to tyrosine kinase inhibitor (TKI) treatment. This hypothesis is based on preliminary data where we determined the sequence of genomic alterations that occurred in a case of MPNST progression from a PNF. Various treatment timepoints are shown (below):\n${previewattachment?fileName=NTAP Summary Steensma 2%2C Figure 1%2Ejpg}\n&nbsp;\nThe earliest genomic alterations observed were MET, HGF and EGFR copy number gains. Our subsequent in vitro and in vivo modeling experiments verified the importance of RAS-­‐MET signal interaction not only in malignant transformation but also therapy response to MET inhibition. We employ a novel, genetically engineered NF mouse model featuring MET overexpression in myelinating peripheral nerve cells to show that the highly selective MET inhibitor, capmatinib, has exquisite activity in MET-­‐addicted murine MPNSTs (below).\n${previewattachment?fileName=NTAP Summary Steensma 2%2CFigure 2%2Ejpg}  \n&nbsp;\n**Impact:**  Innovative and highly translational approach to defining the pathophysiology of CNF initiation and progression, such that unique and novel preventive and/or treatment strategies for NF1 can be developed. \n&nbsp;\n**Publications:** \n* Steensma M.  Enhanced MET signaling drives malignant tumorigenesis in a mouse model of Neurofibromatosis Type 1. (submitted)\n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n## Tables for Curation\n1. ID: syn52299972\nName: Copy Number Variant - CNVkit\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: 0\n- Specimen count: 0\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: \n- Funders: NTAP\n- Contains data created by: NF Service\n- Example files present: VA01.converted.cns, VA01.converted-scatter.png, VA02.converted.bintest.cns, VA01.converted.targetcoverage.cnn, VA02.converted-diagram.pdf\n\n\n\n2. ID: syn35562797\nName: Germline Genomic Variants - DeepVariant Pipeline (from syn31621349)\nSummary:\n- Assays: whole genome sequencing\n- Species: Homo sapiens\n- Individual count: 9\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: \n- File formats present: vcf\n- Funders: NTAP\n- Contains data created by: NF Service\n- Example files present: VA01.vcf.gz, VA02.vcf.gz, VA03.vcf.gz, VA04.vcf.gz, VA05.vcf.gz\n\n\n\n3. ID: syn35562794\nName: Germline Genomic Variants - FreeBayes Pipeline (from syn31621349)\nSummary:\n- Assays: , whole genome sequencing\n- Species: , Homo sapiens\n- Individual count: 9\n- Specimen count: ?\n- Diagnoses present: , Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: \n- File formats present: , vcf\n- Funders: NTAP\n- Contains data created by: NF Service\n- Example files present: FreeBayes_VA01.vcf.gz.tbi, FreeBayes_VA01.vcf.gz, FreeBayes_VA02.vcf.gz.tbi, FreeBayes_VA02.vcf.gz, FreeBayes_VA03.vcf.gz.tbi\n\n\n\n4. ID: syn35562795\nName: Germline Genomic Variants - Mutect2 Pipeline (from syn31621349)\nSummary:\n- Assays: , whole genome sequencing\n- Species: , Homo sapiens\n- Individual count: 9\n- Specimen count: ?\n- Diagnoses present: , Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: \n- File formats present: , vcf\n- Funders: NTAP\n- Contains data created by: NF Service\n- Example files present: Mutect2_unfiltered_VA01.vcf.gz.tbi, Mutect2_filtered_VA01.vcf.gz, Mutect2_unfiltered_VA01.vcf.gz, Mutect2_filtered_VA01.vcf.gz.tbi, Mutect2_filtered_VA02.vcf.gz\n\n\n\n5. ID: syn35562796\nName: Germline Genomic Variants - Strelka Pipeline (from syn31621349)\nSummary:\n- Assays: , whole genome sequencing\n- Species: , Homo sapiens\n- Individual count: 9\n- Specimen count: ?\n- Diagnoses present: , Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: \n- File formats present: , vcf\n- Funders: NTAP\n- Contains data created by: NF Service\n- Example files present: Strelka_VA01_genome.vcf.gz.tbi, Strelka_VA01_variants.vcf.gz, Strelka_VA01_variants.vcf.gz.tbi, Strelka_VA02_genome.vcf.gz.tbi, Strelka_VA02_variants.vcf.gz.tbi\n\n\n\n6. ID: syn64954683\nName: Metadata\nSummary:\n- Assays: methylation array\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma\n- Data types: chromatinActivity\n- File formats present: txt\n- Funders: NTAP\n- Contains data created by: Benjamin Johnson\n- Example files present: STEM_synapse_metadata.txt\n\n\n\n7. ID: syn51199012\nName: NFOSI-RNASeq-To-Process-2023-14-03\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Steven Angus\n- Example files present: 1_S1_R1_001.fastq.gz, 2_S2_R1_001.fastq.gz, 3_S3_R1_001.fastq.gz, 4b_S10_R1_001.fastq.gz, 4_S4_R1_001.fastq.gz\n\n\n\n8. ID: syn29781479\nName: NFOSIprocessing-2022-26-04\nSummary:\n- Assays: whole genome sequencing\n- Species: Homo sapiens\n- Individual count: 9\n- Specimen count: 0\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: , Plexiform Neurofibroma\n- Data types: genomicVariants\n- File formats present: fastq\n- Funders: NTAP\n- Contains data created by: Matt \n- Example files present: 171105_NS500276_0097_AHH7NNBGX3_HH7NNBGX3_ATCATTCC_170065_S2_L001_R1.fastq.gz, 171105_NS500276_0097_AHH7NNBGX3_HH7NNBGX3_GCCACATA_170066_S3_L001_R1.fastq.gz, 171105_NS500276_0097_AHH7NNBGX3_HH7NNBGX3_ACCACTGT_170067_S1_L001_R1.fastq.gz, 171028_NS500270_0211_AHH7KLBGX3_HH7KLBGX3_CTGGCATA_169795_S2_L001_R1.fastq.gz, 171028_NS500270_0211_AHH7KLBGX3_HH7KLBGX3_ACCTCCAA_169794_S1_L001_R1.fastq.gz\n\n\n\n9. ID: syn64954684\nName: Processed_beta_matrix\nSummary:\n- Assays: methylation array\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: chromatinActivity\n- File formats present: txt\n- Funders: NTAP\n- Contains data created by: Benjamin Johnson, Sara Gosline\n- Example files present: STEM_NTAP_CNF_PNF_processed_beta_matrix.txt.gz, STEM_NTAP_CNF_PNF_processed_beta_matrix.txt\n\n\n\n10. ID: syn64954685\nName: Raw_CNF_PNF_EPIC_idats\nSummary:\n- Assays: methylation array\n- Species: Homo sapiens\n- Individual count: 38\n- Specimen count: 60\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma\n- Data types: chromatinActivity\n- File formats present: idat\n- Funders: NTAP\n- Contains data created by: Benjamin Johnson\n- Example files present: 201233650066_R08C01_Grn.idat, 201233650066_R08C01_Red.idat, 201233650020_R05C01_Grn.idat, 201233650020_R05C01_Red.idat, 201233650020_R06C01_Grn.idat\n\n\n\n11. ID: syn64954686\nName: Van Andel - RNAseq and WXS\nSummary:\n- Assays: RNA-seq, whole genome sequencing\n- Species: Homo sapiens\n- Individual count: 9\n- Specimen count: 11\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: , Plexiform Neurofibroma\n- Data types: geneExpression, genomicVariants\n- File formats present: excel, fastq\n- Funders: NTAP\n- Contains data created by: Steven Angus, Matt \n- Example files present: DNA RNA Seq Analysis Manifest Form_UNC TC Facility_v1.xlsx, 1_S1_R1_001.fastq.gz, 2_S2_R1_001.fastq.gz, 3_S3_R1_001.fastq.gz, 4b_S10_R1_001.fastq.gz\n\n\n\n12. ID: syn64954687\nName: Whole Exome Sequencing of Mouse Samples\nSummary:\n- Assays: whole exome sequencing\n- Species: Mus musculus\n- Individual count: 2\n- Specimen count: 7\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor\n- Data types: genomicVariants\n- File formats present: fastq\n- Funders: NTAP\n- Contains data created by: Megan Bowman\n- Example files present: NF1-P53T_R1.fastq.gz, NF1-P53T_R2.fastq.gz, NF1-METblood_R1.fastq.gz, NF1-METblood_R2.fastq.gz, NF1-METtcells_R1.fastq.gz\n\n\n"}]}]}}
{"custom_id":"syn11374353","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn11374353\n\n###Identification of pathways triggered by Schwann cell-fibroblast interactions driving cutaneous neurofibroma growth\n\n&nbsp;\n\n#####**PI:**  Eduard Serra\n\n&nbsp;\n\n######**Background and Study Design:**  \n\nCutaneous neurofibromas (cNF) are benign tumors of the peripheral nerves present in almost all neurofibromatosis Type 1 (NF1) patients. cNFs are composed of different cell types, mainly Schwann cells (SCs) and fibroblasts (FBs). Inactivation of the NF1 gene in SCs is believed to be the cause triggering cNF formation. Extensive analysis has shown that from a genetic and genomic perspective, there is no additional recurrent genetic alteration besides the NF1 inactivation involved in cNFs. Despite its simple genetic etiology, the contribution of the interactions among cells composing cNFs need to be investigated to better understand their role in cNF formation and their potential influence on treatment response. In this work, we propose to use co-cultures of cNF-derived primary SCs and FBs to identify expression signatures in cNFs that are specifically due to SC-FB heterotypic interactions. For this purpose we will compare RNA-Seq data from cNFs, their single cell primary cultures and co-cultures of SCs and FBs. Furthermore, we will identify the genetic variation present in gene coding regions of neurofibroma donors. Since SCs and FBs used in co-cultures will belong to different individuals, we estimate to dissect about 75% of the expression signature due to SC-FB interactions by assigning each differently expressed gene to a specific cell type, according to their genetic variation. Signaling pathways represented by expression signatures will be analyzed and their disruption tested functionally.\n\n&nbsp;\n\n######**Deliverables:**\n\nObtain an expression signature of cNFs specifically due to SC-FB interactions. Dissect from this signature which genes are expressed in SCs and which in FBs. Identify from signatures SC-FB specific signaling pathways. Test the functional impact of their disruption.\n\n&nbsp;\n\n######**Expected Outcomes:**\n\nUnderstand the signaling between SCs and FBs within cNFs and their importance and impact on their viability, proliferation capacity and contribution to cNF development.\n\n&nbsp;\n\n######**Challenges and Gaps:**\n\ncNFs are not only composed by SCs and FBs. Probably interaction with mast cells and other cell types play their role in cNF formation. The present work is only focused in the interaction of the two main cell types present in cNFs.\n\n&nbsp;\n\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n\n## Tables for Curation\n1. ID: syn64954755\nName: 12 month deliverables\nSummary:\n- Assays: , whole exome sequencing\n- Species: , Homo sapiens\n- Individual count: 5\n- Specimen count: 10\n- Diagnoses present: , Neurofibromatosis type 1\n- Tumor types present: , Cutaneous Neurofibroma\n- Data types: , genomicVariants\n- File formats present: pdf, fastq\n- Funders: NTAP\n- Contains data created by: Bernat Gel Moreno\n- Example files present: coculture_protocol.pdf, 1CNF_FB_1.fastq.gz, 1CNF_FB_2.fastq.gz, 1CNF_SC_1.fastq.gz, 1CNF_SC_2.fastq.gz\n\n\n\n2. ID: syn64954756\nName: 18 month deliverables\nSummary:\n- Assays: RNA-seq, \n- Species: Homo sapiens, \n- Individual count: 13\n- Specimen count: 28\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: Cutaneous Neurofibroma, \n- Data types: geneExpression, \n- File formats present: fastq, \n- Funders: NTAP\n- Contains data created by: Bernat Gel Moreno, Christina Parry\n- Example files present: 1cNF_1.fastq.gz, 1cNF_Fibroblasts_1.fastq.gz, 1cNF_2.fastq.gz, 1cNF_Fibroblasts_2.fastq.gz, 1cNF_Fibroblasts_1cNF_SchwannCells_2.fastq.gz\n\n\n\n3. ID: syn64954757\nName: 24 month deliverables\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: Bernat Gel Moreno\n- Example files present: 17CNF1_FB_17CNF1_SC_coculture.csv, 17CNF1_FB_1CNF_SC_coculture.csv, 17CNF1_FB_27CNF1_SC_coculture.csv, 17CNF1_FB_28CNF1_SC_coculture.csv, 1CNF_FB_17CNF1_SC_coculture.csv\n\n\n\n4. ID: syn64954758\nName: 36 month deliverables\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: Bernat Gel Moreno, Helena  Mazuelas\n- Example files present: Luminex_raw_data.xlsx, Experimental_Description.pdf, ClickiT-EdU_27cNF_coculture.pdf, ClickiT-EdU_27cNF_SC_culture.pdf, ClickiT-EdU_28cNF_coculture.pdf\n\n\n\n5. ID: syn64954759\nName: 6 month deliverables\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: excel\n- Funders: NTAP\n- Contains data created by: Bernat Gel Moreno\n- Example files present: cNF_ESerra_mutations_analysis.xlsx\n\n\n\n6. ID: syn51930741\nName: Gene Expression Quantification from RNA-seq\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 13\n- Specimen count: 28\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma\n- Data types: geneExpression\n- File formats present: sf\n- Funders: ?\n- Contains data created by: NF Service\n- Example files present: quant.sf, quant.genes.sf, quant.sf, quant.sf, quant.genes.sf\n\n\n\n7. ID: syn64954760\nName: NF-OSI-processed-data\nSummary:\n- Assays: , RNA-seq\n- Species: , Homo sapiens\n- Individual count: 13\n- Specimen count: 28\n- Diagnoses present: , Neurofibromatosis type 1\n- Tumor types present: , Cutaneous Neurofibroma\n- Data types: , geneExpression, AlignedReads\n- File formats present: , sf, bam\n- Funders: NTAP\n- Contains data created by: NF Service\n- Example files present: 17cNF_Fibroblasts_27cNF_SchwannCells_1_fastqc.html, 1cNF_Fibroblasts_17cNF_SchwannCells_2_fastqc.html, 17cNF_Fibroblasts_17cNF_SchwannCells_1_fastqc.html, 17cNF_Fibroblasts_17cNF_SchwannCells_2_fastqc.zip, 1cNF_1_fastqc.html\n\n\n\n8. ID: syn51198956\nName: NFOSI-RNASeq-To-Process-2023-14-03\nSummary:\n- Assays: ?\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: 28\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Bernat Gel Moreno\n- Example files present: 1cNF_1.fastq.gz, 1cNF_Fibroblasts_1.fastq.gz, 1cNF_2.fastq.gz, 1cNF_Fibroblasts_2.fastq.gz, 1cNF_Fibroblasts_1cNF_SchwannCells_2.fastq.gz\n\n\n\n9. ID: syn51199729\nName: NFOSI-WES-To-Process-2024-03\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Bernat Gel Moreno\n- Example files present: 1CNF_FB_1.fastq.gz, 1CNF_FB_2.fastq.gz, 1CNF_SC_1.fastq.gz, 1CNF_SC_2.fastq.gz, 17CNF1_FB_1.fastq.gz\n\n\n"}]}]}}
{"custom_id":"syn21650484","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn21650484\n\n\n##Stem cell derived RGCs: Improving the success of transplantation strategies\n\n##VRI Subgroup: \nExogenous RGC Replacement\n\n##Principal Investigators: \nMichael Young, PhD (Massachusetts Eye and Ear Infirmary)\nPetr Baranov, MD, PhD (Massachusetts Eye and Ear Infirmary)\n\n##Personnel:\nPetr Baranov, MD, PhD (PI)\n\n##Lay Abstract\n\nOur overall goal is to improve the success of RGC transplantation, using mouse cells, together with tissue engineering and pig to pig transplantation studies.  We will first identify and optimize key variables using mouse cells that can be applied for pig, non-human primate and human retinal ganglion cell precursors. The premise is that the development of RGCs from stem cells is conserved and the cues we identify may be relevant for all RGCs.  Testing them in mouse has two key advantages:  The timeframe for differentiation is much shorter, which allows one to test more variables; and the mouse model allows for mouse to mouse (allograft) studies which is a likely therapeutic strategy in humans. We have shown that mouse stem cells-derived RGCs are diverse, functional and integrate into healthy and RGC-depleted retinas following injection into the chamber of the eye in front of the retina. We have also demonstrated long-term survival and growth of processes into the optic nerve.   We have three sub-aims for this approach:  1 ) Identifying the stage of differentiation with the highest potential for transplantation 2. Evaluate different types of RGCs for transplantation studies 3.  Improving RGC maturation in retinal tissue, differentiated from stem cells. We will work closely with team members to develop appropriate differentiation (DZ) and transplantation (JG) protocols. \nWe will also develop novel tissue engineered transplants aimed at improving graft success.  Using cells and protocols from Aim 1, we will develop polymer composite grafts capable of improving survival, engraftment, and differentiation of transplanted RGCs.  Cells from JG and DZ, along with cells from Aim 1 will be used for these studies.   Lastly, building upon studies by team members using mouse and human RGCs, we will develop pig RGCs for the purpose of performing pig-pig allograft (same species) studies in disease models.  Human and mouse protocols from DZ and PB will be used to generate pig RGCs.\n\n\n## Tables for Curation\n1. ID: syn64954825\nName: Bulk RNA Sequencing Donor RGCs\nSummary:\n- Assays: targeted exome sequencing, \n- Species: Mus musculus, \n- Individual count: ?\n- Specimen count: 2\n- Diagnoses present: Not Applicable, \n- Tumor types present: Not Applicable, \n- Data types: AlignedReads, \n- File formats present: excel, \n- Funders: GFF\n- Contains data created by: Julia Oswald, Christina Parry\n- Example files present: TMM_normed_counted_exons_27_04_20_full.xlsx, TMM_normed_counts_full.xlsx, synapse_storage_manifest_rnaseqtemplate.csv\n\n\n"}]}]}}
{"custom_id":"syn7231973","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn7231973\n\n##Perpetuating NF1+/- and NF1-/- plexiform neurofibroma-derived tumor cells  through the generation of induced pluripotent stem (iPS) cells\n**Initiative:** Cell Culture\n&nbsp;\n**Name:** Eduard Serra, Ph.D.\n**Contact Email:** eserra@igtp.cat\n**Dates:** 5-1-13 to 8-31-15\n**Tumor Focus:** Plexiform Neurofibroma\n**Application:** Preclinical Translational models\n&nbsp;\n**Background:** Neurofibromatosis type 1 (NF1) associated neurofibromas are benign tumors of the peripheral nerves that are difficult to study due to their heterogeneous cellular composition and their genetic heterogeneity regarding the NF1 mutational status of the different cell types. Plexiform neurofibromas (pNFs) differ from discrete neurofibromas (dNFs) in their moment of appearance (though to be congenital in pNFs), the importance of the extension of the nerve and tissues affected (larger in pNFs) and their potential to progress to malignancy, not present in dNFs. Regarding genomics and transcriptomics, Schwann cells (SC) derived from dNFs and pNFs are very much alike. So what is different among these tumors that confer pNFs a risk to become malignant? The extent of affected tissue? The location? The temporal window at which a neural crest-derived cell committed to the SC lineage acquires a double inactivation of the NF1 gene? A particular cellular composition? A combination of factors?\n&nbsp;\n**Goals and Specific Aims:**\n*  Explore the degree of genomic, molecular and cellular variation within a whole plexiform neurofibroma (pNF).\n*  Obtain, authenticate and characterize NF1-/- and NF1+/- induced pluripotent stem cells (iPSC) derived from pNFs.\n&nbsp;\n**Publications:** a manuscript describing this work is currently in progress.\n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n3- Download the data [here](syn17018746)\n\n## Tables for Curation\n1. ID: syn64954703\nName: Exome\nSummary:\n- Assays: , whole exome sequencing\n- Species: Homo sapiens\n- Individual count: 9\n- Specimen count: 35\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Plexiform Neurofibroma\n- Data types: , genomicVariants\n- File formats present: bai, fastq\n- Funders: NTAP\n- Contains data created by: Bernat Gel Moreno\n- Example files present: PNF3AF.postprocessed.bai, PNF3AF_1.fastq.gz, PNF3AF_2.fastq.gz, 3PNF_S_1.fastq.gz, 3PNF_SiPSsv_MM_1.fastq.gz\n\n\n\n2. ID: syn51200209\nName: NFOSI-WES-To-Process-2023-15-03\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Bernat Gel Moreno\n- Example files present: PNF3AF.postprocessed.bai, PNF3AF_1.fastq.gz, PNF3AF_2.fastq.gz, 3PNF_S_1.fastq.gz, 3PNF_SiPSsv_MM_1.fastq.gz\n\n\n\n3. ID: syn64954704\nName: SNParray\nSummary:\n- Assays: SNP array\n- Species: Homo sapiens\n- Individual count: 23\n- Specimen count: 40\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Plexiform Neurofibroma\n- Data types: genomicVariants\n- File formats present: txt\n- Funders: NTAP\n- Contains data created by: Bernat Gel Moreno\n- Example files present: PNF1A.txt, PNF1B.txt, PNF1C.txt, PNF1D.txt, PNF3Y.txt\n\n\n"}]}]}}
{"custom_id":"syn23651229","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn23651229\n\n# Ultra-low-pass whole genome sequencing of plasma cfDNA from patients with plexiform neurofibroma and malignant peripheral nerve sheath tumors. \n\n#### **Principal Investigators:** Jack Shern, MD,  Angela Hirbe, MD/PhD and Aadel Chaudhuri, MD/PhD\n#### **Project Lead / Data Coordinator:** R. Taylor Sundby, MD and Jeff Szymanski, MD/PhD\n#### **Institution:** National Cancer Institute - Pediatric Oncology Branch and Washington University in St Louis\n\n#### **Project Description**\nThe leading cause of mortality for patients with the neurofibromatosis type 1 (NF1) cancer predisposition syndrome is the development of malignant peripheral nerve sheath tumor (MPNST), an aggressive soft tissue sarcoma. In the setting of NF1, this cancer type frequently\narises from within its common and benign precursor, plexiform neurofibroma (PN). Transformation from PN to MPNST is challenging to diagnose due to difficulties in distinguishing cross-sectional imaging results and intralesional heterogeneity resulting in biopsy sampling errors. This multi-institutional study from the National Cancer Institute and Washington University in St. Louis used fragment size analysis and ultra-low-pass whole genome sequencing (ULP-WGS) of plasma cell-free DNA (cfDNA) to distinguish between MPNST and PN in patients with NF1. Results and analysis are published  in \"Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study\" (https://doi.org/10.1371/journal.pmed.1003734). \n\n## Tables for Curation\n1. ID: syn52299273\nName: Copy Number Variant - CNVkit\nSummary:\n- Assays: whole genome sequencing\n- Species: Homo sapiens\n- Individual count: 59\n- Specimen count: 117\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable, Unknown\n- Tumor types present: Plexiform Neurofibroma, Not Applicable, Malignant Peripheral Nerve Sheath Tumor\n- Data types: ?\n- File formats present: ?\n- Funders: NIH-NCI, Children’s Cancer Foundation, Cancer Research Foundation, The V Foundation for Cancer Research, Center for Cancer Research\n- Contains data created by: NF Service\n- Example files present: cnvkit.reference.target-tmp.bed, cnvkit.reference.antitarget-tmp.bed, lib003.converted.cnr, lib003.converted.bintest.cns, lib009.converted-scatter.png\n\n\n\n2. ID: syn35562839\nName: Germline Genomic Variants - DeepVariant Pipeline (from syn31726450)\nSummary:\n- Assays: whole genome sequencing\n- Species: Homo sapiens\n- Individual count: 59\n- Specimen count: 117\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable, Unknown\n- Tumor types present: ?\n- Data types: \n- File formats present: vcf\n- Funders: NIH-NCI, Children’s Cancer Foundation, Cancer Research Foundation, The V Foundation for Cancer Research, Center for Cancer Research\n- Contains data created by: NF Service\n- Example files present: lib003.vcf.gz, lib009.vcf.gz, lib012.vcf.gz, lib014.vcf.gz, lib019.vcf.gz\n\n\n\n3. ID: syn35562836\nName: Germline Genomic Variants - FreeBayes Pipeline (from syn31726450)\nSummary:\n- Assays: , whole genome sequencing\n- Species: , Homo sapiens\n- Individual count: 59\n- Specimen count: 117\n- Diagnoses present: , Neurofibromatosis type 1, Not Applicable, Unknown\n- Tumor types present: ?\n- Data types: \n- File formats present: , vcf\n- Funders: NIH-NCI, Children’s Cancer Foundation, Cancer Research Foundation, The V Foundation for Cancer Research, Center for Cancer Research\n- Contains data created by: NF Service\n- Example files present: FreeBayes_lib003.vcf.gz.tbi, FreeBayes_lib009.vcf.gz.tbi, FreeBayes_lib012.vcf.gz, FreeBayes_lib009.vcf.gz, FreeBayes_lib019.vcf.gz.tbi\n\n\n\n4. ID: syn35562837\nName: Germline Genomic Variants - Mutect2 Pipeline (from syn31726450)\nSummary:\n- Assays: , whole genome sequencing\n- Species: , Homo sapiens\n- Individual count: 42\n- Specimen count: 90\n- Diagnoses present: , Neurofibromatosis type 1, Unknown\n- Tumor types present: ?\n- Data types: \n- File formats present: , vcf\n- Funders: NIH-NCI, Children’s Cancer Foundation, Cancer Research Foundation, The V Foundation for Cancer Research, Center for Cancer Research\n- Contains data created by: NF Service\n- Example files present: Mutect2_unfiltered_lib003.vcf.gz.tbi, Mutect2_filtered_lib003.vcf.gz, Mutect2_filtered_lib009.vcf.gz, Mutect2_filtered_lib012.vcf.gz.tbi, Mutect2_filtered_lib009.vcf.gz.tbi\n\n\n\n5. ID: syn35562838\nName: Germline Genomic Variants - Strelka Pipeline (from syn31726450)\nSummary:\n- Assays: , whole genome sequencing\n- Species: , Homo sapiens\n- Individual count: 59\n- Specimen count: 117\n- Diagnoses present: , Neurofibromatosis type 1, Not Applicable, Unknown\n- Tumor types present: ?\n- Data types: \n- File formats present: , vcf\n- Funders: NIH-NCI, Children’s Cancer Foundation, Cancer Research Foundation, The V Foundation for Cancer Research, Center for Cancer Research\n- Contains data created by: NF Service\n- Example files present: Strelka_lib003_genome.vcf.gz.tbi, Strelka_lib003_variants.vcf.gz.tbi, Strelka_lib012_variants.vcf.gz.tbi, Strelka_lib003_variants.vcf.gz, Strelka_lib009_variants.vcf.gz\n\n\n\n6. ID: syn29784079\nName: NFOSIprocessing-2022-26-04\nSummary:\n- Assays: whole genome sequencing\n- Species: Homo sapiens\n- Individual count: 59\n- Specimen count: 117\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable, Unknown\n- Tumor types present: Plexiform Neurofibroma, Not Applicable, Malignant Peripheral Nerve Sheath Tumor\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by:  \n- Example files present: lib014.dedup.sorted.bam, lib003.dedup.sorted.bam, lib012.dedup.sorted.bam, lib009.dedup.sorted.bam, lib023.dedup.sorted.bam\n\n\n\n7. ID: syn64954906\nName: ULP Whole Genome Sequencing\nSummary:\n- Assays: whole genome sequencing, \n- Species: Homo sapiens, \n- Individual count: 59\n- Specimen count: 117\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable, Unknown, \n- Tumor types present: Plexiform Neurofibroma, Not Applicable, Malignant Peripheral Nerve Sheath Tumor, \n- Data types: genomicVariants, clinical, metadata\n- File formats present: bam, excel, \n- Funders: NIH-NCI, Children’s Cancer Foundation, Cancer Research Foundation, The V Foundation for Cancer Research, Center for Cancer Research\n- Contains data created by:  \n- Example files present: lib014.dedup.sorted.bam, lib003.dedup.sorted.bam, lib012.dedup.sorted.bam, lib009.dedup.sorted.bam, lib023.dedup.sorted.bam\n\n\n"}]}]}}
{"custom_id":"syn52740594","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn52740594\n\n${image?fileName=CTF Synodos Data Site Headers6%2Ejpg&align=None&scale=100&responsive=true&altText=}\n\n#Welcome to Synodos NF1 Preclinical Models\nSynodos NF1 represents a unique endeavor to coordinate researchers from across scientific and clinical domains to accelerate cures for NF1.  This wiki represents an open space between the three Synodos groups.  To visit the private sites, navigate to the folder tab. \n\n\n### **Minnesota, CCHMC and Recombinetics**\n\nThe data for this team can be found [here](https://www.synapse.org/#!Synapse:syn5611496). \n\n### **See the other team project (Iowa, Sanford and Exemplar Genetics) at syn5610418**\n\n\n---\n${buttonlink?text=Back to CTF Data Portal&url=https://nf%2Esynapse%2Eorg/Organizations/DetailsPage%3Fabbreviation%3DCTF&align=None}\n\n## Tables for Curation\n1. ID: syn65468086\nName: Minnesota CCHMC Recombinetics Team Data\nSummary:\n- Assays: conventional MRI, RNA-seq, cell viability assay, \n- Species: , Sus scrofa, Homo sapiens\n- Individual count: 20\n- Specimen count: 21\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: , Plexiform Neurofibroma, Malignant Peripheral Nerve Sheath Tumor\n- Data types: image, geneExpression, drugScreen, \n- File formats present: excel, 7z, fastq, txt, doc, zip, pzfx, csv, R script, hdf5, sf, \n- Funders: CTF\n- Contains data created by: Sue Rathe, Jon Hawkinson, Kyle Williams, Mike Mason, Robert Allaway, Nasim Sanati, Sara Gosline,  \n- Example files present: Description of Pig Imaging Files.xlsx, Pig1728_DICOM.7z, Pig1734_DICOM.7z, HSC1L_S27_R1_001.fastq.gz, HSC1L_S27_R2_001.fastq.gz\n\n\n"}]}]}}
{"custom_id":"syn18904024","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn18904024\n\nPROJECT TITLE: Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.\n\nAUTHORS: J. Elliott Robinson^1^, Gerard M. Coughlin^1^, Acacia M. Hori^1^, Elisha D. Mackey^1^, Jounhong Ryan Cho^1^, Zeynep Turan^1^, Tommaso Patriarchi^2^, Lin Tian^2^, and Viviana Gradinaru*^1^\n\nAFFILIATIONS:\n^1^Division of Biology and Biological Engineering, California Institute of Technology, 1200 E California Blvd, Pasadena, CA 91125, USA\n^2^Department of Biochemistry and Molecular Medicine, University of California, Davis, One Shield Ave, Davis, CA 95616, USA\n\nABSTRACT: \n\nNeurofibromatosis type 1 (NF1) is an autosomal dominant disorder whose neurodevelopmental symptoms include impaired executive function, attention, and spatial learning that could be due to perturbed mesolimbic dopaminergic circuitry. However, these circuits have never been directly assayed in vivo. We employed the genetically encoded optical dopamine sensor dLight1 to monitor dopaminergic neurotransmission in the ventral striatum of NF1 mice during motivated behavior. Additionally, we developed novel systemic AAV vectors to facilitate morphological reconstruction of dopaminergic populations in cleared tissue. We found that NF1 mice exhibit -reduced spontaneous dopaminergic neurotransmission that was associated with excitation/inhibition imbalance in the ventral tegmental area and abnormal neuronal morphology. NF1 mice also had more robust dopaminergic and behavioral responses to salient visual stimuli, which were stimulus-dependent, independent of learning, and rescued by optogenetic inhibition of GABAergic neurons in the VTA. Overall, these studies provide a first in vivo characterization of dopaminergic circuit function in the context of NF1 and reveal novel pathophysiological mechanisms. \n\nFUNDING: National Institutes of Health, Heritage Medical Research Institute, the Tianqiao and Chrissy Chen Institute for Neuroscience, the National Science Foundation, the Children's Tumor Foundation, and the National Science and Engineering Research Council of Canada \n\n## Tables for Curation\n1. ID: syn65468113\nName: Optical Dopamine Monitoring with dLight1 in NF1 Model Mice\nSummary:\n- Assays: , contextual conditioning behavior assay, in vivo bioluminescence, whole-cell patch clamp, immunofluorescence, HPLC-ED, active avoidance learning behavior assay , novelty response behavior assay\n- Species: , Mus musculus\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: , Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: , behavior process, electrophysiology, immunoassay, proteomics\n- File formats present: excel, pdf\n- Funders: CTF\n- Contains data created by: Elliott Robinson\n- Example files present: Supplementary_Statistical_Analysis.xlsx, Cued_Fear_Conditioning.xlsx, dLight_Light_and_Tone_Response.xlsx, Electrophysiology.xlsx, Histological_Morphological_Analysis.xlsx\n\n\n"}]}]}}
{"custom_id":"syn22267284","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn22267284\n\n## **Mapping and Identifying the Roles of Protein Glycosylation in Neurofibromatosis 1**\n\n### CTF Young Investigator:\n#### Kevin Bruemmer\n\n### Investigator Institution:\nStanford University\n\n### Abstract:\nNeurofibromin is a regulator of cancer driver proteins through its functional role as a Ras-GTPase activating protein. Upon loss-of-function mutations to neurofibromin, patients develop benign or malignant nerve sheath tumors that lead to the disease neurofibromatosis 1 (NF1), affecting 1 in 2,000 people. Due to the complex signaling network of neurofibromin and the cancer-driver pathways it regulates, phosphorylation post-translation modifications have been extensively studied to explain the biological mechanisms for tumor development. Protein glycosylation, specifically N-acetylglucosamine (GlcNAc), is known to have significant crosstalk with phosphorylation sites in the proteome, but has never been studied in the context of a living model system for potential regulation and contribution to the pathogenesis of NF1. To better characterize glycosylation changes at various stages of NF1 malignancies, this proposal aims to develop three complimentary chemical biology approaches to create tools for the understanding of protein GlcNAcylation in cellular model systems of NF1 and MPNSTs. We will use glycoproteomics to investigate how loss of neurofibromin affects O-GlcNAc incorporation in the proteome to reveal key sites of biological regulation affected by the Ras cancer driver pathway. We will also perform protein engineering on a N-acetylglucosamine transferase V (GnT-V), known to be overexpressed in malignant tumors, to identify protein substrates in non-malignant and malignant Schwann cells. Revealing the substrate scope of GnT-V will allow the identification of biological pathways that are aberrant in malignant nerve cells due to increased glycosylation at specific glycosites. We will also biochemically investigate glycosylation marks directly on neurofibromin, to give a clearer picture of how post-translational modifications affect the interaction of neurofibromin with cancer driver proteins and affect neurofibromin localization.\n\n## Tables for Curation\n1. ID: syn64954865\nName: 20201125-ipNF0.23 and ipnF05.5 O-glycosylation\nSummary:\n- Assays: mass spectrometry, \n- Species: Homo sapiens, \n- Individual count: ?\n- Specimen count: 2\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: Not Applicable, \n- Data types: proteomics, \n- File formats present: excel, \n- Funders: CTF\n- Contains data created by: Kevin Bruemmer, Anh Nguyet Vu\n- Example files present: 023_cell_O_Glycan.xlsx, 055_cell_O_Glycan.xlsx, synapse_storage_manifest_proteomicsassaytemplate.csv\n\n\n\n2. ID: syn64954866\nName: NF1 Proteomics\nSummary:\n- Assays: mass spectrometry, \n- Species: Homo sapiens, \n- Individual count: ?\n- Specimen count: 2\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: Not Applicable, \n- Data types: proteomics, \n- File formats present: raw, \n- Funders: CTF\n- Contains data created by: Kevin Bruemmer, Anh Nguyet Vu\n- Example files present: 202103_09_NF1_023_2Az.raw, 202103_09_NF1_023_6Az.raw, 202103_09_NF1_023_DMSO.raw, 202103_09_NF1_023_GalNAz.raw, 202103_09_NF1_023_GalNAzMCR.raw\n\n\n\n3. ID: syn64954867\nName: Neurofibromin Immunoprecipitation 20201123\nSummary:\n- Assays: mass spectrometry, \n- Species: Homo sapiens, \n- Individual count: ?\n- Specimen count: 1\n- Diagnoses present: Not Applicable, \n- Tumor types present: Unknown, \n- Data types: proteomics, \n- File formats present: txt, \n- Funders: CTF\n- Contains data created by: Kevin Bruemmer, Anh Nguyet Vu\n- Example files present: NF_IP_proteinGroups_20201123.txt, allPeptides.txt, evidence.txt, syn23573389_synapse_storage_manifest.csv\n\n\n"}]}]}}
{"custom_id":"syn4939878","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn4939878\n\n##Development of a Child Neurofibromatosis Type 1 Health Related Quality of Life Measure\n**Initiative:** Patient Reported Outcome (PRO) \n&nbsp;\n**Name:** Nancy Swigonski, MD, MPH (Principal Investigator)\n**Name:** Kavitha Nutakki, MBBS, MPH (Project Manager)\n**Contact Email:** knutakki@iupui.edu\n**Dates:** 2-1-14 to 1-31-17\n**Tumor Focus:** plexiform neurofibroma\n**Disease Focus:** Neurofibromatosis Type 1 (NF1)\n**Application**: Clinical Endpoint Tool\n&nbsp;\n**Goals of Project:** To develop and test the feasibility, reliability and validity of the child self-report and parent proxy-report versions of the Pediatric Quality of Life InventoryTM (PedsQLTM) NF1 module.\n&nbsp;\n**Aims:** To develop and test the measurement properties of the Pediatric Quality of Life InventoryTM (PedsQLTM) Neurofibromatosis Type 1 Module for pediatric patients ages 5-25 with NF1 from the perspectives of patients and parents.\n&nbsp;\n**Impact**: The PedsQLTM NF1 Module Scales demonstrated acceptable to excellent measurement properties, and may be utilized as standardized metrics to assess NF1-specific symptoms and problems in clinical research and practice in children, adolescents, and young adults. The PedsQL™ NF1 Module will have a significant impact on the design of clinical trials targeted to better understand and improve clinical treatment for NF1. \n&nbsp;\n**Publications**:  \n1.\tNutakki K, Varni JW, Steinbrenner S, Draucker CB, Swigonski NL. Development of the pediatric quality of life inventory neurofibromatosis type 1 module items for children, adolescents and young adults: qualitative methods. J Neurooncol. 2017 Mar;132(1):135-143. doi: 10.1007/s11060-016-2351-2. Epub 2017 Jan 11. PubMed PMID: 28078640, http://link.springer.com/article/10.1007%2Fs11060-016-2351-2 \n&nbsp;\n2.\tDraucker CB, Nutakki K, Varni JW, Swigonski NL. The health-related quality of life of children, adolescents, and young adults with neurofibromatosis type 1 and their families: Analysis of narratives. J Spec Pediatr Nurs. 2017 Feb 15. doi: 10.1111/jspn.12174. [Epub ahead of print] PubMed PMID: 28198162, http://onlinelibrary.wiley.com/doi/10.1111/jspn.12174/abstract\n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n\n## Tables for Curation\n1. ID: syn64954678\nName: PRO Reports\nSummary:\n- Assays: questionnaire\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: surveyData\n- File formats present: csv\n- Funders: NTAP\n- Contains data created by: Sara Gosline\n- Example files present: NF study data_IUSM 5.16.2017_responses.csv, NF study data_IUSM 5.16.2017_variables.csv\n\n\n"}]}]}}
{"custom_id":"syn11681835","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn11681835\n\n###Novel Therapeutics in Malignant Peripheral Nerve Sheath Tumor (MPNST)\n\n&nbsp;\n\n#####**PI:**  Ping Chi, MD, PhD\n**Memorial Sloan Kettering Cancer Center **\n\n&nbsp;\n\n######**Background:**  \n\nMalignant Peripheral Nerve Sheath Tumor (MPNST) arising from the cellular component of the peripheral nerves represents a group of highly aggressive soft tissue sarcomas with limited treatment options. They can occur in the setting of type I neurofibromatosis (NF1-associated), or sporadically or in association with prior radiotherapy (RT-associated). Using comprehensive genomic approaches, we and others have discovered that the majority of MPNSTs have inactivation of three tumor suppressor pathways, including the NF1, the CDKN2A (INK4A/ARF) and the Polycomb repressive complex 2 (PRC2) pathways. Here, we propose to use multidisciplinary approaches to establish authentic MPNST model systems for preclinical investigation. We will also evaluate a combination treatment strategy of trametinib (a MEK inhibitor) and ribociclib (a CDK4/6 inhibitor) in various cell line and animal models of MPNST. Lastly, we will conduct a screen using RNA interference technology to identify and characterize the genes that are important for MPNST growth and survival when the PRC2 pathway is inactivated. These studies will build important resources for the NF1-research community and can identify novel treatment strategies and streamline clinical therapeutic development for patients with NF1-associated MPNSTs. \n\n&nbsp;\n\n######**Technical Study Design:**  \n\nMPNST arising from peripheral nerves represents a group of highly aggressive soft tissue sarcomas with limited treatment options. Using comprehensive genomic approaches, we and others recently discovered concurrent inactivating mutations of the Polycomb repressive complex 2 (PRC2) core components (EED or SUZ12), CDKN2A, and NF1. The highly recurrent and specific inactivation of PRC2, NF1 and CDKN2A, posits their critical and potentially cooperative roles in MPNST pathogenesis. MPNSTs with PRC2 loss showed complete loss of H3K27me3 and aberrant transcriptional activation of multiple PRC2-repressed homeobox master regulators and their regulated developmental pathways. Interestingly, Both PRC2-loss and PRC2-wild type MPNSTs and plexiform neurofibromas express high levels of ETV1 and are dependent on ETV1 for cell growth and survival and tumorigenesis. ETV1 and NF1 loss cooperates in MPNST oncogenesis. Here, we propose to build authentic in vitro and in vivo PDX and GEM MPNST modes, evaluate the combination strategy of MEK and CDK4/6 inhibitors to target NF1 loss-ETV1 cooperation and CDKN2A loss in preclinical models, and   investigate the therapeutic vulnerability of PRC2 loss using a non-biased RNAi based screen and subsequent validation. This proposal employs multidisciplinary integrative approaches and leverages the expertise of team of mentors and the sarcoma DMT. These studies will establish important resources for NF1-research, and provide of novel combination strategies in targeting transcriptional dysregulation with near-term translation potential in MPNST therapeutics. They will also provide mechanistic and therapeutic insights of PRC2 loss involved in MPNST tumorigenesis, which may apply to other cancer types with PRC2 functional loss.\n\n&nbsp;\n\n######**Hypothesis and Deliverables:**\n\nMPNSTs represent a group of highly aggressive soft tissue sarcomas that may occur in distinct clinical settings: NF1-associated, sporadic or radiotherapy (RT)-associated. Using comprehensive and integrative genomic approaches, we have identified recurrent loss of function genetic alterations of three central pathways: Polycomb repressive complex 2 (PRC2, 80%) core components (EED or SUZ12), CDKN2A (81%) and NF1 (>70% of non-NF1-associated) in all MPNSTs, and the three components significantly co-occur1-3. **_These data suggest_** that, despite the clinical and histological heterogeneity, the NF1-associated, sporadic and RT-associated MPNSTs represent a relatively homogeneous group of disease at the molecular level. We demonstrated that MPNSTs with complete PRC2 loss showed complete loss of H3K27me3 and aberrant transcriptional activation of multiple PRC2-repressed homeobox master regulators and their regulated developmental pathways. Introduction of the PRC2 component in a PRC2-deficient MPNST cell line restored H3K27me3 and decreased cell growth. The highly recurrent and specific inactivation of PRC2, NF1 and CDKN2A posits their critical and potentially cooperative roles in MPNST pathogenesis3. Using H3K27me3 IHC based clinical assay, we and others have confirmed loss of H3K27me3 staining indicative of PRC2 loss in ~ 60-70% of high grade NF1-associated MPNSTs4,5. Moreover, H3K27me3 IHC staining is universally intact in neurofibromas including plexiform neurofibromas, but >60% NF1-associated MPNSTs have lost H3K27m3 IHC staining, suggesting that the PRC2 loss is a critical and recurrent event in malignant transformation from benign neurofibroma to MPNST, which likely dictate the clinical behavior and therapeutic responses.  \n\n&nbsp;\n\n**_Based on these observations, we hypothesize_** that the frequent and concurrent CDKN2A loss and NF1 loss, as well as PRC2 loss in NF1-associated MPNSTs may create therapeutic opportunities for novel therapeutics development and H3K27me3 IHC may represent a novel therapeutic biomarker in MPNST that specifically target PRC2 loss. \n\n&nbsp;\n\nHere, **_we propose_** a focused investigation of specific aims centered on creating authentic model systems for novel therapeutic development to target the recurrent genetic alterations encompassing NF1, CDKN2A and PRC2 loss in NF1-associated MPNST. Given the molecular homogeneity, **_these studies will also provide_** us with the molecular underpinnings of therapeutic vulnerabilities of PRC2 loss in all MPNSTs, and shall facilitate therapeutic development for this difficult disease and other tumors that are dependent on PRC2 functional loss.\n\n&nbsp;\n\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n\n## Tables for Curation\n1. ID: syn64954766\nName: NF-OSI-processed-data\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: NF Service\n- Example files present: SRR19761312_2_fastqc.zip, SRR19761310_1_fastqc.zip, SRR19761311_1_fastqc.html, SRR19761310_1_fastqc.html, SRR19761311_1_fastqc.zip\n\n\n\n2. ID: syn51199007\nName: NFOSI-RNASeq-To-Process-2023-14-03\nSummary:\n- Assays: RNA-seq, single-cell RNA-seq\n- Species: Homo sapiens\n- Individual count: 41\n- Specimen count: 41\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor\n- Data types: geneExpression\n- File formats present: fastq\n- Funders: ?\n- Contains data created by: Christina Parry\n- Example files present: SRR19761314_1.fastq.gz, SRR19761315_1.fastq.gz, SRR19761320_1.fastq.gz, SRR19761321_1.fastq.gz, SRR19761327_1.fastq.gz\n\n\n"}]}]}}
{"custom_id":"syn26238842","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn26238842\n\n# Signaling pathways regulated by nitrated proteins as novel therapeutic targets for neurofibromatosis type 2\n## CTF Young Investigator Award\n\n### Principal Investigator: Maria C. Franco\n### Project Lead / Data Coordinator: Maria C. Franco,  Isabelle E. Logan\n### Institution: Oregon State University, University of Central Florida\n\n### Project Description:\nNeurofibromatosis type 2 (NF2) is a genetic disorder caused by inactivating mutations in the gene encoding the tumor suppressor merlin. NF2 patients develop schwannomas, meningiomas, and ependymomas throughout their life. NF2 patients have few therapeutic options; given the chronic and recurring nature of NF2, careful monitoring and resection radio surgery remains the treatment of choice. Further understanding the drivers of cell proliferation in NF2 and identifying new potential therapeutic targets remains paramount to improve the selectivity of drugs intended for the treatment of these chronic, recurrent tumors. Our group made a fundamental discovery: production of the powerful oxidant peroxynitrite and subsequent tyrosine (Tyr) nitration, an oxidative modification to proteins that occurs in pathological conditions, are essential for NF2 schwannoma cell survival. Excitingly, protein Tyr nitration is very low or absent in healthy cells. Our published and preliminary data posit nitrated proteins as a new category of tumor-directed targets for the development of tumor-directed therapies. We are determined to identify the role of nitrated proteins in the pathogenesis of NF2 and propose Tyr nitrated proteins are a novel therapeutic target. We have identified a number of proteins that are endogenously nitrated in vestibular schwannomas (VS) from NF2 patients. Six of these nitrated proteins are directly involved in signaling pathways dysregulated by the loss of merlin: Galectin 1 (Gal-1), Ras homolog family member A (RhoA), RhoC, Ras related protein 35, 14-3-3, Vimentin and Heat shock protein 90 (Hsp90). We discovered that nitrated Hsp90 supports schwannoma cell survival through a gain-of-function, but we also discovered that Hsp90 is not the only nitrated protein with pro-tumorigenic functions, and these other players remain unidentified. Therefore, the goals of the project are to 1) determine the regulation of signaling pathways by Tyr nitration in general, and Tyr nitrated Hsp90 in particular; and 2) identify the specific nitrated protein(s) that support NF2 tumor cell survival, providing a wealth of novel information and opening the door to the development of new therapies for NF2 treatment.\n\n## Tables for Curation\n1. ID: syn31802704\nName: Trial Run HscWT and Hsc45 Proteomics\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Isabelle Logan\n- Example files present: Hsc_Proteomics_Trial01.xlsx, Hsc_PhosphoProteomics_Trial01.xlsx\n\n\n"}]}]}}
{"custom_id":"syn11374354","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn11374354\n\n###A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings\n&nbsp;\n####**PI:**  Alice Soragni\n**[Soragni Lab at UCLA](http://www.soragnilab.com/)**\n####**cNF Organoid Project**  \nGiven the absence of therapeutic options and the heterogeneous nature of cutaneous neurofibromas (cNF), a physiological system that supports the growth of cNF tumor cells is required for drug screening efforts. To date, surgical removal or laser desiccation are the only treatment options, but can result in scarring and the leave a potential for regrowth.\nTo support drug discovery efforts focused on identifying effective systemic therapies for cNF, we introduce an approach to routinely establish and screen cNF tumor organoids. We optimized conditions to support ex vivo growth of genomically-diverse cNFs. Patient-derived cNF organoids closely recapitulate the molecular and cellular heterogeneity of these tumors as measured by immunohistopathology, DNA methylation, RNA-seq and flow cytometry. Lastly, we have adapted our high-throughput 3D mini-ring approach to screen cNF organoids. Our tractable patient-derived cNF organoid platform enables rapid screening of hundreds of compounds in a patient- and tumor-specific manner.\n\n#### Manuscript\n${buttonlink?text=Link to our published paper&url=https://www.cell.com/cell-reports-methods/fulltext/S2667-2375(24)00116-4&highlight=true&align=None}\n\n#### Data Access\nTo download the files, access the links in the table below:\n\nData Type | Dataset  | Metadata\n--- | --- | -- \nRNASeq | syn45172099 | syn57257803\nRRBS | syn45172461 | syn57257804\nNF1 Mutations | syn25831644\n\nData can be easily browsed with metadata on the [NF Data Portal](http://nfdataportal.org).  The cNF Organoid Project and all of its information can be found [here](https://nf.synapse.org/Explore/Studies/DetailsPage/Files?studyId=syn11374354). \n\n\nAll data files, results,  and associated metadata (that align with NF Data portal standards) can be programmatically queried, browsed, and downloaded from the [project metadata](syn11601495) table. We included a summary of data below:\n\n${synapsetable?query=select id%2Cname%2CdataType%2CindividualID%2Csex%2Cage%2CfileFormat%2CcreatedOn from syn11601495 where individualID is not NULL order by createdOn desc &showquery=true&tableonly=false}\n\n\n### Analysis code to reproduce results\n\nAll code to generate preliminary figures can be found [on GitHub](https://github.com/PNNL-CompBio/cNFOrganoidAnalysis). \n\n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n\n\n## Tables for Curation\n1. ID: syn64954761\nName: 12 months deliverable\nSummary:\n- Assays: immunohistochemistry\n- Species: Homo sapiens, \n- Individual count: 9\n- Specimen count: 76\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: , Cutaneous Neurofibroma\n- Data types: image, \n- File formats present: tif, doc, jpg, pdf\n- Funders: NTAP\n- Contains data created by: Alice Soragni\n- Example files present: PT.2.9.S100.40X.tif, PT2.9.CD34.40X.tif, PT2.9.CD56.20X.tif, PT2.9.CD56.40X.tif, PT2.9.S100.20X.tif\n\n\n\n2. ID: syn64954762\nName: 6 month deliverables\nSummary:\n- Assays: immunohistochemistry\n- Species: Homo sapiens\n- Individual count: 1\n- Specimen count: 2\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: image, \n- File formats present: pdf, powerpoint, jpg\n- Funders: NTAP\n- Contains data created by: Alice Soragni\n- Example files present: Human CD56 IHC Staining Protocol.pdf, Human SOX10 IHC Staining Protocol.pdf, Human SOX2 IHC Staining Protocol.pdf, Human NGFR IHC Protocol.pdf, Human S100 IHC Protocol.pdf\n\n\n\n3. ID: syn61847288\nName: Aligned reads from RNA-seq of cutaneous neurofibroma organoid model\nSummary:\n- Assays: RNA-seq\n- Species: , Homo sapiens\n- Individual count: 5\n- Specimen count: 54\n- Diagnoses present: , Neurofibromatosis type 1\n- Tumor types present: , Cutaneous Neurofibroma\n- Data types: dataIndex, AlignedReads\n- File formats present: bai, bam\n- Funders: ?\n- Contains data created by: Orca Service\n- Example files present: 1_S1_L001.markdup.sorted.bam.bai, 1_S1_L001.markdup.sorted.bam, 10_S10_L001.markdup.sorted.bam.bai, 10_S10_L003.markdup.sorted.bam.bai, 10_S10_L002.markdup.sorted.bam.bai\n\n\n\n4. ID: syn61847298\nName: Gene expression quantification of cutaneous neurofibroma organoid model\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 5\n- Specimen count: 55\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma\n- Data types: geneExpression\n- File formats present: sf\n- Funders: ?\n- Contains data created by: Orca Service\n- Example files present: quant.sf, quant.genes.sf, quant.genes.sf, quant.sf, quant.sf\n\n\n\n5. ID: syn45172461\nName: NF Organoid Bisulfite-seq\nSummary:\n- Assays: bisulfite sequencing, bisulfiteSeq, RNA-seq\n- Species: Homo sapiens\n- Individual count: 5\n- Specimen count: 55\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma\n- Data types: chromatinActivity\n- File formats present: fastq\n- Funders: NTAP\n- Contains data created by: ?\n- Example files present: NF0002-8-19--D-plus-C_S46_L003_R2_001.fastq.gz, NF0002-8-19--D-plus-C_S46_L003_R1_001.fastq.gz, NF0002-8-19--M--Mammo_S42_L003_R2_001.fastq.gz, NF0002-8-19--D--DMEM_S45_L003_R2_001.fastq.gz, NF0002-8-19--M--Mammo_S42_L003_R1_001.fastq.gz\n\n\n\n6. ID: syn45172099\nName: NF Organoid RNA-seq\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 5\n- Specimen count: 57\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma\n- Data types: geneExpression\n- File formats present: fastq\n- Funders: NTAP\n- Contains data created by: ?\n- Example files present: 1_S1_L003_R1_001.fastq.gz, 1_S1_L001_R1_001.fastq.gz, 1_S1_L001_R2_001.fastq.gz, 1_S1_L002_R2_001.fastq.gz, 1_S1_L003_R2_001.fastq.gz\n\n\n\n7. ID: syn51198895\nName: NFOSI-RNASeq-To-Process-2023-14-03\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 5\n- Specimen count: 57\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma\n- Data types: geneExpression\n- File formats present: fastq\n- Funders: NTAP\n- Contains data created by: Alice Soragni\n- Example files present: 1_S1_L003_R1_001.fastq.gz, 1_S1_L001_R1_001.fastq.gz, 1_S1_L001_R2_001.fastq.gz, 1_S1_L002_R2_001.fastq.gz, 1_S1_L003_R2_001.fastq.gz\n\n\n\n8. ID: syn64954763\nName: RNASeq - Failed QC\nSummary:\n- Assays: RNA-seq, \n- Species: Homo sapiens\n- Individual count: 2\n- Specimen count: 6\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma\n- Data types: geneExpression\n- File formats present: fastq, sf\n- Funders: NTAP\n- Contains data created by: Alice Soragni, Sara Gosline\n- Example files present: 44_S44_L001_R1_001.fastq.gz, 44_S44_L001_R2_001.fastq.gz, 44_S44_L002_R1_001.fastq.gz, 44_S44_L002_R2_001.fastq.gz, 44_S44_L003_R1_001.fastq.gz\n\n\n"}]}]}}
{"custom_id":"syn28545963","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn28545963\n\n\n${image?fileName=SchwannomatosisOpenResearchCollaborativeBanner%2DV1%2DR1%2D4x%2Epng&align=Center&scale=100&responsive=true&altText=}\n# Welcome!\n**Schwannomatosis** (SWN) is a rare, understudied genetic disorder that predisposes individuals to the development of nerve sheath tumors. While SWN is in some cases caused by germline mutations in the SMARCB1 and LZTR1 genes, the genomic landscape and genetic modifiers of this disorder are poorly understood. Recent efforts to study the genomics of SWN patients have increased our understanding of the disorder, and much of the data from this research is now publicly available. With support from the Children's Tumor Foundation, we have developed the **Schwannomatosis Open Research Collaborative (SORC)**, a community-based research project with the goal of utilizing public data to uncover new scientific insights into SWN.\n\n#  Objectives\n\nThe primary objective of this project is to perform comprehensive genomic analyses to uncover **noncoding variants**, **coding variants in under-studied genes**, or other genomic features that contribute to disease etiology and heterogeneity in SWN, including SMARCB1-related SWN, LZTR1-SWN, 22q-related SWN, SWN-not otherwise specified, and NF2-related SWN. Our secondary objective is to expand the NF community’s capacity for computational research.\n\n#  Apply for a SORC Computational Partnership to get help analyzing your SWN data\n**UPDATE MARCH 2024:** We are excited to launch the **SORC Computational Partnership Initiative**, in which we will work with selected researchers to design and complete genomic analyses, providing the necessary genomics expertise and computational resources.\n\n**To be eligible for this initiative, applicants must:**\n-have data available at the launch of the partnership, either directly from the researcher or through publicly available data repositories\n-have a specific question they are trying to answer or an analysis they are trying to perform\n-agree to complete a data sharing plan and share data used in the analyses through the [NF data portal](https://nf.synapse.org/) at the conclusion of the project or upon publication of a relevant manuscript\n-co-author a [micropublication](https://sagebionetworks.pubpub.org/) describing the partnership effort\n\nApplicants should develop an **outline of the proposed analysis** they are hoping to perform or the biological question they would like to answer using the available data. Interested researchers should set up a meeting with SORC leadership for an informal, preliminary discussion to brainstorm and refine analysis ideas. Upon completion of analyses, SORC will provide a written report with all necessary information that can be included in a relevant publication. Our capacity is limited, so we will prioritize projects based on feasibility which will be evaluated on a first-come first-serve basis. Priority will also be given to projects focused on rarer classifications of SWN.\n\n**To apply:**\nPlease [email us at nf-osi@sagebionetworks.org](mailto:nf-osi@sagebionetworks.org) with the subject line “SORC Computational Partnership Proposal” and provide an **outline of your proposed analysis**. We will then set up an informal meeting to discuss your analysis needs or ideas.\n\n\n# Available Data and Data Access\n${image?fileName=SWNTS%5Fdata%5Fprocessing%5Fschematic%2Epng&align=right&scale=35&responsive=true&altText=}\nThis project utilizes data from the [Synodos for Schwannomatosis initiative](https://nf.synapse.org/Explore/Studies/DetailsPage?studyId=syn9727752).  We have reprocessed available genomic data using standardized pipelines from [nf-core](https://nf-co.re/).  \n\nProcessed data such as variant calls and gene counts are available to project participants\nTo access the files, a user must:\n1. [Create a Synapse account](https://www.synapse.org/#!RegisterAccount:0). \n2. [Take the Synapse certification quiz](https://www.synapse.org/#!Quiz:Certification).\n3. [Fill in your user profile](https://www.synapse.org/#!Profile:v/profile). At a minimum, first name, last name, current affiliation and [ORCID](https://orcid.org/) are  required.\n4. Processed data files can be found [here](https://www.synapse.org/#!Synapse:syn9727752/files/). Click on the file you wish to access and then click the ***Request Access*** button.\n5. Accept the Terms and Conditions of Use for Synodos Schwannomatosis Data\n\n# Join us! Propose or contribute to an analysis\n\nIf you would like to join this collaborative effort, please fill out the registration form linked below. This will insure that you receive proper credit for your contributions in publications and any other materials produced as a result of this project. Contributions to this project should be made through the [GitLab repository](https://gitlab.com/nf-community/swnts/). If you have any other questions about this project or accessing the data, please email [nf-osi@sagebionetworks.org](mailto:nf-osi@sagebionetworks.org).\n\n${buttonlink?text=Registration Form&url=https://docs%2Egoogle%2Ecom/forms/d/e/1FAIpQLSd%2DlL6x2ub5LAjbzsK1469KWca6qhSEA24lMUJ%5FQkCxdeSEOA/viewform%3Fusp%3Dsf%5Flink&align=center}\n\n\n## Analyses\n\nAll code and results from project analyses will be maintained through the project [GitLab Repository](https://gitlab.com/nf-community/swnts/). \n\n### Proposed analyses\n\nSeveral analyses have already been proposed, and can be found on the [issues](https://gitlab.com/nf-community/swnts/-/issues) GitLab page. Proposed analyses include genome-wide variant interpretation and prioritization, transcript analyses to identify novel splice variants or gene fusions in schwannomas, analyses that integrate multiple data types to identify genes or biological pathways of interest, and machine learning analyses trained on larger cancer datasets in order to identify novel biological processes or disrupted patterns that are important in schwannomatosis.\n${image?fileName=SWNTS%5Fproposed%5Fanalyses%2Epng&align=center&scale=35&responsive=true&altText=}\n\n### Ideas for new analyses\nIf you have an idea for an analysis you would like to see utilizing this data, you can submit that idea to the project [GitLab page](https://gitlab.com/nf-community/swnts/-/issues/new).\n\n\n\n\n\n\n\n\n\n\n\n\n## Tables for Curation\n1. ID: syn44195326\nName: Viral Counts (CTAT-VIF)\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Robert Allaway\n- Example files present: swn_patient_10_tumor_109.VirusDetect.virus_read_counts_summary.tsv, swn_patient_10_tumor_110.VirusDetect.virus_read_counts_summary.tsv, swn_patient_10_tumor_111.VirusDetect.virus_read_counts_summary.tsv, swn_patient_10_tumor_112.VirusDetect.virus_read_counts_summary.tsv, swn_patient_17_tumor_31.VirusDetect.virus_read_counts_summary.tsv\n\n\n\n2. ID: syn32354801\nName: WES\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: \n- Example files present: \n\n\n"}]}]}}
{"custom_id":"syn4939892","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn4939892\n\n##Identification of Neurofibroma Growth and Drug Resistance Pathways\n**Initiative:** Open\n&nbsp;\n**Name:** Nancy Ratner, Ph.D.\n**Contact Email:** nancy.ratner@cchmc.org\n**Dates:** 2-1-14 to 1-31-16\n**Tumor Focus:** Plexiform Neurofibroma\n**Application:** Biomarkers, Omics\n&nbsp;\n**Background:** Up to 50%>  of children  with NF1 develop plexiform  neurofibromas  that can cause severe disfigurement  and serious morbidity-- and death when they compress vital organs.  Most plexiform neurofibromas are resistant to chemotherapy and surgical removal is often impossible due to tumor size, location, and nerve integration.  We jo not know why some  human neurofibromas  grow slowly and some rapidly,  nor why some neurofibromas respond to therapy but others do not.  Plexiform neurofibromas grow most aggressively in young children, and an appealing (unproven) idea is that transiently blocking growth of plexiform neurofibromas early in tumor development  will prevent  tumor progression.   Models  to study these critical issues have been lacking.   Our laboratory  has recently  developed  mouse models  that recapitulate  1) slow  and fast growing neurofibromas, and 2) neurofibromas that respond or fail to respond to targeted molecular therapy.   We plan to use new methods in gene expression  analysis to identify molecular  pathways  that correlate with these phenotypes  in mouse models, with verification on human tissues.   We also plan test if early treatment delays or halts neurofibroma formation by administering drugs before tumors develop in a neurofibroma mouse model\n&nbsp;\n**Goals of Project:** To identify tumor markers that serve as biomarkers in NF growth and tumors that are resistant to therapy\n&nbsp;\n**Impact:** \nThe work proposed in Aim 1A is expected to identify biomarkers of slow versus fast growing tumors. For example, we might find that fast growing tumors express a secreted factor predicted to be detected in serum or urine. In addition, we might identify targets which, when blocked, can slow the growth of rapidly growing plexiform neurofibromas. Identified markers can be analyzed in human tissues.  The work proposed in Aim 1B is expected to identify pathways that can be targeted to reduce growth of or kill neurofibroma cells. Thus, if we identify genes with high expression in tumors that fail to respond to a drug, we will co-target that pathway with the given drug (e.g. MEKi). If this succeeds in mice, we will test for expression of the gene/pathway in human tissue samples. Thus, we are defining cells and targets to use in clinical trials of plexiform neurofibroma.\n&nbsp;\n**Publications:** We will include the Stat genes in a paper that we are beginning to write now, with our MEK/Stat preclinical therapeutics. We will publish the MEK Resistance story after we carry out the preclinical test which we have planned. We will publish the fast versus slow growing tumors if and when we verify that one or more differentially regulated genes have a role in tumor growth.\n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n## Tables for Curation\n1. ID: syn65467784\nName: Gene Expression for Identification of Neurofibroma Growth and Drug Resistance Pathways\nSummary:\n- Assays: RNA-seq, \n- Species: Mus musculus, \n- Individual count: 2\n- Specimen count: 2\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Plexiform Neurofibroma, \n- Data types: geneExpression, \n- File formats present: excel\n- Funders: NTAP\n- Contains data created by: Kwangmn Choi\n- Example files present: DESeq2-PD0325901_all-vs-control-featureCounts-noFilter-output.xls, DESeq2-PD0325901_R-vs-PD0325901_NR-featureCounts-noFilter-output.xls, edgeR-PD0325901_all-vs-control-featureCounts-noFilter-output.xls, edgeR-PD0325901_R-vs-PD0325901_NR-featureCounts-noFilter-output.xls, Voom-PD0325901_all-vs-control-featureCounts-noFilter-output.xls\n\n\n"}]}]}}
{"custom_id":"syn51133946","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn51133946\n\n${buttonlink?text=DHART SPORE Home Page&url=https://www%2Esynapse%2Eorg/#!Synapse:syn5666132/wiki/&highlight=true&align=None}\n\n# DHART SPORE Project 3 Phase 1 - A High Content Clinical Trial of the MEK Inhibitor Trametinib in Juvenile Myelomonocytic Leukemia (JMML)\n## NIH-NCI - Developmental and HyperActive Ras Tumor Specialized Programs of Research Excellence\n### Principal Investigator: Kevin Shannon, Mignon Loh\n### Project Lead / Data Coordinator: Kevin Shannon, Mignon Loh\n### Institution: University of California, San Francisco\n### Project Description:\nChildren with NF1 are predisposed to juvenile myelomonocytic leukemia (JMML), an aggressive myeloproliferative neoplasm (MPN) that responds poorly to chemotherapy. Hematopoietic stem cell transplantation (HSCT) cures ~50% of patients. Our studies of JMML specimens proved that NF1 functions as a tumor suppressor gene in hematopoietic cells, and provided the first direct evidence of deregulated Ras signaling in primary cancer cells from NF1 patients. These studies support the role of hyperactive Ras signaling in JMML pathogenesis, and our group and other researchers subsequently discovered mutations in NRAS, KRAS, PTPN11, and CBL in JMML patient specimens. Overall, >85% of JMML cases have mutations in one of these genes, including 15-20% with clinical NF1 or mutations in the NF1 gene. Despite the routine use of HSCT, up to 30% of JMML patients progress to acute myeloid leukemia (AML). Consistent with the molecular genetics of JMML, using the Mx1-Cre transgene to inactivate the conditional mutant Nf1flox allele generated by the Parada lab or to express oncogenic KrasG12D or NrasG12D in the hematopoietic compartment induces a JMML-like MPN in mice. Preclinical trials in these accurate GEM models revealed remarkable efficacy of MEK inhibitors. Importantly, however, this, treatment does not eradicate mutant bone marrow cells, but modulates their proliferation and differentiation in vivo. The overall goals of Project 3 are to translate these promising preclinical data in JMML patients though an innovative clinical trial that includes deep molecular analysis.\n\n## Tables for Curation\n1. ID: syn54700333\nName: ADVL1521 Omic Data Repository\nSummary:\n- Assays: single-cell RNA-seq\n- Species: Homo sapiens\n- Individual count: 7\n- Specimen count: 14\n- Diagnoses present: ?\n- Tumor types present: Juvenile Myelomonocytic Leukemia\n- Data types: geneExpression\n- File formats present: fastq\n- Funders: NIH-NCI\n- Contains data created by: ?\n- Example files present: UPN3037_HM5230_Pre_S6_L003_I1_001.fastq.gz, UPN3037_HM5230_Pre_S6_L003_I2_001.fastq.gz, UPN3037_HM5230_Pre_S6_L003_R1_001.fastq.gz, UPN3037_HM5230_Pre_S6_L003_R2_001.fastq.gz, UPN3037_HM5230_Pre_S6_L004_I1_001.fastq.gz\n\n\n"}]}]}}
{"custom_id":"syn4939918","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn4939918\n\n##Using PNF-derived NF1(+/-) and NF1 (-/-) iPS Cells: Understanding PNF-cell of Origin, First Steps in Malignant Progression and Specific Inhibition of NF1 (-/-) Cell Proliferation\n**Initiative:** Open\n&nbsp;\n**Name:** Edu Serra \n**Contact Email:** eserra@igtp.cat\n**Dates:** 12-1-15 to 5-31-18\n**Tumor Focus:** plexiform neurofibroma\n**Application:** Cell Culture\n&nbsp;\n**Background:** In order to identify effective drugs against plexiform neurofibroma (PNF) formation/ progression we need to test them in the right in vitro and in vivo model systems. This involves, among other things, being able to use large quantities of NF1(+/-) and (-/-) cells closely resembling cells driving PNF formation and growth. PNF-derived NF1(+/-) and (-/-) iPS cells have been generated and can be used to test differentiation protocols towards the Neural Crest (NC) -Schwann cell (SC) lineage. Differentiated cells at different points of this lineage commitment can be characterized and engrafted into the sciatic nerve of nude mice to test their tumor-formation capacity and, in this way, interrogate about the identity of the cells originating PNFs. Two things, the setting up the right in vitro iPSC differentiation conditions towards NC and SC in one side and on the other, the characterization of the different steps of differentiation in the NC-SC lineage, will proportionate the basis for performing future drug screenings for PNFs using iPSC-derived cells.\n&nbsp;\n**Goals & Aims:** \n•\tTo set up in vitro conditions to efficiently differentiate iPS cells into cells of the Neural Crest -Schwann cell lineage. Characterize the methylome and transcriptome of these cells with distinct NF1 genotypes and test their potential engraftment/tumor formation capacity.\n•\tGenerate new iPSC and edit control iPSC with distinct NF1 genotypes to interrogate the presence of epigenetic memory in the PNF-derived iPS cells generated\n&nbsp; \n**Publications/Posters/Presentations:** Two manuscripts are being written. \nIn one manuscript the intra-PNF variability concerning histology and genomics is described. A correlation between histological and genomic findings is presented. All PNFs used for the iPSC generation were included.\nIn a second manuscript the generation, characterization and use of the PNF-derived NF1(+/-) and NF1(-/-) cell lines is fully described. These cell lines are being deposited in a stem cell bank to give access to interested NF1 researchers.\n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n## Tables for Curation\n1. ID: syn51930713\nName: Gene Expression Quantification from RNA-seq\nSummary:\n- Assays: \n- Species: ?\n- Individual count: 4\n- Specimen count: 27\n- Diagnoses present: ?\n- Tumor types present: Not Applicable\n- Data types: geneExpression\n- File formats present: sf\n- Funders: ?\n- Contains data created by: NF Service\n- Example files present: quant.sf, quant.sf, quant.genes.sf, quant.genes.sf, quant.genes.sf\n\n\n\n2. ID: syn64954688\nName: MethylationArray\nSummary:\n- Assays: \n- Species: \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: ?\n- Data types: chromatinActivity, \n- File formats present: idat, \n- Funders: NTAP\n- Contains data created by: Bernat Gel Moreno, Kaitlin Throgmorton\n- Example files present: 202915420028_R07C01_Grn.idat, 202908420087_R05C01_Grn.idat, 202915420028_R01C01_Red.idat, 202908420087_R04C01_Grn.idat, 202908540037_R04C01_Grn.idat\n\n\n\n3. ID: syn51198953\nName: NFOSI-RNASeq-To-Process-2023-14-03\nSummary:\n- Assays: \n- Species: \n- Individual count: 4\n- Specimen count: 27\n- Diagnoses present: ?\n- Tumor types present: Not Applicable\n- Data types: geneExpression\n- File formats present: fastq\n- Funders: NTAP\n- Contains data created by: Bernat Gel Moreno\n- Example files present: EX16_FiPS_NC_1.fastq.gz, FiPS_PSC_2.fastq.gz, 5PNF_TDiPSsv_MM_PSC_1.fastq.gz, 3PNF_SiPSsv_MM_PSC_1.fastq.gz, EXP13_EXP14_3PNFiPS_5PNFiPS_14_2.fastq.gz\n\n\n\n4. ID: syn64954689\nName: RNAseq\nSummary:\n- Assays: RNA-seq, \n- Species: Homo sapiens, \n- Individual count: 4\n- Specimen count: 27\n- Diagnoses present: ?\n- Tumor types present: Not Applicable, \n- Data types: geneExpression, \n- File formats present: fastq, \n- Funders: NTAP\n- Contains data created by: Bernat Gel Moreno, Christina Parry\n- Example files present: EX16_FiPS_NC_1.fastq.gz, FiPS_PSC_2.fastq.gz, 5PNF_TDiPSsv_MM_PSC_1.fastq.gz, 3PNF_SiPSsv_MM_PSC_1.fastq.gz, EXP13_EXP14_3PNFiPS_5PNFiPS_14_2.fastq.gz\n\n\n\n5. ID: syn64954690\nName: SNParray\nSummary:\n- Assays: SNP array, \n- Species: Homo sapiens, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: ?\n- Data types: genomicVariants, \n- File formats present: txt, \n- Funders: NTAP\n- Contains data created by: Bernat Gel Moreno, Kaitlin Throgmorton\n- Example files present: PNF13_S.txt, PNF13_FiPS_PM_5.txt, PNF13_SiPS_PM_4.txt, PNF13.txt, PNF13_F.txt\n\n\n"}]}]}}
{"custom_id":"syn7239560","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn7239560\n\n##Evotec Drug-Target discovery\n\nThis site serves as the landing page for the upload and analysis of the drug target research carried out by [Evotec](https://www.evotec.com/). \n\n###Compound structures\nThe structure data for each of the drugs annotated by Evotec can be found in two tables. These include the [supplier-provided structures](https://www.synapse.org/#!Synapse:syn7239560/wiki/410637) and the [unique structure properties](https://www.synapse.org/#!Synapse:syn7239560/wiki/410636) computed from KNIME.\n\n###Compound Annotations\nThis resource contains numerous annotations of compounds. \n\n\n## Tables for Curation\n1. ID: syn65467787\nName: Compound Annotations from Evotec Drug Target Research\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: doc, sdf, csv, txt\n- Funders: CTF\n- Contains data created by: Tim James, Robert Allaway\n- Example files present: explanation.docx, unique_structures_with_calculated_properties.sdf, supplier_structures.sdf, pubchem_inactivity_unique_pairs.csv, chembl_matches.csv\n\n\n"}]}]}}
{"custom_id":"syn4939906","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn4939906\n\n##Screening (Single Agent MIPEs, combo)\n\n**Initiative:** Cell Culture\n&nbsp;\n**Name:** Marc Ferrer, Ph.D. (NCATS)\n**Contact Email:** marc.ferrer@nih.gov\n**Dates:** 2014-2017 (ongoing)\n**Tumor Focus:** Plexiform Neurofibroma\n**Application:** Efficacy, potency, and synergy data profiles, as well as pathways and targets\n&nbsp;\n**Background:** A lack of cellular model systems was identified as a major gap in pNF therapeutics-focused research when NTAP was launched in 2012. Hence, creating a cell culture initiative was an early priority. While current animal models can faithfully mimic some aspects of pNF (tumor histology, imaging characteristics, natural history), they are based on relatively narrow genetically engineered platforms and are not fully representative of human NF1 diversity. Moreover, the tumors in these models are slow growing (requiring 9-12 months for a single compound efficacy study) and costly. Hence, there is a need for in vivo models that allow more rapid drug screening (particularly when considering possible combinatorial therapies) and a need for in vitro models that allow more facile manipulation of the NF1 gene in order to understand the molecular genomics influencing tumor behavior. \n&nbsp;\n**Goals of Project:** \nTo create a panel of cell culture systems that represent pNF complexity and can be utilized to both screen new compounds as well as to identify new therapeutic targets.\n&nbsp;\n**Specific Aims:**\n1. Single agent screen of the MIPE 4.0 library of approx. 1912 small molecules against 9 different cell-lines (5 NF1 nullizygous, 1 carrier, 2 normal, and 1 control) with diverse modes of action, and the generation of single agent viability results for each cell line to ID ~40 top hits (with highest potency and efficacy)\n2. Execution of 6 x 6 screen of the top 40 compounds from initial screening, to elicit 780 combinations, such that the top 72 unique combinations (with preliminary optimal synergism profiles) can be elucidated\n3. Execution of 10 x 10 screen of top 72 compounds from 2nd screen, in order to focus on 9 combinations prioritized for validation in mouse NF1-/- primary Schwann cells.\n&nbsp;\n**Impact:** The screening studies yielded new data about drugs to be considered for pNF, new tools and guidelines for reproducible, transferable cell culture methodology for pNF and new biologic observations that may lead to unanticipated therapeutic discoveries.\n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n**Curation Notes:**\nIn April 2021, Peggy Wallace, et al., determined that the ipnNF95.11c cell line, distributed by ATCC, is probably a / cell line, not a +/- cell line as was originally thought. Thus, the nf1Genotype annotation on data files for these samples has been altered from +/- to -/-,+/-.\n\n## Tables for Curation\n1. ID: syn51917001\nName: 10x10 Combination Screens of pNF Cell Lines\nSummary:\n- Assays: cell viability assay\n- Species: Homo sapiens\n- Individual count: 4\n- Specimen count: 4\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: Plexiform Neurofibroma, \n- Data types: drugCombinationScreen\n- File formats present: csv\n- Funders: NTAP\n- Contains data created by: ?\n- Example files present: iPNF05.5_10x10_CCG_16h_calc.csv, iPNF05.5_10x10_CCG_16h_metadata.csv, iPNF05.5_10x10_CCG_16h_responses.csv, iPNF05.5_10x10_CTG_48h_calc.csv, iPNF05.5_10x10_CTG_48h_metadata.csv\n\n\n\n2. ID: syn51917244\nName: 6x6 Combination Screens of pNF Cell Lines\nSummary:\n- Assays: cell viability assay\n- Species: Homo sapiens\n- Individual count: 6\n- Specimen count: 6\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: Plexiform Neurofibroma, \n- Data types: drugCombinationScreen\n- File formats present: csv\n- Funders: NTAP\n- Contains data created by: ?\n- Example files present: iPN02.3l_6x6_CTG_48h_calc.csv, iPN02.3l_6x6_CTG_48h_metadata.csv, iPN02.3l_6x6_CTG_48h_responses.csv, ipNF05.5_6x6_CTG_48h_calc.csv, ipNF05.5_6x6_CTG_48h_metadata.csv\n\n\n\n3. ID: syn51914953\nName: Single Agent Screens of pNF Cell Lines\nSummary:\n- Assays: cell viability assay, \n- Species: Homo sapiens, , Mus musculus\n- Individual count: 11\n- Specimen count: 11\n- Diagnoses present: , Neurofibromatosis type 1\n- Tumor types present: , Plexiform Neurofibroma\n- Data types: drugScreen, \n- File formats present: csv, txt, png\n- Funders: NTAP\n- Contains data created by: ?\n- Example files present: NTAP ipNF02.3 2l MIPE qHTS.csv, NTAP ipNF02.8 MIPE qHTS.csv, NTAP ipNF05.5 MC MIPE qHTS.csv, NTAP ipNF05.5 SC MIPE qHTS.csv, NTAP ipNF06.2A MIPE qHTS.csv\n\n\n"}]}]}}
{"custom_id":"syn53185180","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn53185180\n\n# Translating Basic Research towards Improved Clinical and Therapeutic Approaches\n## GFF - Other\n### Principal Investigator: Raymond Mattingly\n### Project Lead / Data Coordinator: Raymond Mattingly\n### Institution: Wayne State University\n### Project Description:\nSynergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers\nSummary: Activated RAS proteins drive the proliferation and survival of many human tumors. For example, in type 1 neurofibromatosis (NF1), loss of expression of neurofibromin allows hyper-activation of RAS. Drug treatments to block activated RAS have been long sought as a rational and targeted approach to treating cancer, but numerous obstacles have been discovered. We have designed a combinatorial approach to block the maturation of RAS in cellular models of malignant peripheral nerve sheath tumors (MPNSTs) from NF1 patients. The combination of a prodrug farnesyl transferase inhibitor (FTI) that is competitive with the prenyl co-factor of the enzyme plus a low dose of lovastatin to reduce cellular pools of prenyl precursors was effective and selective in blocking the proliferation of NF1 MPNST cells in vitro and in an orthotopic xenograft on the murine sciatic nerve. This approach could also be applicable to other cancers that are driven by activated RAS.\n\n\n## Tables for Curation\n1. ID: syn53185351\nName: Colony forming assays\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Robert Allaway\n- Example files present: S462TY colony formation.xlsx, Schwann_rat colony formation.xlsx, ST88-14 colony formation.xlsx\n\n\n"}]}]}}
{"custom_id":"syn20608511","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn20608511\n\n#  Whole Body MRI of NF Patients\n\n### **Principal Investigator / Data Contributors:**  Dr. Wenli Cai ( @wcai ) and Dr. Gordon Harris\n### **Institution:** Massachusetts General Hospital (MGH)\n\n### General scientific questions:\n\nCan we identify features of MRIs to diagnose specific tumor types or predict disease progression? Can we improve upon current segmentation algorithms?  \n\nDataset: 2 image modalities (STIR and T1) from 48 NF1, NF2, and schwannomatosis patients using whole-body magnetic resonance imaging (WB MRI). We'll also provide matching structured clinical data (diagnosis, tumor burden, etc) to facilitate phenotypic analysis of the imaging data.\n\n### Data available: \n\n- Imaging: 96 stacks (two imaging modalities) from 48 patients with NF1, NF2 or Schwannomatosis. Image stacks are [here](https://www.synapse.org/#!Synapse:syn20704059). Combined .avis for each stack are also available in the [reports folder](https://www.synapse.org/#!Synapse:syn20708336).\n- Clinical metadata: tumor burden information including tumor type and location, available in clinical reports [here](https://www.synapse.org/#!Synapse:syn20708336).\n\n### Accessing the data:\n\nPlease navigate to [\"Accessing the Data\"](https://www.synapse.org/#!Synapse:syn20608511/wiki/595382) and follow the instructions to request access to the data. \n\n### Quality Assurance of the Data:\nWe will publish these 50 retrospectively collected WBMRI dataset for volumetric image analysis of whole-body MRI for patients diagnosed with NF, including NF1, NF2, and schwannomatosis. All these patients were scanned at MGH by using the clinical standard operational procedures for a clinical MRI system.  The image quality was examined by the board-certified radiologists. These are real clinical MRI data for longitudinal tracking of NF patients. \n\n## Tables for Curation\n1. ID: syn64962007\nName: Whole Body MRI of NF Patients\nSummary:\n- Assays: conventional MRI, \n- Species: Homo sapiens, \n- Individual count: 9\n- Specimen count: 9\n- Diagnoses present: Neurofibromatosis type 1, Schwannomatosis, Neurofibromatosis type 2, \n- Tumor types present: unknown, \n- Data types: image, \n- File formats present: DICOM, \n- Funders: CTF\n- Contains data created by: Robert Allaway, Jineta Banerjee\n- Example files present: 001-67.0.dcm, 016-83.0.dcm, 005-72.0.dcm, 008-75.0.dcm, 017-84.0.dcm\n\n\n"}]}]}}
{"custom_id":"syn51133914","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn51133914\n\n${buttonlink?text=DHART SPORE Home Page&url=https://www%2Esynapse%2Eorg/#!Synapse:syn5666132/wiki/&highlight=true&align=None}\n\n# DHART SPORE Project 1 Phase 1 - Molecular, Developmental, and Genetic Evaluation of Plexiform Neurofibromas to Inform Clinical Trials\n## NIH-NCI - Developmental and HyperActive Ras Tumor Specialized Programs of Research Excellence\n### Principal Investigator: D. Wade Clapp, Jaishri Blakeley, Brigitte Widemann, Lu Le\n### Project Lead / Data Coordinator: D. Wade Clapp, Jaishri Blakeley, Brigitte Widemann, Lu Le\n### Institution: Indiana University; Johns Hopkins University; National Institutes of Health; University of Texas Southwestern Medical Center\n### Project Description:\nPlexiform neurofibromas (PNs) PNs are complex nerve and soft tissue tumors that affect 25-50% of people with NF1, cause serious lifelong morbidity and mortality due to organ compression, and progress to malignant peripheral nerve sheath tumors (MPNST) in ~8-13% of patients. Collaborative studies performed by Drs. Clapp and Luis Parada in a genetically engineered mouse (GEM) model of PNs unexpectedly demonstrated a central role of infiltrating Nf1 haploinsufficient bone marrow-derived mast cells in promoting the growth of PN lesions in vivo. These novel data led to a clinical trial administering imatinib mesylate to target aberrant stem cell factor (SCF)/c-kit signaling in the tumor microenvironment, which induced objective clinical responses in a subset of patients. Based on the observation that young children with head, neck, and airway tumors were most likely to have partial tumor regression, Drs. Robertson, Blakeley, Widemann and Michael Fisher are pursuing a registration trial in this patient population. More recently, studies in GEM models informed successful clinical trials of MEK inhibitors to directly inhibit aberrant Ras/Raf/MEK/ERK signaling in PN cells. The objective of Project 1 is to extend these promising data to investigate the developmental, molecular, and pharmacokinetic effects of c-kit and MEK inhibition alone and in combination. Our investigative team will characterize the adaptive responses of PNs to these kinase inhibitors in GEM models and in parallel studies in patients.\n\n## Tables for Curation\n1. ID: syn65468212\nName: Histopathology - Human PN , ANNUBP and MPNST Specimens\nSummary:\n- Assays: brightfield microscopy\n- Species: Homo sapiens\n- Individual count: 30\n- Specimen count: 61\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: [\"Plexiform Neurofibroma\"], [\"Fibromatosis\"], [\"Neurofibroma\"], [\"Malignant Peripheral Nerve Sheath Tumor\"], [\"Hemorrhagic Neoplasm\", \"Necrotic Neoplasm\"], , [\"ANNUBP\"]\n- Data types: image, \n- File formats present: svs, xml, pdf, xlsx, \n- Funders: NIH-NCI\n- Contains data created by: Steven Rhodes, Andrew Horvai, Elliot Stieglitz\n- Example files present: S12-24613 A1 PNF.svs, S12-24613 D8.svs, S15-14936 A5.svs, S15-14936 A5.xml, S15-33141 F3.svs\n\n\n\n2. ID: syn65468144\nName: Van Andel - Kinome\nSummary:\n- Assays: \n- Species: \n- Individual count: 16\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: kinomics\n- File formats present: excel, csv\n- Funders: NIH-NCI\n- Contains data created by: Steven Angus, Sara Gosline\n- Example files present: CHOP-Le-VanAndel-Kinome-log2LFQ.xlsx, VA09_sampls_spore_kinome.csv, VA08_sampls_spore_kinome.csv, VA07_sampls_spore_kinome.csv, VA06_sampls_spore_kinome.csv\n\n\n"}]}]}}
{"custom_id":"syn22268639","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn22268639\n\n## **Understanding the role of purinerigic signaling on tumor formation in a mouse model of Neurofibromatosis Type 1**\n\n### CTF Young Investigator:\n#### Jennifer Patritti Cram\n\n### Investigator Institution:\nCincinnati Medical Center\n\n### Abstract:\nNeurofibromatosis type 1 (NF1) is a disorder that affects 1:3,000 individuals worldwide. Loss of function of the neurofibroma gene (NF1) causes over activation of the RAS oncogenic signaling pathway. People with NF1 have an increased risk of developing tumors (neurofibromas), both benign and malignant anywhere along the peripheral nervous system (PNS). Neurofibromas arise from Schwann cells (SCs) and/or Schwann cell precursors (SCP). SCs support axons in the peripheral nervous system (PNS). To date, there is no cure for this disease. Therefore, the purpose of this proposal is to identify potential treatments for NF1 by studying the mechanisms involved in tumor formation. \n\nTo identify potential markers and therapeutic targets for NF1, we performed microarray analysis on human plexiform neurofibromas. We dissociated human neurofibromas and sorted tumor derived cells into SCs (p75+/EGFR-) and SCP tumor-initiating cells (p75+/EGFR+) (p75 marks neural crest cells, SC precursors, and non-myelinating SCs, and EGFR+ marks cells that express the Epidermal Growth Factor Receptor) [Schwann cells are EGFR negative]. The hypothesis behind the cell sorting is that genes expressed in neurofibroma SCP-tumor initiating cells (p75+/EGFR+) more than in differentiated neurofibroma Schwann cells (p75+/EGFR-) contribute to tumor initiation. From this microarray study, we found that a purinergic receptor, P2RY14 expression was increased in SCP-like tumor initiating cells (p75+/EGFR+). Then, we sorted the SCP tumor initiating cells (p75+/EGFR+) into P2RY14 positive or negative (p75+/EGFR+/P2RY14+ or p75+/EGFR+/P2RY14-) and we found that the p75+/EGFR+/P2RY14+ cells show an increased ability to self-renew and form spheres in vitro. These results suggest that tumor initiating cells (p75+/EGFR+) that are P2RY14+ might drive tumor growth.\n\nTo test if P2RY14 is tumor promoting in vivo, I bred our genetically engineered neurofibroma mouse model (Nf1 fl/fl DhhCre) to P2RY14 knockout mice (P2RY14-/-). Knocking out P2RY14 in the neurofibroma mice (P2Y14-/-; Nf1 fl/fl DhhCre) increases survival and reduces tumor number. This data demonstrates that P2RY14 is involved in neurofibroma formation and that knockout of this receptor in the neurofibroma mouse model increases survival rate in neurofibroma bearing mice. \n\nI hypothesize that P2RY14 promotes neurofibroma growth by enhancing tumor cell self-renewal and/or proliferation in vitro and that inhibition of this receptor in vivo will result in a decrease of tumor growth. This hypothesis will be tested by completion of these specific aims:\n\n**Aim 1:** Determine if the P2RY14 receptor is necessary for neurofibroma tumor cell proliferation in vitro. I hypothesize that P2RY14 signaling promotes neurofibroma growth in a cell autonomous way by regulating SCP proliferation and/or self-renewal in vitro. A) To determine if P2RY14 activation affects SCP cell proliferation, I will measure proliferating cell rates in WT and Nf1-/- SCP after addition of UDP (P2RY14 agonist). B) To determine if P2RY14 is necessary for neurofibroma SCP proliferation, I will silence P2RY14 expression in WT and Nf1-/- SCP in vitro using the P2RY14 pharmacological inhibitor and/or short-hairpin RNA (shRNA) and measure the rate of proliferating cells. If a change is found, I will determine if the change is MAPK dependent by monitoring RAS signaling or, determine if the change is P2RY14 dependent by monitoring cAMP levels.\n\n**Aim 2:** Determine if the P2RY14 inhibitor drug can decrease neurofibroma growth. I will perform a drug study to determine if administration of a P2RY14 inhibitor by itself and/or in combination with the MEK inhibitor selumetinib for 7 days decreases cell proliferation, cell death, PKA and/or MAPK signaling. I will read out results by immunohistochemistry in tumor sections. If no change is found then, I will conclude that P2RY14 effects are mainly through tumor initiation. If an effect is seen, I will determine what cell types are involved in this process and increase the duration of the drug treatment to assess tumor size and tumor growth kinetics overtime.\n\nUpon completion of the proposed aims in this grant, I will determine if P2RY14 is necessary for neurofibroma tumor cell proliferation in vitro and test if P2RY14 inhibition by drug delivery has an effect on tumor growth in vivo.\n\nA critical gap in the field are the absence of mechanistic studies on the cause of tumor formation and the limited number of drugs available to treat NF1. Therefore, to fill this critical gap in knowledge, in Aim 1 I propose to determine if P2RY14 is necessary for neurofibroma cell proliferation in vitro. In Aim 2, I propose to determine if a P2RY14 pharmacological inhibitor can decrease neurofibroma growth.\n\nOur results will impact the neurofibroma field not only by defining purinergic signaling mechanisms relevant to neurofibroma development but I will also establish if the P2RY14 inhibitor can be used as a treatment for NF1.\n\n## Tables for Curation\n1. ID: syn64954874\nName: P2RY14 and NF1\nSummary:\n- Assays: western blot\n- Species: Homo sapiens, Mus musculus (humanized)\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Not Applicable, Neurofibroma\n- Data types: immunoassay\n- File formats present: pdf\n- Funders: CTF\n- Contains data created by: Jennifer Patritti Cram\n- Example files present: Figure 3F total ERK and pAKT-source data 3.pdf, Figure 3G-2-source data 1.pdf, Figure 4B-source data 1.pdf, Figure 4C neurofibroma b-actin-source data 1.pdf, Figure 4C neurofibroma P2RY14-source data 2.pdf\n\n\n"}]}]}}
{"custom_id":"syn32128792","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn32128792\n\n# Genomic landscape of malignant peripheral nerve sheath tumor (MPNST) \n## NFRI - Genomics of MPNST (GeM) Consortium\n### Principal Investigator: David Miller\n### Project Lead / Data Coordinator: Katherine Piculell\n### Institution: Boston Children's Hospital\n### Project Description:\n####  Neurofibromatosis type 1 (NF1) is the most common tumor predisposition syndrome, and is associated with an aggressive soft-tissue sarcoma, malignant peripheral nerve sheath tumours (MPNSTs), the greatest cause of morbidity and mortality in people with NF1. The only potentially curative therapy involves surgery which is not always possible. Even therapy with curative intent is associated with poor overall survival for both sporadic and NF1-related MPNSTs. The development of novel therapies has been largely hindered by a lack of understanding of the molecular events underpinning MPNST pathogenesis. This is a comprehensive multi-omic study of MPNST evolution based on whole genome sequencing and transcriptomic data.  \n\n### PLEASE NOTE: This project links to data stored in EGA, annotated with the NF-OSI metadata dictionary to make this dataset visible in the NF Data Portal.  The data itself _is not available_ on Synapse or the NF Data Portal. You must request permission and access the data on [EGA](https://ega-archive.org/datasets/EGAD00001008608/).\n\n## Tables for Curation\n1. ID: syn38299187\nName: EGA Raw Data (requires approval on EGA)\nSummary:\n- Assays: \n- Species: \n- Individual count: 79\n- Specimen count: 139\n- Diagnoses present: Not Applicable, Neurofibromatosis type 1\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, Not Applicable\n- Data types: geneExpression\n- File formats present: fastq\n- Funders: NFRI\n- Contains data created by: ?\n- Example files present: S00005M1_R1.fastq.gz, S00005M1_R2.fastq.gz, S00006M1_R1.fastq.gz, S00006M1_R2.fastq.gz, S00006M2_R1.fastq.gz\n\n\n\n2. ID: syn38893832\nName: EGAD00001008608 RNA-Seq Processed Data - quant.genes.sf (requires approval on EGA)\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 79\n- Specimen count: 139\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, Not Applicable\n- Data types: geneExpression\n- File formats present: sf\n- Funders: ?\n- Contains data created by: ?\n- Example files present: quant.genes.sf, quant.genes.sf, quant.genes.sf, quant.genes.sf, quant.genes.sf\n\n\n\n3. ID: syn58895011\nName: EGAD00001008608 RNA-Seq Processed Data - quant.sf (requires approval on EGA)\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 79\n- Specimen count: 139\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, Not Applicable\n- Data types: geneExpression\n- File formats present: sf\n- Funders: ?\n- Contains data created by: Robert Allaway\n- Example files present: quant.sf, quant.sf, quant.sf, quant.sf, quant.sf\n\n\n"}]}]}}
{"custom_id":"syn22268689","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn22268689\n\n## **Identification and functional characterization of the substrates of LZTR1 (schwannomatosis)**\n\n### CTF Young Investigator:\n#### Aram Ko\n\n### Investigator Institution:\nColumbia University\n\n### Abstract:\nLZTR1 is a substrate adaptor protein of the CUL3 ubiquitin ligase complex whose substrates and cellular functions remain mostly unknown. Our laboratory reported for the first time that human brain tumors harbor somatic mutations of the LZTR1 gene. Later studies revealed that LZTR1 is somatically mutated across many types of human tumors. Furthermore, mutations of LZTR1 were identified as the causal event leading to a significant number of cases of schwannomatosis. Schwannomatosis is a rare form of Neurofibromatosis that has only recently been identified. The genetic disorder affects less than 1 in 40,000 people, and causes the development of schwannomas on cranial, spinal and peripheral nerves. Schwannomas may cause pain that may be hard to manage. Although the causal tumor suppressor role of LZTR1 as genetic basis of schwannomatosis has been firmly established, the mechanism by which loss of the activity of the LZTR1 ubiquitin ligases triggers tumor development remains elusive. Temporally coordinated destruction of key cell regulatory proteins by the Ubiquitin-Proteasome System (UPS) represents an important control mechanism to ensure that specific protein functions are turned off at the right time, in the right compartment, and in a unidirectional fashion. Cullin/Ring/Ligase complexes (CRL) control the proteolysis of many important cell regulators. In humans, there are approximately 200 CRL ligases, each characterized by a different substrate recognition subunit that provides specificity by directly recruiting the substrates. Cullin-3 is the molecular scaffold of a major class of CRLs that use BTB domain proteins as substrate-specific adaptors. Despite their large number, only a handful of BTB domain proteins have well-established substrates and their biological functions are largely unknown. Recently, RAS and Rit1 have been proposed as potential substrates of LZTR1. In the context of this work, it was suggested that LZTR1 may inhibit MAPK pathway by repressing RAS activity, but the mechanism of RAS inhibition remains controversial. Furthermore, the full scope of LZTR1 substrates and cellular functions remain unknown. \n\nHere, we will elucidate the normal biochemical and biological functions of LZTR1 and substrates and the mechanisms by which LZTR1 suppresses tumor growth. This work will use state of the art proteomics to identify and demonstrate the significance of crucial LZTR1 substrates in the context of cancer cells driven by LZTR1 inactivation. We anticipate that the proteomic-based discovery of new LZTR1 substrates will provide a major advance in our understanding of the links between ubiquitin ligases, tumor suppression and of the pathogenesis of Schwannomatosis and the many sporadic tumors driven by loss-of-function genetic alterations (mutations and deletions) of LZTR1. We postulate that LZTR1 substrates\nimplement oncogenic functions that are normally restrained by LZTR1-mediated ubiquitin-dependent degradation. The expected overall impact of this innovative grant application is that it will fundamentally advance our mechanistic understanding of the LZTR1 ubiquitin ligase as genetic driver of schwannomatosis and sporadic tumors and lay the foundation for the optimization of new therapeutic strategies in syndromic and sporadic tumors associated with loss-of-function genetic alterations of LZTR1.\n\n### Acknowledgement:\nData was provided by:\n\n**Ko A, Hasanain M, Oh YT, D'Angelo F, Sommer D, Frangaj B, Tran S, Bielle F, Pollo B, Paterra R, Mokhtari K, Soni RK, Peyre M, Eoli M, Papi L, Kalamarides M, Sanson M, Iavarone A, Lasorella A. LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL. Cancer Discov. 2023 Mar 1;13(3):702-723. doi: 10.1158/2159-8290.CD-22-0376. PMID: 36445254.**\n\nThe results published here are in whole or in part based on data obtained from the NF Data Portal (http://www.nf.synapse.org, RRID:SCR_021683) and made available through the NF Open Science Initiative.\n**Accessing the data from this study requires a Synapse account.**\n\n## Tables for Curation\n1. ID: syn64954875\nName: Proteomics\nSummary:\n- Assays: mass spectrometry, TMT quantitation, \n- Species: Mus musculus, Homo sapiens, \n- Individual count: ?\n- Specimen count: 1\n- Diagnoses present: Not Applicable, \n- Tumor types present: Not Applicable, Glioblastoma, \n- Data types: proteomics, \n- File formats present: excel, \n- Funders: CTF\n- Contains data created by: Aram Ko, James Moon\n- Example files present: DiGly proteomics.xlsx, immunoprecipitation mass spectrometry.xlsx, TMT.xlsx, synapse_storage_manifest_proteomicsassaytemplate.csv\n\n\n\n2. ID: syn64954876\nName: in vitro viability assay\nSummary:\n- Assays: cell viability assay, \n- Species: Mus musculus, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Not Applicable, \n- Tumor types present: Not Applicable, \n- Data types: drugCombinationScreen, \n- File formats present: excel, \n- Funders: CTF\n- Contains data created by: Aram Ko, James Moon\n- Example files present: in vitro viability assay.xlsx, synapse_storage_manifest_clinicalassaytemplate.csv\n\n\n"}]}]}}
{"custom_id":"syn11374345","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn11374345\n\n###Leveraging human induced pluripotent stem cells (iPSCs) to determine the impact of patient-derived NF1 gene mutations on peripheral sensory neuron-driven Schwann cell growth\n&nbsp;\n\n#####**PI:**  David H. Gutmann, MD, PhD\n#####**Team:** Corina Anastasaki, PhD, Jason B. Papke, MS, and Morgan E. Freret, MS\n\n**University of Washington**\n\n&nbsp;\n\n######**Background and Rationale:**  \n\nCutaneous or dermal neurofibromas (cNFs) represent one of the signature tumor types in individuals with the Neurofibromatosis type 1 (NF1) cancer predisposition syndrome. These benign tumors are composed of neoplastic Schwann cells embedded in a microenvironment containing terminal nerve endings, fibroblasts, mast cells, and macrophages. While caused by loss of NF1 protein function in Schwannian lineage cells, studies in mouse plexiform neurofibroma models have revealed a critical role for non-neoplastic stromal cells (fibroblasts, mast cells, and macrophages) in tumor formation, maintenance, and continued growth. In this regard, inhibition of stromal cell (mast cells, macrophages) function in preclinical genetically-engineered mice resulted in attenuated plexiform neurofibroma growth. In addition to fibroblasts, mast cells, and macrophages, the NF1-deficient Schwann cells in cNFs often grow in proximity to terminal nerve endings. The intimate relationship between neurons and Schwann cells during normal peripheral nervous system development and function raises the intriguing possibility that neurons are important drivers of cNF growth. This notion is supported by recent studies in which the proliferation of myelinating cells in the central nervous system (oligodendrocytes) is regulated by neuronal production of a novel growth factor (neuroligin-3). Based on these provocative findings, **we hypothesize that peripheral sensory neurons accelerate NF1-deficient Schwann cell growth through the elaboration of mitogens.** To identify these potentially clinically-actionable mitogens, we have designed a series of milestone-driven experiments using a novel collection of patient-derived and isogenic human induced pluripotent stem cells harboring NF1-patient germline NF1 gene mutations.\n\n&nbsp;\n\n######**Study Design:**\n\nThe overall conceptual framework for this proposal is illustrated in the **Figure**, where the differential impact of the germline NF1 gene mutation in sensory neurons on human NF1-deficient Schwann cell growth will be analyzed.\n\n&nbsp;\n\n${image?fileName=gutmann%2Epng&align=Center&scale=100&responsive=true}\n\n&nbsp;\n\n######**Deliverables and Timeline:**\n\n&nbsp;\n\n${image?fileName=gutmannTable%2Epng&align=Center&scale=100&responsive=true}\n\n&nbsp;\n\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n\n## Tables for Curation\n1. ID: syn64954745\nName: 12 month deliverables\nSummary:\n- Assays: , immunofluorescence, real-time PCR\n- Species: Homo sapiens, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: ?\n- Data types: , image, geneExpression, metadata\n- File formats present: pdf, png, excel, \n- Funders: NTAP\n- Contains data created by: Corina Anastasaki\n- Example files present: Progress report July 2019.pdf, Figure 1.png, Figure 2.png, Figure 3.png, Figure 4.png\n\n\n\n2. ID: syn64954746\nName: 18 month deliverables - Jan 2020\nSummary:\n- Assays: , immunocytochemistry, real-time PCR\n- Species: , Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: , image, geneExpression, metadata\n- File formats present: doc, pdf, excel, png, \n- Funders: NTAP\n- Contains data created by: Corina Anastasaki, Christina Parry\n- Example files present: Progress report Jan 2020.docx, Figure 1 BRN3A NF200 over time.pdf, Figure 2 Peripherin TRKA CALCA TRKB TRKC PV.pdf, qPCR relative expression data.xlsx, Group 1 WK3 NF200 BRN3A.png\n\n\n\n3. ID: syn64954747\nName: 30 month deliverables -  December 2020\nSummary:\n- Assays: local field potential recording, array, cell proliferation, cell count, western blot, immunocytochemistry, immunohistochemistry, \n- Species: Homo sapiens, Mus musculus, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: electrophysiology, image, raw counts, metadata\n- File formats present: , excel\n- Funders: NTAP\n- Contains data created by: Corina Anastasaki\n- Example files present: collated MEA sensory data.xlsx, Sensory burst frequency.emf, Sensory mean firing.emf, Sensory network burst frequency.emf, DRG NSCs proliferation data.xlsx\n\n\n\n4. ID: syn64954748\nName: 6 month deliverables\nSummary:\n- Assays: immunocytochemistry, , western blot, quantitative PCR\n- Species: Homo sapiens, \n- Individual count: ?\n- Specimen count: 2\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: ?\n- Data types: image, , metadata\n- File formats present: png, doc, tif, \n- Funders: NTAP\n- Contains data created by: Corina Anastasaki\n- Example files present: all schwann cell markers Figure 5.png, Combined progress report.docx, Figure 2 (2).tif, Figure 3 (2).tif, Figure 4 (2).tif\n\n\n"}]}]}}
{"custom_id":"syn9727752","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn9727752\n\n${image?fileName=CTF Synodos Data Site Headers5%2Ejpg&align=Center&scale=100&responsive=true}\n###**Welcome to the Synodos Schwannomatosis Data Portal**\n\nSynodos for Schwannomatosis was a two-year initiative that will bring together basic, translational, and clinical researchers towards the end goal of developing effective treatments for schwannomatosis. The project aims to perform an extensive molecular analysis of schwannomatosis tumor samples to identify new therapeutic targets, and advance the understanding and management of the disease, with a focus on pain. Experts from institutions spread across four different countries are working together to:\n1. Develop a clinically annotated schwannomatosis biobank;\n2. Develop a comprehensive pain registry for schwannomatosis patients\n3. Establish the genomic and epigenomic landscape of schwannomatosis to identify disease-driving alterations; and,\n4. Correlate the molecular findings with key clinical parameters, including pain.\n\nThis site serves as the landing page for all data and analysis coming from this project. Further details can also be found on the [study details page](https://nf.synapse.org/Explore/Studies/DetailsPage?studyId=syn9727752) for this project on the [NF Data Portal](https://nf.synapse.org/).\n\nIf you are new to the project, please register for an account and learn how to start working with the data by reading the [Accessing the Data](https://www.synapse.org/#!Synapse:syn9727752/wiki/424913) page to the left. \n\n---\n${buttonlink?text=Visit Study Details Page&url=https://nf%2Esynapse%2Eorg/Explore/Studies/DetailsPage%3FstudyId%3Dsyn9727752&align=None}\n${buttonlink?text=Back to CTF Data Portal&url=https://nf%2Esynapse%2Eorg/Organizations/DetailsPage%3Fabbreviation%3DCTF&align=None}\n\n\n## Tables for Curation\n1. ID: syn53604698\nName: Deep Variant Tumor Calls\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: \n- Example files present: \n\n\n\n2. ID: syn64954726\nName: Methylation\nSummary:\n- Assays: methylation array\n- Species: Homo sapiens\n- Individual count: 45\n- Specimen count: 91\n- Diagnoses present: Schwannomatosis\n- Tumor types present: Schwannoma\n- Data types: chromatinActivity\n- File formats present: idat\n- Funders: CTF\n- Contains data created by: Sheila Mansouri\n- Example files present: 202259490164_R07C01_Red.idat, 202259490164_R07C01_Grn.idat, 202262730105_R08C01_Red.idat, 202262730105_R08C01_Grn.idat, 202262730105_R07C01_Red.idat\n\n\n\n3. ID: syn64954727\nName: RNAseq\nSummary:\n- Assays: RNA-seq, \n- Species: Homo sapiens, \n- Individual count: 14\n- Specimen count: 24\n- Diagnoses present: , Schwannomatosis\n- Tumor types present: Schwannoma, \n- Data types: geneExpression, \n- File formats present: fastq, \n- Funders: CTF\n- Contains data created by: Robert Allaway\n- Example files present: swn_patient_64_tumor_121_S7_L001_R1_001.fastq.gz, swn_patient_64_tumor_121_S7_L001_R2_001.fastq.gz, swn_patient_64_tumor_121_S7_L002_R1_001.fastq.gz, swn_patient_64_tumor_121_S7_L002_R2_001.fastq.gz, swn_patient_64_tumor_121_S7_L003_R1_001.fastq.gz\n\n\n\n4. ID: syn30423895\nName: SWNTS_processing_2020-05-13\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: ?\n- Example files present: ?\n\n\n\n5. ID: syn43709762\nName: Schwannomatosis RNA-seq Raw Data (NF-OSI Merged fastq)\nSummary:\n- Assays: rnaSeq\n- Species: Homo sapiens\n- Individual count: 14\n- Specimen count: 24\n- Diagnoses present: Schwannomatosis, \n- Tumor types present: Schwannoma\n- Data types: ?\n- File formats present: fastq\n- Funders: ?\n- Contains data created by: ?\n- Example files present: swn_patient_10_tumor_111_2.merged.fastq.gz, swn_patient_10_tumor_109_2.merged.fastq.gz, swn_patient_10_tumor_110_1.merged.fastq.gz, swn_patient_10_tumor_108_1.merged.fastq.gz, swn_patient_63_tumor_123_1.merged.fastq.gz\n\n\n\n6. ID: syn41825491\nName: Schwannomatosis RNA-seq Raw Data (Unmerged, Original fastq)\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: ?\n- Example files present: ?\n\n\n\n7. ID: syn63540453\nName: Schwannomatosis RNA-seq quant.sf files\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 14\n- Specimen count: 22\n- Diagnoses present: Schwannomatosis\n- Tumor types present: Schwannoma\n- Data types: geneExpression\n- File formats present: sf\n- Funders: CTF\n- Contains data created by: ?\n- Example files present: quant.sf, quant.genes.sf, quant.genes.sf, quant.sf, quant.sf\n\n\n\n8. ID: syn53403828\nName: Somatic Mutations\nSummary:\n- Assays: \n- Species: \n- Individual count: 0\n- Specimen count: 0\n- Diagnoses present: \n- Tumor types present: ?\n- Data types: \n- File formats present: \n- Funders: CTF\n- Contains data created by: ?\n- Example files present: Strelka_swn_patient_45_tumor_139_vs_swn_patient_45_blood_somatic_snvs.vcf.gz, Strelka_swn_patient_25_tumor_56_vs_swn_patient_25_blood_somatic_snvs.vcf.gz.tbi, Strelka_swn_patient_3_tumor_32_vs_swn_patient_3_blood_somatic_snvs.vcf.gz, Strelka_swn_patient_45_tumor_139_vs_swn_patient_45_blood_somatic_snvs.vcf.gz.tbi, Strelka_swn_patient_25_tumor_56_vs_swn_patient_25_blood_somatic_snvs.vcf.gz\n\n\n\n9. ID: syn64720237\nName: Somatic Variants - Strelka - WES\nSummary:\n- Assays: \n- Species: \n- Individual count: 0\n- Specimen count: 40\n- Diagnoses present: Schwannomatosis\n- Tumor types present: Schwannoma\n- Data types: SomaticVariants\n- File formats present: vcf\n- Funders: CTF\n- Contains data created by: Sasha Scott\n- Example files present: swn_patient_10_tumor_108_vs_swn_patient_10_blood.strelka.somatic_snvs.vcf.gz, swn_patient_10_tumor_109_vs_swn_patient_10_blood.strelka.somatic_snvs.vcf.gz, swn_patient_10_tumor_108_vs_swn_patient_10_blood.strelka.somatic_indels.vcf.gz, swn_patient_10_tumor_109_vs_swn_patient_10_blood.strelka.somatic_indels.vcf.gz, swn_patient_10_tumor_110_vs_swn_patient_10_blood.strelka.somatic_snvs.vcf.gz\n\n\n\n10. ID: syn64954728\nName: Whole genome sequencing\nSummary:\n- Assays: whole genome sequencing, \n- Species: Homo sapiens, \n- Individual count: 8\n- Specimen count: 18\n- Diagnoses present: Schwannomatosis, \n- Tumor types present: schwannoma, Not Applicable, \n- Data types: genomicVariants, \n- File formats present: fastq, \n- Funders: CTF\n- Contains data created by: Robert Allaway\n- Example files present: swn_patient_3_tumor_32_S3_L006_R2_001.fastq.gz, swn_patient_17_blood_S5_L006_R1_001.fastq.gz, swn_patient_17_blood_S5_L006_R2_001.fastq.gz, swn_patient_25_blood_S6_L007_R1_001.fastq.gz, swn_patient_25_blood_S6_L007_R2_001.fastq.gz\n\n\n\n11. ID: syn64954729\nName: whole exome sequencing\nSummary:\n- Assays: whole exome sequencing\n- Species: Homo sapiens\n- Individual count: 38\n- Specimen count: 91\n- Diagnoses present: Schwannomatosis, \n- Tumor types present: Schwannoma, \n- Data types: genomicVariants\n- File formats present: fastq\n- Funders: CTF\n- Contains data created by: Fulvio D'Angelo\n- Example files present: swn_patient_19_tumor_29_1.fastq.gz, swn_patient_41_blood_1.fastq.gz, swn_patient_8_tumor_30_2.fastq.gz, 009_swn_patient_1_blood_ACC8LEANXX_CATCAAGT-TCTTTCCC_L007.R2.fastq.gz, 025_swn_patient_51_tumor_2_BCD0UFANXX_GCTAACGA_L001.R2.fastq.gz\n\n\n"}]}]}}
{"custom_id":"syn4939916","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn4939916\n\n##Transition to Confirmatory and Secondary Screening of Plexiform Neurofibroma Models in 96-well Format\n**Initiative:** Unsolicited\n&nbsp;\n**Name:** Raymond Mattingly, Ph.D.\n**Contact Email:** rmatting@med.wayne.edu\n**Dates:** 8-1-15 to 10-31-16\n**Tumor Focus:** plexiform neurofibroma\n**Application:** Translational models\n&nbsp;\n**Background:** \nIn our [primary NTAP project](syn7217928) we developed and optimized 3D models of NF1 plexiform neurofibromas (PNs) with the goal of providing efficient and effective systems for secondary screening of compounds that would be identified as promising new approaches for these tumors. Another primary NTAP project was performed at NCATS to screen for potential therapeutics using the CellTiter-Glo assay of proliferation as the read-out in a 1536-well 2D growth format.\n&nbsp;\n**Goals of Project:** \nTo prove that cells grown in 3D matrices, as compared to those growing in 2D (on plastic) will exhibit drug sensitivity that is a better clinical predictor. We will perform confirmatory and secondary assays in collaboration with NCATS. We will develop a 96-well format Cell-Titer Glo assay procedure for 2D and 3D PN cultures that will be useful for general confirmatory testing. We expect that the 2D results should directly reproduce those of the initial screen, i.e., that the outcome is independent of the platform (1536-well vs. 96-well) or performance site (NCATS vs. WSU). Further, with transition to the 3D culture, 96-well format assay, we will advance from confirmation to a secondary screen of initial results. We hypothesize that cells growing in 3D matrices, as compared to those growing in 2D on plastic, will exhibit drug sensitivity that is a better predictor of eventual clinical effectiveness.\n&nbsp;\n**Impact:** \n1. We have developed and optimized assays of proliferation of 3D PN cultures in 96-well plates to provide secondary screening of potential drug treatments. \n2. The fact that some potential treatments for NF1 PNs, as defined by their ability to inhibit growth in 2D cultures, are much less active against the 3D PN models could be highly significant. Inherent resistance to initially promising compounds is often encountered when transferring from in vitro screens to subsequent in vivo testing. If the 3D models can better predict which screening hits are likely to subsequently fail to be effective then they will be of great value.\n&nbsp;\n\n**Publications:** manuscript(s) in process\n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n## Tables for Curation\n1. ID: syn65467786\nName: Screening of Plexiform Neurofibroma Models in 96-well Format\nSummary:\n- Assays: cell viability assay\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Plexiform Neurofibroma\n- Data types: drugScreen\n- File formats present: excel\n- Funders: NTAP\n- Contains data created by: Markiesha Baines\n- Example files present: Drug 01_4000cells_3D.xlsx, Drug 01_1500cells_2D.xlsx, Drug 01_8000cells_2D.xlsx, Drug 02_8000cells_2D.xlsx, Drug 02_1500cells_2D.xlsx\n\n\n"}]}]}}
{"custom_id":"syn11374333","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn11374333\n\n###Cutaneous Neurofibroma: Models, Biology and Translation\n\n&nbsp;\n\n#####**PI:** Lu Q. Le, M.D., Ph.D. \n**University of Texas Southwestern Medical Center**\n\n&nbsp;\n\n######**Background and Rationale:**  \n\nNeurofibromatosis type 1 (NF1) is a genetic disorder that affects around 1:3000 live births. While the disease has nearly 100% penetrance in patients, NF1 has a diverse spectrum of manifestations. Hallmark traits of the disease include café-au-lait macules, cutaneous neurofibromas (cNF), plexiform neurofibromas (pNF) and malignant peripheral nerve sheath tumors (MPNST), among other symptoms. In NF1 patients, cNFs usually arise at puberty and beyond, can range widely in size and number, and can cause itching, pain, superficial infections as well as psychosocial and cosmetic burdens. Currently, there is no approved therapeutic option for cNFs aside from elective surgery. The development of new therapeutic approaches for cNF will require an understanding of the cNF cellular origin that can be used to elucidate mechanisms that underpin cNF formation and growth. While biallelic inactivation of NF1 in neoplastic Schwann cells is essential for cNF formation, it is not sufficient, pointing to the critical roles of other genetic or epigenetic changes as well as extrinsic signals from other cell types in the tumor microenvironment. While the field has made significant inroads towards our understanding of these tumors, there are still gaps in our knowledge of cNF pathogenesis that could be addressed by the adoption of a systemic approach to decipher all the biological steps in cNF development from the cell of origin to tumor stage to identify the “rate limiting step” that can be therapeutically targeted to prevent or delay cNF formation. Therefore, in this application, we propose a set specific aims to fill this knowledge gap: We will define the identity of the cNF cell of origin in mice that will guide us to identify the cells of origin for human cNF. We will next decipher how the cell of origin and the tumor microenvironment contribute to drive cNF initiation that will uncover its pathogenesis to delineate biological steps and mechanisms in tumor development as well as generating of preclinical models system that elucidate cNF biology and enable preclinical therapeutic testing.\n\n&nbsp;\n\n######**Goals, Innovation and Potential Impact:**\nOur overall project will advance via two parallel but interwoven efforts: \n\n1. Characterize cNF cell of origin to trace their developmental origin as well as to define their phenotypes and interactions with the tumor microenvironment. This will provide a framework for elucidating the functional contributions of cNF cell of origin in neurofibroma development. \n2. To determine biological steps that are critical for cNF development. A major innovation in our work is linking these approaches in a synergistic manner to our novel neurofibroma models that can be used broadly to decipher the pathogenesis as well as pre-clinical models for therapeutic testing.\n\n&nbsp;\n\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\nResults for some of the work from this project have been published in Cancer Discovery (Chen et al, Cancer Discovery, 2019). [Click here](http://cancerdiscovery.aacrjournals.org/content/9/1/114.long)\n\n## Tables for Curation\n1. ID: syn64954730\nName: 12 month deliverables\nSummary:\n- Assays: immunofluorescence, \n- Species: ?\n- Individual count: ?\n- Specimen count: 1\n- Diagnoses present: , \n- Tumor types present: , \n- Data types: image, \n- File formats present: tif, \n- Funders: NTAP\n- Contains data created by: Lu Le, Robert Allaway\n- Example files present: Figure 1.tif, Figure 2.tif, Figure 3.tif, Figure 4.tif, Figure 5.tif\n\n\n\n2. ID: syn64954731\nName: 18 month deliverables\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: immunofluorescence\n- File formats present: tif\n- Funders: NTAP\n- Contains data created by: Lu Le\n- Example files present: Figure 1.tif, Figure 4.tif, Figure 5.tif, Figure 6.tif, Figure 7.tif\n\n\n\n3. ID: syn64954732\nName: 24 month deliverables\nSummary:\n- Assays: , immunofluorescence, brightfield microscopy, immunohistochemistry, quantitative PCR, immunocytochemistry, western blot\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: , Teratoma, Plexiform Neurofibroma, Cutaneous Neurofibroma\n- Data types: , geneExpression, image\n- File formats present: , jpg\n- Funders: NTAP\n- Contains data created by: Lu Le\n- Example files present: Figure 2.tif, Figure 3.tif, Figure 4.tif, Figure 5.tif, Figure 1.tif\n\n\n\n4. ID: syn64954733\nName: 36 month deliverables\nSummary:\n- Assays: immunohistochemistry, reporter gene assay, brightfield microscopy, immunofluorescence, cell count, whole exome sequencing, \n- Species: Mus musculus, Homo sapiens, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Not Applicable, Neurofibromatosis type 1, \n- Tumor types present: , Cutaneous Neurofibroma, Not Applicable, Plexiform Neurofibroma\n- Data types: geneExpression, image, \n- File formats present: jpg, \n- Funders: NTAP\n- Contains data created by: Renee McKay\n- Example files present: pNF Nf null SKPs+nf het DRG GAP43.jpg, pNF Nf null SKPs+Nf het DRG LacZ hi mag.jpg, pNF Nf null SKPs+Nf het DRG LacZ.jpg, pNF Nf null SKPs+Nf het nerve GAP43.jpg, pNF Nf null SKPs+Nf het nerve hi mag.jpg\n\n\n\n5. ID: syn64954734\nName: 6 month deliverables\nSummary:\n- Assays: immunofluorescence, \n- Species: ?\n- Individual count: ?\n- Specimen count: 1\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: , \n- Data types: image, \n- File formats present: jpg, \n- Funders: NTAP\n- Contains data created by: Lu Le, Robert Allaway\n- Example files present: Figure 1.jpg, Figure 2.jpg, Figure 3.jpg, synapse_storage_manifest.csv\n\n\n"}]}]}}
{"custom_id":"syn21650493","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn21650493\n\n\n##Retina regeneration in zebrafish-Endogenous RGC replacement\n\n##VRI Subgroup: \nEndogenous RGC Replacement\n\n##Principal Investigator: \nDaniel Goldman, PhD (University of Michigan)\n\n##Personnel:\nAresh Sahu, PhD (Post-Doc)\nJonathan Jui PhD (Post-Doc)\nSulochan Devi, PhD (Research Associate)\nMuchu Zhou, PhD (Research Technician)\n\n##Lay Abstract\n\nNF1 is a disease resulting from reduced levels of neurofibromin 1 that functions as a tumor suppressor. One in five children with NF1 have optic nerve tumors that can lead to retinal ganglion cell death and blindness. One approach for treating NF1-related blindness is to regenerate retinal ganglion cells from endogenous stem cells. Because zebrafish use endogenous stem cells to regenerate retinal ganglion cells, we propose that understanding this process in fish will inform us of strategies for stimulating a similar process in humans. With this goal in mind, we aim to identify gene expression changes and small molecules that are sufficient to drive retina regeneration in zebrafish and test their effect on retina regeneration in mammals.\n\n\n## Tables for Curation\n1. ID: syn64954827\nName: AAV Ascl1 v YapS5A EdU\nSummary:\n- Assays: immunofluorescence, \n- Species: Mus musculus, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: raw counts, \n- File formats present: excel, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: Mouse AAV 20220219 EdU+cells.xlsx, synapse_storage_manifest.csv\n\n\n\n2. ID: syn64954828\nName: AAV Ascl1 v YapS5A EdU image\nSummary:\n- Assays: immunofluorescence, \n- Species: Mus musculus, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: immunoassay, \n- File formats present: tif, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: mouse AAV ascl1 v yapS5A EdU.tif, synapse_storage_manifest.csv\n\n\n\n3. ID: syn64954829\nName: ATACseq Ascl1a lin28a OE v control uninj Muller glia\nSummary:\n- Assays: , ATAC-seq\n- Species: Danio rerio, \n- Individual count: 4\n- Specimen count: 5\n- Diagnoses present: , Not Applicable\n- Tumor types present: , Not Applicable\n- Data types: chromatinActivity, \n- File formats present: fastq, \n- Funders: GFF\n- Contains data created by:  , Christina Parry\n- Example files present: 2971-SD-1_TAAGGCGA-GTGTAGAT_S107_R1_001.fastq.gz, 2971-SD-1_TAAGGCGA-GTGTAGAT_S107_R2_001.fastq.gz, 2971-SD-3_TCCTGAGC-GTGTAGAT_S109_R1_001.fastq.gz, 2971-SD-2_AGGCAGAA-GTGTAGAT_S108_R1_001.fastq.gz, 2971-SD-2_AGGCAGAA-GTGTAGAT_S108_R2_001.fastq.gz\n\n\n\n4. ID: syn64954830\nName: ATACseq DAPT v DMSO\nSummary:\n- Assays: ATAC-seq, \n- Species: Danio rerio, \n- Individual count: 1\n- Specimen count: 1\n- Diagnoses present: nan, \n- Tumor types present: NA, \n- Data types: raw counts, \n- File formats present: fastq, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: uninj_DAPT_MG_1_R1.fastq.gz, uninj_DAPT_MG_1_R2.fastq.gz, uninj_DAPT_MG_2_R1.fastq.gz, uninj_DAPT_MG_2_R2.fastq.gz, uninj_DAPT_MG_3_R1.fastq.gz\n\n\n\n5. ID: syn64954831\nName: ATACseq inj v uninj\nSummary:\n- Assays: ATAC-seq, \n- Species: Danio rerio, \n- Individual count: 1\n- Specimen count: 1\n- Diagnoses present: nan, \n- Tumor types present: NA, \n- Data types: raw counts, \n- File formats present: fastq, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: inj_4dpi_MG_1_R1.fastq.gz, inj_4dpi_MG_1_R2.fastq.gz, inj_4dpi_MG_2_R1.fastq.gz, inj_4dpi_MG_2_R2.fastq.gz, inj_4dpi_MG_3_R1.fastq.gz\n\n\n\n6. ID: syn64954832\nName: Cxcl18b injury dep gene exp\nSummary:\n- Assays: quantitative PCR, \n- Species: Danio rerio, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: geneExpression, \n- File formats present: excel, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: cxcl18b qPCR.xlsx, synapse_storage_manifest.csv\n\n\n\n7. ID: syn64954833\nName: Cxcl18b knockdown EdU\nSummary:\n- Assays: ?\n- Species: Danio rerio, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: immunoassay, \n- File formats present: excel, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: cxcl18b EdU.xlsx, synapse_storage_manifest.csv\n\n\n\n8. ID: syn64954834\nName: Drug screen\nSummary:\n- Assays: ?\n- Species: Danio rerio, \n- Individual count: 1\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: drugScreen, \n- File formats present: excel, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: drug screeing data.xlsx, synapse_storage_manifest.csv\n\n\n\n9. ID: syn64954835\nName: Flt1 knockdown and mutant EdU injury data\nSummary:\n- Assays: immunofluorescence, \n- Species: Danio rerio, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: immunoassay, \n- File formats present: excel, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: Flt1 knockdow and mutant EdU injury data.xlsx, synapse_storage_manifest.csv\n\n\n\n10. ID: syn64954836\nName: Images NF1 knockdown\nSummary:\n- Assays: immunofluorescence, \n- Species: nan, \n- Individual count: 1\n- Specimen count: 1\n- Diagnoses present: nan, \n- Tumor types present: NA, \n- Data types: image, \n- File formats present: tif, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: control MO-330_c1+2.tif, control MO-333_c1+2.tif, control MO-342_c1+2.tif, NF1 MO-451_c1+2.tif, NF1 MO-463_c1+2.tif\n\n\n\n11. ID: syn64954837\nName: Myc\nSummary:\n- Assays: quantitative PCR, immunofluorescence, \n- Species: Danio rerio, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: geneExpression, cellularPhysiology, \n- File formats present: excel, tif, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: myc family gene exp.xlsx, Mych, mycb knockdown and mutant EdU TUNEL.xlsx, Fig 2 myc.tif, Fig 3 myc.tif, Fig 1 myc.tif\n\n\n\n12. ID: syn64954838\nName: NF1 qPCR and MO knockdown\nSummary:\n- Assays: quantitative PCR, \n- Species: Danio rerio, \n- Individual count: 1\n- Specimen count: 1\n- Diagnoses present: nan, \n- Tumor types present: NA, \n- Data types: geneExpression, \n- File formats present: excel, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: morpholino nf1, ascl1a.xlsx, nf1 qPCR data 4 expt.xlsx, synapse_storage_manifest.csv\n\n\n\n13. ID: syn64954840\nName: RNAseq Ascl1a-Lin28a v control\nSummary:\n- Assays: RNA-seq, \n- Species: Danio rerio, \n- Individual count: 1\n- Specimen count: 1\n- Diagnoses present: nan, \n- Tumor types present: nan, \n- Data types: geneExpression, \n- File formats present: bam, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: Sample_1091-JJ-8.genome.bam, Sample_1091-JJ-9.genome.bam, Sample_1091-JJ-10.genome.bam, Sample_128293.genome.bam, Sample_128294.genome.bam\n\n\n\n14. ID: syn64954841\nName: RNAseq DAPT v DMSO MG\nSummary:\n- Assays: RNA-seq, \n- Species: Danio rerio, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: geneExpression, \n- File formats present: fastq, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: 121565_AGTTCAGG-CCAACAGA_S1_L003_R1_001.fastq.gz, 121566_GACCTGAA-TTGGTGAG_S2_L003_R1_001.fastq.gz, 121567_TCTCTACT-CGCGGTTC_S3_L003_R1_001.fastq.gz, 121568_CTCTCGTC-TATAACCT_S4_L003_R1_001.fastq.gz, 121569_CCAAGTCT-AAGGATGA_S5_L003_R1_001.fastq.gz\n\n\n\n15. ID: syn64954842\nName: RNAseq inj v uninj MG\nSummary:\n- Assays: RNA-seq, \n- Species: Danio rerio, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: geneExpression, \n- File formats present: fastq, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: 14131_GTGAAA_L003_R1_001.fastq.gz, 14131_GTGAAA_L003_R1_002.fastq.gz, 14131_GTGAAA_L003_R1_003.fastq.gz, 14131_GTGAAA_L003_R1_004.fastq.gz, 14131_GTGAAA_L003_R1_005.fastq.gz\n\n\n\n16. ID: syn64954843\nName: RNAseq uninj v inj retina non-Muller glia\nSummary:\n- Assays: RNA-seq, \n- Species: Danio rerio, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: geneExpression, \n- File formats present: fastq, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: Sample_134894_R1.fastq.gz, Sample_134894_R2.fastq.gz, Sample_134896_R1.fastq.gz, Sample_134896_R2.fastq.gz, Sample_134897_R1.fastq.gz\n\n\n\n17. ID: syn64954845\nName: Vegf signaling component gene expression\nSummary:\n- Assays: quantitative PCR, \n- Species: Danio rerio, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: geneExpression, \n- File formats present: excel, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: Vegf signaling component gene expression qPCR.xlsx, synapse_storage_manifest.csv\n\n\n\n18. ID: syn64954846\nName: scRNAseq zf retina\nSummary:\n- Assays: single-cell RNA-seq, \n- Species: Danio rerio, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: geneExpression, \n- File formats present: fastq, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: MG_GFP_1_S9_L000_R1_001.fastq.gz, MG_GFP_1_S9_L000_R2_001.fastq.gz, MG_GFP_1_S10_L000_R1_001.fastq.gz, MG_GFP_1_S10_L000_R2_001.fastq.gz, MG_GFP_1_S11_L000_R1_001.fastq.gz\n\n\n"}]}]}}
{"custom_id":"syn27761862","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn27761862\n\n# Leveraging Synodos NF2 data to test novel single and combination drugs in NF2-deficient meningioma models\n## CTF - Drug Discovery Initiative Registered Reports\n### Principal Investigator: Vijaya Ramesh (PI), Lei Xu (Co-investigator)\n### Project Lead / Data Coordinator: Roberta Beauchamp\n### Institution: Massachusetts General Hospital\n### Project Description:\nMeningiomas arise from meningothelial arachnoid cap cells and are the most common primary intracranial tumors in adults. NF2 inactivation is frequently associated with primary atypical (WHO grade II) tumors. Meningiomas that progress despite surgery and radiation are responsible for significant morbidity and mortality. Therefore, effective systemic therapies are greatly needed. For meningioma modeling and preclinical drug screening, we employ human primary meningioma (MN) cell lines derived from surgically resected tumors and CRISPR-Cas9 genome-edited isogenic, human arachnoidal cell lines (ACs) that either express or lack NF2. Employing these models, we established that NF2-deficient meningiomas reveal aberrant activation of mTORC1/mTORC2 signaling, which led to clinical trials for NF2 and meningiomas. In Synodos for NF2 project, we undertook large-scale kinome, transcriptome and drug screening studies in our AC and MN cell models to identify other potential targets. Kinome and transcriptome data revealed increased activation and expression of several EPH receptor family tyrosine kinases (EPH-RTKs), Src family kinase members (SFKs) and c-KIT. Our large-scale drug screening efforts, in collaboration with NIH-NCATS, revealed a set of proteasome inhibitors exhibiting cytotoxic effects with selectivity toward NF2-null cells. Taken together, here we propose to examine three different drugs targeting the proteasome (provided by Millennium/Takeda Pharmaceutical, and two NUAK2 specific inhibitors alone and combined with TAK-228 (mTOR inhibitor) in 2 grade I and 2 grade II MN lines as well as human Schwann cells (SC) with NF2 loss. Anti-tumor efficacy of proteasome drugs will also be evaluated in orthotopic NF2-deficient SC and MN models. Our overall approach of leveraging the ‘omics and drug screening results from Synodos for NF2 studies for further testing in our in vitro and orthotopic NF2-deficient in vivo meningioma models is timely, novel and will provide a framework to pursue new avenues in NF2 research and for clinical care.\n\n## Tables for Curation\n1. ID: syn65467792\nName: Proteasome-targeting drugs tested on NF2-deficient meningioma models\nSummary:\n- Assays: cell viability assay, \n- Species: Homo sapiens, Mus musculus, \n- Individual count: ?\n- Specimen count: 1\n- Diagnoses present: , \n- Tumor types present: , Meningioma, \n- Data types: drugScreen, \n- File formats present: ?\n- Funders: CTF\n- Contains data created by: Roberta Beauchamp, Anh Nguyet Vu\n- Example files present: NF2+_AC-CRISPR drug treatment.xlsx, NF2-_AC-CRISPR-A17 drug treatment.xlsx, NF2-_AC-CRISPR-A19 drug treatment.xlsx, NF2-_Ben-Men-1 drug treatment.xlsx, NF2-_MN597 drug treatment.xlsx\n\n\n"}]}]}}
{"custom_id":"syn11374341","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn11374341\n\n###Microenvironmental targets of cutaneous neurofibromas: T-cells and mast cells as tumor contributors\n&nbsp;\n\n#####**PIs:**  Juha and Sirkku Peltonen\n**Institution**: University of Turku \n**E-mail**: uhpel@utu.fi and sipelto@utu.fi\n&nbsp;\n\n######**Background and Rationale:**  \n\nImmunity has a central and complex role in tumor growth, which can be utilized when developing new treatment modalities for tumors. To date, the role of immune system in cNFs has gained little attention. Transformed cells are normally eradicated by cooperation of innate and adaptive immune cells. Immune surveillance could be expected to recognize neurofibromin neoepitopes resulting from the second hit of the NF1 gene, but this is not taking place in cNFs. Mast cells are known to be abundant in cNFs and they are increasingly more interesting as druggable targets in tumor biology and neurogenic itch. It is also not known whether mast cells of cNFs are tumorigenic or anti- tumorigenic.\n\n&nbsp;\n\n######**Expected Outcomes:**\nTo prove that T cells and mast cells are valid targets for the treatment of cNF. Elucidating the characteristics, roles and effects of these prominent tumor microenvironment components in promoting tumorigenesis could be used to facilitate finding of targeted therapies for the treatment of cNF. The therapeutic modalities include those already approved and those being developed for tumor biology as well as for inflammatory diseases.\n\n&nbsp;\n\n######**Challenges/Gaps:**\nThere are challenges in the sensitivity of mass spectrometry with single cell samples. T cell receptor sequencing is advancing fast but to date the algorithms still need to be developed to predict T cell specificity form T cell receptor sequence.\n\n&nbsp;\n\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n## Tables for Curation\n1. ID: syn64954741\nName: Kallionpaa et al., Dermatology 2022\nSummary:\n- Assays: brightfield microscopy\n- Species: Homo sapiens, Human\n- Individual count: 61\n- Specimen count: 183\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma, \n- Data types: image, \n- File formats present: jpg, excel\n- Funders: NTAP\n- Contains data created by: Roope Kallionpää\n- Example files present: CD117_01.jpg, CD117_02.jpg, CD117_03.jpg, CD117_04.jpg, CD117_05.jpg\n\n\n\n2. ID: syn64954742\nName: Kallionpaa et al., Immune cell populations in cNFs, T cell receptor sequencing\nSummary:\n- Assays: ?\n- Species: Human\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: cutaneous neurofibroma\n- Data types: ?\n- File formats present: excel\n- Funders: NTAP\n- Contains data created by: Roope Kallionpää\n- Example files present: TCR_sequencing_Kallionpaa_et_al.xlsx\n\n\n\n3. ID: syn64954744\nName: Kallionpaa et al., Mass spectrometry of human cutaneous neurofibromas and the overlying skin\nSummary:\n- Assays: LC-MSMS\n- Species: Human\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: proteomics\n- File formats present: excel\n- Funders: NTAP\n- Contains data created by: Roope Kallionpää\n- Example files present: MS_dataset_Kallionpaa_et_al.xlsx\n\n\n"}]}]}}
{"custom_id":"syn11374337","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn11374337\n\n###Use of the mouse model of cutaneous NFs for identification of cells of origin and drug screening studies\n&nbsp;\n\n#####**PI:** Piotr Topilko\n\n&nbsp;\n\n######**Background and Rationale:**  \n\n\nDespite major progress in the understanding of the mechanisms driving development of NFs, the cells of origin and scenario governing initiation of cNFs, remains unknown. We have recently shown that the neural crest derived boundary cap (BC) cells, transiently present at the interface between central and peripheral nervous system in a mouse embryo, migrate sequentially along nerve roots and along peripheral nerves under the skin, two locations where NFs develop with a higher incidence in NF1 patients. Furthermore, in the adult skin, BC derivatives correspond to various types of Schwann cells and dermal stem cells with gliogenic potential, two cell populations considered as the primary pathogenic target of NF1. Based on these observations, we hypothesized that BCs could be directly implicated in the development NFs. To explore such possibility, we have generated mouse line carrying NF1 loss combined with fluorescent tracer in BC cells and their derivatives. All mutant mice develop both paraspinal plexiform and cutaneous NFs whose location and cellular composition faithfully recapitulates NFs present in human NF1 patients.\n\n&nbsp;\n\n######**Goal:**\n\nThe aim of this study is to take advantage of this unique model and our extensive expertise of NF1 pathology and of mechanisms governing the development of Schwann cells to tackle three important issues concerning the _initiation and progression_, _cellular origin_ and _novel treatment_ of cNFs.\n\n&nbsp;\n\n######**Collaboration:**\n\nThe success of this project implies close collaboration with two other Partners: the team of Dr. Anne-Marie Schmitt from Pierre Fabre Research Institute and of Professor Pierre Wolkenstein from Hopital Henri Mondor, both from France. Together, we propose well-integrated and complementary aims requiring the specific skills and knowledge of all Partners that are indispensable for the technical and conceptual aspects of this study.\n\nResults from some of this work have been published in Cancer Discovery (Radomska, et al. Cancer Discovery, 2019).  [Click here](http://cancerdiscovery.aacrjournals.org/content/9/1/130.long)\n&nbsp;\n\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n## Tables for Curation\n1. ID: syn64954735\nName: Chronic injuries experiment\nSummary:\n- Assays: immunofluorescence, \n- Species: Mus musculus, \n- Individual count: 27\n- Specimen count: ?\n- Diagnoses present: Not Applicable, \n- Tumor types present: Not Applicable, , Cutaneous Neurofibroma\n- Data types: image, \n- File formats present: tif, , czi\n- Funders: NTAP\n- Contains data created by: Piotr Topilko\n- Example files present: CF287.zip, CF583.zip, CF584.zip, CF588.zip, CF819.zip\n\n\n\n2. ID: syn64954736\nName: Development of cNFs\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: Piotr Topilko\n- Example files present: 2021-04-28 PP.zip, 2021-05-18 PP.zip, 2021-05-27 PP.zip, 2021-06-09 PP.zip, 2021-06-11 PP.zip\n\n\n\n3. ID: syn64954737\nName: Grafts of tumor cells into sciatic nerve\nSummary:\n- Assays: in vivo tumor growth, \n- Species: Mus musculus, \n- Individual count: 11\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: Cutaneous Neurofibroma, \n- Data types: image, \n- File formats present: jpg, \n- Funders: NTAP\n- Contains data created by: Piotr Topilko, Christina Parry\n- Example files present: D_2021-05-18-sphere_Hetero_c Image005.jpg, E_2021-05-18-sphere_Hetero_c-Image002 .jpg, F_2021-05-18-sphere_Hetero_c-Image003 .jpg, G_2021-05-18-sphere_Hetero_D- 153 .jpg, H_2021-05-18-sphere_Hetero_D.-221 .jpg\n\n\n\n4. ID: syn63944429\nName: Mouse model cutaneous imaging of chronic injuries\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: 27\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Piotr Topilko\n- Example files present: CF287.zip, CF583.zip, CF584.zip, CF588.zip, CF819.zip\n\n\n\n5. ID: syn51199726\nName: NFOSI-RNASeq-To-Process-2023-15-03\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Piotr Topilko\n- Example files present: reads_P75-P0-1.fastq.bz2, reads_P75-P0-2.fastq.bz2, reads_P75-P0-3.fastq.bz2, reads_P75-P5-1.fastq.bz2, reads_P75-P5-2.fastq.bz2\n\n\n\n6. ID: syn64954738\nName: RNAseq Bulk Sphere P0 vs P5\nSummary:\n- Assays: RNA-seq, \n- Species: Mus musculus, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: Not Applicable, \n- Data types: geneExpression, \n- File formats present: fastq, \n- Funders: NTAP\n- Contains data created by: Piotr Topilko, Kaitlin Throgmorton\n- Example files present: reads_P75-P0-1.fastq.bz2, reads_P75-P0-2.fastq.bz2, reads_P75-P0-3.fastq.bz2, reads_P75-P5-1.fastq.bz2, reads_P75-P5-2.fastq.bz2\n\n\n\n7. ID: syn64954739\nName: Single cell transcriptomic analysis, for the identification of new markers of supepidermal glia\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: fastq, \n- Funders: NTAP\n- Contains data created by: Piotr Topilko\n- Example files present: Sample_2019_M_fastq_path.zip, Sample_2020_10_fastq_path.zip, 2019-014_S1_L001_I1_001.fastq.gz, 2019-014_S1_L001_R1_001.fastq.gz, 2019-014_S1_L001_R2_001.fastq.gz\n\n\n\n8. ID: syn64954740\nName: Vascular detection with Itae\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: jpg\n- Funders: NTAP\n- Contains data created by: Piotr Topilko\n- Example files present: 1.1-0.jpg, 1.1-1.jpg, 1.1.jpg, a1.1-0.jpg, a1.2-0.jpg\n\n\n"}]}]}}
{"custom_id":"syn11638893","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn11638893\n\n###Development of a Preclinical NF1-MPNST Platform Suitable for Precision Oncology Drug Discovery and Evaluation\n&nbsp;\n#####**PI:**  Angela C. Hirbe, MD, PhD\n\n**Washington University School of Medicine in St. Louis**\n\n&nbsp;\n\n######**Technical Background and Rationale:** \n\nOne of the most common malignancies affecting adults with neurofibromatosis type 1 (NF1) are malignant peripheral nerve sheath tumors (MPNSTs), highly aggressive sarcomas that typically develop from benign plexiform neurofibromas. 8-13% of individuals with NF1 will develop MPNSTs during young adulthood.  There are few therapeutic options, and the vast majority of people with these cancers will die within 5 years of diagnosis. Despite advances in our understanding of the pathobiology of these tumors and the identification of seemingly-promising therapeutic targets using a single mouse MPNST model system (NPCis mice and derivative cell lines), no investigational agents have demonstrated efficacy following translation to human clinical trials. However, there is limited genetic diversity being modeled in these systems, which does not capture the full spectrum of genetic diversity that characterizes human NF1-MPNSTs. In this regard, p53 loss, a common feature of the currently-used preclinical models, is observed in a minority of human MPNSTs. We hypothesize that one of the major reasons that rationally-chosen drugs underperform in human clinical trials is that the preclinical models used to discover and evaluate promising therapeutic agents do not capture the genetic heterogeneity of the human cancer. To optimize clinical translation, we aim to develop a collection of MPNST Patient Derived Xenografts (MPNST-PDXs) for the NF community, which more fully represent the spectrum of genetic heterogeneity seen in the human condition.  \n\n&nbsp;\n\n######**Hypothesis and Specific Aims:**\n\nMalignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas, which occur at an increased frequency in individuals with NF1, where they often arise from a benign plexiform neurofibroma. Currently, the only curative therapy involves complete surgical resection; however, this is often impossible due to the size or the degree of invasiveness of the primary tumor or the presence of metastatic disease at diagnosis.  In this situation, therapy is often limited to standard cytotoxic chemotherapy or enrollment in a clinical trial using rationally-chosen molecularly-targeted therapies.  Despite advances in our understanding of the biology of MPNSTs, no successful clinical trials have resulted in improved survival for individuals with NF1-MPNST. For example, while EGFR inhibition was effective in shrinking murine Nf1/p53 MPNSTs,1 no activity was demonstrated in a phase II clinical trial.2 Similarly, subsequent trials also based on preclinical model successes failed to show efficacy when translated to human clinical trials (sorafenib or imatinib). **We hypothesize that the poor translation of preclinical findings to the bedside reflect three barriers: **\n\n1. current preclinical models do not encompass the spectrum of genetic heterogeneity observed in human MPNSTs \n2. Treatments may work better for one disease subtype, which is currently not captured using a single genetic model, and \n3. NF1-MPNSTs may develop adaptive mechanisms that allow for escape from the effects of therapy. \n\n&nbsp;\n\nIn this proposal, we plan to **address those _three barriers_ **by: \n1. generating human preclinical models that more fully recapitulate the genetic diversity seen in human NF1-MPNSTs, \n2. evaluating the responsiveness to conventional and targeted therapies using a diverse collection of patient-derived MPNST xenograft models, and \n3. defining potential therapeutic escape mechanisms. The generation of these NF1-MPNST lines will serve as a valuable resource for the NF research community relevant to the design and evaluation of future therapeutic strategies to treat NF1-MPNST.\n\n&nbsp;\n\n######**Objectives:**\nThe main goal of this research project is to develop a set of NF1-MPNST PDX lines that captures the spectrum of molecular heterogeneity of the human disease. The proposal aims to meet the following objectives:\n\na. Create enabling resources including 10 NF1-MPNST PDX lines for preclinical studies.\nb. Histologically and genomically characterize these 10 NF1-MPNST PDX lines, thereby defining the molecular heterogeneity of these tumors.\nc. Determine whether there is a correlation between molecular subtype and response to chemotherapy or targeted therapy.\nd. Assess potential adaptive mechanisms or tumor resistance by assessing genomic changes following treatment.\n\n&nbsp;\n\n######**Milestones and Deliverables:**\n\n**Period 1 objectives a and b:**\nDefine MPNST molecular heterogeneity by developing and characterizing NF1-MPNST Patient-Derived Xenograft (PDX) lines.\n• Histologic characterization of 4 lines\n• Begin development of two more lines\n• Send RNA and DNA for sequencing on 5 lines (the line used as preliminary data in the grant and the 4 others characterized above)\n\n&nbsp;\n\n**Period 2 objectives a and b:**\nDefine MPNST molecular heterogeneity by developing and characterizing NF1-MPNST Patient-Derived Xenograft (PDX) lines.\n• Histologic characterization of 2 lines\n• Begin development of one more line\n• Send RNA and DNA for sequencing on 3 lines\n\n&nbsp;\n\n**Period 3 objectives a and b:**\nDefine MPNST molecular heterogeneity by developing and characterizing NF1-MPNST Patient-Derived Xenograft (PDX) lines.\n• Generation of 2 PDX lines\n• Histologic characterization of 2 PDX lines\n• Send RNA and DNA for sequencing on 2 lines\n\n&nbsp;\n\n**Period 4 objective c:**\nDetermine whether there is a correlation between the specific mutational subtype and the response of the tumors to conventional therapy.\n• In vivo murine experiments with anthracyclines\n\n&nbsp;\n\n**Period 5 objective c:**\nDetermine whether there is a correlation between the specific mutational subtype and the response of the tumors to targeted therapy.\n• In vivo murine experiments with mTOR inhibitors and potentially other drugs\n\n&nbsp;\n\n**Period 6 objective d:**\nAssess potential adaptive mechanisms of tumor resistance by examining changes in gene expression following treatment.\n• In vivo murine experiments with sequencing and other tumor analyses post treatment with chemotherapy and targeted agents\n\n&nbsp;\n\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n\n## Tables for Curation\n1. ID: syn52298742\nName: Copy Number Variation - CNVkit\nSummary:\n- Assays: ?\n- Species: Homo sapiens\n- Individual count: 5\n- Specimen count: 10\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: NF Service\n- Example files present: JHU002-048.converted.antitargetcoverage.cnn, JHU002-048.converted.call.cns, JHU002-048.converted-diagram.pdf, JHU002-048.converted-scatter.png, JHU023-049.converted-scatter.png\n\n\n\n2. ID: syn42174758\nName: Filtered Single Cell RNASeq Data\nSummary:\n- Assays: single-cell RNA-seq\n- Species: Homo sapiens\n- Individual count: 8\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor\n- Data types: geneExpression\n- File formats present: tsv, mtx\n- Funders: NTAP,NFRI\n- Contains data created by: ?\n- Example files present: barcodes.tsv.gz, features.tsv.gz, matrix.mtx.gz, barcodes.tsv.gz, features.tsv.gz\n\n\n\n3. ID: syn35563963\nName: Germline Genomic Variants - DeepVariant Pipeline (from syn31715607)\nSummary:\n- Assays: whole genome sequencing\n- Species: Homo sapiens\n- Individual count: 5\n- Specimen count: 9\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor\n- Data types: \n- File formats present: vcf\n- Funders: NTAP,NFRI\n- Contains data created by: NF Service\n- Example files present: JHU031-045.vcf.gz, JHU002-048.vcf.gz, JHU031-050.vcf.gz, WU505-041.vcf.gz, JHU023-044.vcf.gz\n\n\n\n4. ID: syn35563960\nName: Germline Genomic Variants - FreeBayes Pipeline (from syn31715607)\nSummary:\n- Assays: , whole genome sequencing\n- Species: , Homo sapiens\n- Individual count: 5\n- Specimen count: 9\n- Diagnoses present: , Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: \n- File formats present: , vcf\n- Funders: NTAP,NFRI\n- Contains data created by: NF Service\n- Example files present: FreeBayes_JHU023-044.vcf.gz.tbi, FreeBayes_JHU023-049.vcf.gz.tbi, FreeBayes_JHU031-045.vcf.gz.tbi, FreeBayes_JHU002-048.vcf.gz, FreeBayes_WU505-041.vcf.gz.tbi\n\n\n\n5. ID: syn35563961\nName: Germline Genomic Variants - Mutect2 Pipeline (from syn31715607)\nSummary:\n- Assays: , whole genome sequencing\n- Species: , Homo sapiens\n- Individual count: 5\n- Specimen count: 9\n- Diagnoses present: , Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: \n- File formats present: , vcf\n- Funders: NTAP,NFRI\n- Contains data created by: NF Service\n- Example files present: Mutect2_unfiltered_JHU002-048.vcf.gz.tbi, Mutect2_unfiltered_JHU002-048.vcf.gz, Mutect2_unfiltered_JHU023-044.vcf.gz.tbi, Mutect2_filtered_JHU023-044.vcf.gz.tbi, Mutect2_unfiltered_JHU031-045.vcf.gz\n\n\n\n6. ID: syn35563962\nName: Germline Genomic Variants - Strelka Pipeline (from syn31715607)\nSummary:\n- Assays: , whole genome sequencing\n- Species: , Homo sapiens\n- Individual count: 5\n- Specimen count: 9\n- Diagnoses present: , Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: \n- File formats present: , vcf\n- Funders: NTAP,NFRI\n- Contains data created by: NF Service\n- Example files present: Strelka_JHU002-048_variants.vcf.gz.tbi, Strelka_JHU002-048_genome.vcf.gz.tbi, Strelka_JHU023-049_genome.vcf.gz.tbi, Strelka_JHU002-048_variants.vcf.gz, Strelka_JHU023-044_variants.vcf.gz.tbi\n\n\n\n7. ID: syn63093965\nName: NFOSI-WES-To-Process-2024-09\nSummary:\n- Assays: whole exome sequencing, \n- Species: Mus musculus (humanized), Homo sapiens, \n- Individual count: 6\n- Specimen count: 13\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, \n- Data types: genomicVariants, \n- File formats present: fastq, \n- Funders: NTAP,NFRI\n- Contains data created by: Chang In Moon\n- Example files present: ATGGCGAA-CGATAGAG_S8_L003_R1_001.fastq.gz, ATAAGGCG-TCTAACGC_S9_L002_R2_001.fastq.gz, GTACTCTC-TACCAGGA_S17_L003_R2_001.fastq.gz, TCCAATCG-GTCAGTTG_S23_L003_R1_001.fastq.gz, TGTTGTGG-AAGGACAC_S28_L003_R1_001.fastq.gz\n\n\n\n8. ID: syn29783617\nName: NFOSIprocessing-2022-26-04\nSummary:\n- Assays: whole genome sequencing\n- Species: Homo sapiens, Mus musculus (humanized)\n- Individual count: 5\n- Specimen count: 11\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor\n- Data types: genomicVariants\n- File formats present: bam\n- Funders: NTAP,NFRI\n- Contains data created by: Chang In Moon\n- Example files present: step2_mkdup_hg38_TWFE-JHU002-43_2-lib1_tumor.bam, step2_mkdup_hg38_TWFE-JHU002-48-lib1_normal.bam, step2_mkdup_hg38_TWFE-JHU023-44-lib1_tumor.bam, step2_mkdup_hg38_TWFE-JHU023-49-lib1_normal.bam, step2_mkdup_hg38_TWFE-JHU031-45-lib1_tumor.bam\n\n\n"}]}]}}
{"custom_id":"syn23662493","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn23662493\n\n\n# Developing an Improved mAb Against Neurofibromin\n\n### **Principal Investigator:** Michelle Mattson-Hoss, PhD\n### **Company:** Infixion Bioscience, Inc.\n\n### Project Description: \nNeurofibromatosis Type 1 (NF1) is an autosomal dominant genetic disorder in which the amount of wild type neurofibromin produced by the remaining functional gene is a significant factor in the progression and severity of NF1 symptoms (i.e., haploinsufficiency driven). Given neurofibromin’s impact in regulating the Ras pathway and the importance of neurofibromin protein levels directly impacting many downstream pathways the availability of sensitive and specific antibodies to facilitate protein measurement becomes critically important.\n\nUnfortunately, commercially available NF1 antibodies (both polyclonal and monoclonal) have been shown to have significant limitations, including the inability to use these antibodies in ELISA and IHC applications. Utilizing full-length neurofibromin (isolated and purified by the Frank McCormick lab and Dominic Esposito’s team at the Frederick National Lab) as the immunogen, and leveraging a proprietary antibody development platform, Alicanto©, from Digital Proteomics, LLC, the San Diego-based team at Infixion Bioscience set out to develop a new and improved monoclonal antibody against NF1. Project goals include:\n1) identifying a mAb with increased sensitivity and specificity against neurofibromin as determined by western blot, and \n2) demonstrate expanded utility with function in ELISAs, sandwich ELISAs and immunohistochemistry (IHC) applications.\n\nAdditional collaborating partners on the project included: Dr. Michael Frost (IHC development), Dr. Dominic Esposito (epitope mapping), and Dr. Eduard Serra Lab (characterization in NF1 iPSC lines).\n\n\n## Tables for Curation\n1. ID: syn64954907\nName: Affinity Purified ELISA Screen\nSummary:\n- Assays: ELISA\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: immunoassay\n- File formats present: csv\n- Funders: NTAP\n- Contains data created by: Michelle Mattson-Hoss\n- Example files present: AP_NF1-His_ELISA.csv\n\n\n\n2. ID: syn64954908\nName: Epitope Mapping\nSummary:\n- Assays: western blot, \n- Species: Homo sapiens, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: immunoassay, \n- File formats present: tif, \n- Funders: NTAP\n- Contains data created by: Michelle Mattson-Hoss\n- Example files present: 211027 NF1 07E Merge.tif, 211027 NF1 07E AntiMBP.tif, 201105 07E.tif, 211027 NF1 07E Anti NF1.tif, synapse_storage_manifest.csv\n\n\n\n3. ID: syn64954909\nName: IHC Data\nSummary:\n- Assays: immunohistochemistry, \n- Species: Homo sapiens, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: nan, \n- Tumor types present: ?\n- Data types: image, \n- File formats present: tif, pdf, excel, \n- Funders: NTAP\n- Contains data created by: Michelle Mattson-Hoss\n- Example files present: iNF1-07E IHC - 1-20 of Adrenal.tif, iNF1-07E IHC - 1-20 of Cerbellar cortex 1.tif, iNF1-07E IHC - 1-20 of Cerbellar cortex 2.tif, iNF1-07E IHC - 1-20 of Cerbral cortex - occipital lobe.tif, iNF1-07E IHC - 1-20 of Cerbral cortex.tif\n\n\n\n4. ID: syn64954910\nName: Sandwich ELISA\nSummary:\n- Assays: ?\n- Species: Homo sapiens, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Not Applicable, \n- Tumor types present: ?\n- Data types: immunoassay, \n- File formats present: txt, \n- Funders: NTAP\n- Contains data created by: Michelle Mattson-Hoss\n- Example files present: 20210204_Sandwich ELISA.txt, synapse_storage_manifest.csv\n\n\n\n5. ID: syn64954911\nName: Sequence Data\nSummary:\n- Assays: liquid chromatography/tandem mass spectrometry, next generation targeted sequencing\n- Species: Oryctolagus cuniculus\n- Individual count: 1\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: proteomics, geneExpression\n- File formats present: mzML, tsv\n- Funders: NTAP\n- Contains data created by: Michelle Mattson-Hoss\n- Example files present: MSB48021HCPeps052620.mzML.gz, MSB48021HCTryp052620.mzML.gz, MSB48021LCChym052520.mzML.gz, MSB48021LCElas052520.mzML.gz, MSB48021LCPeps052520.mzML.gz\n\n\n\n6. ID: syn64954912\nName: Titer Report\nSummary:\n- Assays: ELISA\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: Michelle Mattson-Hoss\n- Example files present: PAC 14429, 14430-final.pdf\n\n\n\n7. ID: syn64954913\nName: Western Blot Screening\nSummary:\n- Assays: western blot\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: [\"Not Applicable\", \"Plexiform Neurofibroma\"]\n- Data types: image\n- File formats present: png\n- Funders: NTAP\n- Contains data created by: Michelle Mattson-Hoss\n- Example files present: 05D.png, 06G.png, 07E.png, 08D.png, 10D.png\n\n\n"}]}]}}
{"custom_id":"syn4939888","text":{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\nThe result will be submitted to an important data catalog; researchers depend on you! Here's your review checklist to help provide great results:\n1. For fields like measurementTechnique, diseaseFocus, dataType, manifestation, use only the exact, predefined values specified in the schema's enum list. Do not use variations or other terms.\n2. Ensure every field's value matches its required schema type; avoid using `null` unless explicitly permitted by the schema for that field.\n3. The output MUST be valid JSON according to RFC 8259. Do not include comments.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Most preferred is the project PI or data lead who's responsible for its conception and initial content creation.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Creator\",\n        \"type\": \"array\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate data in dataset, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"2D AlamarBlue absorbance\",\n            \"2D AlamarBlue fluorescence\",\n            \"3D confocal imaging\",\n            \"3D electron microscopy\",\n            \"3D imaging\",\n            \"3D microtissue viability\",\n            \"actigraphy\",\n            \"AlgometRx Nociometer\",\n            \"auditory brainstem response\",\n            \"ATAC-seq\",\n            \"ATPase activity assay\",\n            \"BrdU proliferation assay\",\n            \"CAPP-seq\",\n            \"CUT&RUN\",\n            \"ChIP-seq\",\n            \"Child Behavior Checklist for Ages 1.5-5\",\n            \"Child Behavior Checklist for Ages 6-18\",\n            \"CODEX\",\n            \"confocal microscopy\",\n            \"Corsi blocks\",\n            \"current clamp assay\",\n            \"diffusion MRI\",\n            \"distortion product otoacoustic emissions\",\n            \"DNA optical mapping\",\n            \"ELISA\",\n            \"ERR bisulfite sequencing\",\n            \"EdU proliferation assay\",\n            \"FIA-MSMS\",\n            \"FLIPR high-throughput cellular screening\",\n            \"Fluorescence In Situ Hybridization\",\n            \"Focus group\",\n            \"FTIR spectroscopy\",\n            \"HI-C\",\n            \"HPLC\",\n            \"Interview\",\n            \"ISO-seq\",\n            \"MIB/MS\",\n            \"Matrigel-based tumorigenesis assay\",\n            \"MudPIT\",\n            \"Migration Assay\",\n            \"NIH Toolbox\",\n            \"NOMe-seq\",\n            \"RNA array\",\n            \"RNA-seq\",\n            \"RPPA\",\n            \"Riccardi and Ablon scales\",\n            \"SNP array\",\n            \"SUSHI\",\n            \"Sanger sequencing\",\n            \"Social Responsiveness Scale\",\n            \"Social Responsiveness Scale, Second Edition\",\n            \"T cell receptor repertoire sequencing\",\n            \"TIDE\",\n            \"TMT quantitation\",\n            \"TriKinetics activity monitoring\",\n            \"Von Frey test\",\n            \"active avoidance learning behavior assay\",\n            \"array\",\n            \"atomic force microscopy\",\n            \"autoradiography\",\n            \"bisulfite sequencing\",\n            \"blood chemistry measurement\",\n            \"blue native PAGE\",\n            \"body size trait measurement\",\n            \"bone histomorphometry\",\n            \"brightfield microscopy\",\n            \"cAMP-Glo Max Assay\",\n            \"calcium retention capacity assay\",\n            \"cell competition\",\n            \"cell count\",\n            \"cell painting\",\n            \"cell proliferation\",\n            \"cell viability assay\",\n            \"clinical data\",\n            \"cNF-Skindex\",\n            \"cognitive assessment\",\n            \"combination library screen\",\n            \"combination screen\",\n            \"complex II enzyme activity assay\",\n            \"compound screen\",\n            \"contextual conditioning behavior assay\",\n            \"conventional MRI\",\n            \"Children's Dermatology Life Quality Index Questionnaire\",\n            \"differential scanning calorimetry\",\n            \"dynamic light scattering\",\n            \"electrochemiluminescence\",\n            \"electrophoretic light scattering\",\n            \"elevated plus maze test\",\n            \"FACE-Q Appearance-related Distress\",\n            \"flow cytometry\",\n            \"focus forming assay\",\n            \"functional MRI\",\n            \"gait measurement\",\n            \"gel filtration chromatography\",\n            \"gel permeation chromatography\",\n            \"genotyping\",\n            \"high content screen\",\n            \"high frequency ultrasound\",\n            \"high-performance liquid chromatography/tandem mass spectrometry\",\n            \"immunoassay\",\n            \"immunocytochemistry\",\n            \"immunofluorescence\",\n            \"immunohistochemistry\",\n            \"in silico synthesis\",\n            \"in vitro tumorigenesis\",\n            \"in vivo PDX viability\",\n            \"in vivo bioluminescence\",\n            \"in vivo tumor growth\",\n            \"jumping library\",\n            \"label free mass spectrometry\",\n            \"laser speckle imaging\",\n            \"light scattering assay\",\n            \"liquid chromatography-electrochemical detection\",\n            \"liquid chromatography/mass spectrometry\",\n            \"liquid chromatography/tandem mass spectrometry\",\n            \"lncRNA-seq\",\n            \"local field potential recording\",\n            \"long term potentiation assay\",\n            \"mRNA counts\",\n            \"magnetic resonance angiography\",\n            \"magnetic resonance spectroscopy\",\n            \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n            \"mass spectrometry\",\n            \"massively parallel reporter assay\",\n            \"metabolic screening\",\n            \"methylation array\",\n            \"miRNA array\",\n            \"miRNA-seq\",\n            \"microrheology\",\n            \"Skindex-16\",\n            \"multi-electrode array\",\n            \"nanoparticle tracking analysis\",\n            \"NanoString nCounter Analysis System\",\n            \"n-back task\",\n            \"neuropsychological assessment\",\n            \"next generation targeted sequencing\",\n            \"novelty response behavior assay\",\n            \"open field test\",\n            \"optical tomography\",\n            \"optical coherence tomography\",\n            \"optokinetic reflex assay\",\n            \"oscillatory rheology\",\n            \"oxBS-seq\",\n            \"oxygen consumption assay\",\n            \"pattern electroretinogram\",\n            \"perineurial cell thickness\",\n            \"pharmocokinetic ADME assay\",\n            \"phase-contrast microscopy\",\n            \"photograph\",\n            \"polymerase chain reaction\",\n            \"polysomnography\",\n            \"positron emission tomography\",\n            \"PROMIS Cognitive Function\",\n            \"proximity extension assay\",\n            \"pure tone average\",\n            \"quantitative PCR\",\n            \"questionnaire\",\n            \"reactive oxygen species assay\",\n            \"reporter gene assay\",\n            \"rheometry\",\n            \"ribo-seq\",\n            \"rotarod performance test\",\n            \"sandwich ELISA\",\n            \"scCGI-seq\",\n            \"scale\",\n            \"SaferSeqS\",\n            \"single molecule drug screen assay\",\n            \"single-cell RNA-seq\",\n            \"single cell ATAC-seq\",\n            \"single-nucleus RNA-seq\",\n            \"small molecule library screen\",\n            \"sorbitol dehydrogenase activity level assay\",\n            \"spatial frequency domain imaging\",\n            \"spatial transcriptomics\",\n            \"static histomorphometry\",\n            \"static light scattering\",\n            \"survival\",\n            \"targeted exome sequencing\",\n            \"traction force microscopy\",\n            \"transcranial doppler ultrasonography\",\n            \"twin spot assay\",\n            \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n            \"western blot\",\n            \"whole exome sequencing\",\n            \"whole genome sequencing\",\n            \"whole-cell patch clamp\",\n            \"word recognition score\",\n            \"STR profile\"\n          ],\n          \"title\": \"Assay\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Measurement Technique\",\n        \"type\": \"array\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn4939888\n\n##Development of Patient Reported Outcomes System for Patients with NF1-Associated Plexiform Neurofibromas using Mixed Method Approach\n**Initiative:** PRO\n&nbsp;\n**Name:** Jin-Shei Lai, Ph.D.\n**Contact Email:** js-lai@northwestern.edu \n**Dates:** 2-1-14 to 5-31-18\n**Tumor Focus:** Plexiform Neurofibroma\n**Application:** Clinical Endpoint Tool\n&nbsp;\n**Background:** \nPatient Reported Outcome (PRO) measures assess the treatment outcomes most relevant to patients, and constitute potential outcomes to evaluate in clinical trials. PROs meeting FDA guidelines are critical to ensuring patient-centered endpoints are incorporated. Historically, NF1-associated plexiform neurofibromas (pNF) treatment trials have under-utilized PROs specific to pNF. A psychometrically sound measure incorporating input from patients, families and clinicians, is critical for inclusion in treatment trials. To address the need for a pNF-specific PRO measure for use in clinical trials, this project sought to develop a PRO measurement system utilizing input from patients, families and clinicians, as well as well as psychometric analysis methods to ensure the developed measures are reliable and valid.\n&nbsp;\n**Goals of Project:** \nAdvancing a PRO system for children and young adults with pNF by (1) establishing a conceptual model describing HRQOL, 2) Developing item pools (e.g.,  pain, stigma, and organ dysfucntion measures), 3) Evaluating psychometric properties of the pools, 4) affirming clinical differences.\n&nbsp;\n**Specific Aims:** \n1a. To establish a conceptual model describing health-related quality of life (HRQOL) for patients with pNF across the lifespan via individual interviews with patients, parents, and clinicians. This ensures inclusion of the patient’s voice in future clinical trials. \n1b. To develop item pools based on findings from Aim 1a and literature review. We anticipated that pain, stigma and organ dysfunction measures would be developed, with the possibility of additional domains, some from existing instruments. \n2. To develop a PRO system for patients with pNF across the lifespan by evaluating the psychometric properties of the existing, modified, and newly developed item pools from Aim 1. \n3. To establish clinically important differences (IDs) for the PRO system developed in Aim 2. This will enable evaluation of clinical interventions’ impact upon patient-reported symptoms using clinically-based and psychometrically-sound methodology consistent with FDA guidance for PROs. \n\n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n\n## Tables for Curation\n1. ID: syn65467781\nName: Patient Reported Outcomes Dataset\nSummary:\n- Assays: questionnaire\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: surveyData\n- File formats present: dat, pdf, csv\n- Funders: NTAP\n- Contains data created by: Jin-Shei Lai, Sara Gosline\n- Example files present: ntappeds_finalforanalysis.sas7bdat, NTAP Pediatric PRO Variable Information _ Synapse.pdf, NTAP Adult PRO Variable Information_Synapse.pdf, ntapadult_finalforanalysis.sas7bdat, syn12617093asCSV.csv\n\n\n"}]}]}}
